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Abstract

RACIAL AND ETHNIC DIFFERENCES IN RECEIPT OF IMMEDIATE BREAST
RECONSTRUCTION SURGERY: DO HOSPITAL CHARACTERISTICS MATTER?

By Jaya Khushalani, Ph.D., MHA, MBBS
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of
Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2017
Director: Dr. Jan Clement, Ph.D.
Professor, Department of Health Administration

Immediate Breast Reconstruction Surgery (IBRS) is associated with better psychosocial
and quality of life outcomes for women who undergo mastectomy for breast cancer. In spite of
insurance coverage for IBRS, utilization of IBRS remains low. Not much is known about the
association between hospital and market characteristics where patients receive mastectomy and
receipt of IBRS by the patient. Patient, hospital and market-level data for the years 2010 to 2012
from multiple publicly available sources are used for this study. Findings suggest that higher bed
size, lower racial and ethnic mix, not-for-profit ownership, teaching status, higher market
concentration, higher density of plastic surgeons in the market, and large metropolitan status of
the market are associated with higher likelihood of receipt of IBRS.
Racial and ethnic minorities are less likely to receive IBRS. The role of hospital and
market characteristics in moderating these racial and ethnic differences is not known. A mixed

xvi
effects logistic regression model with interactions between Black/Hispanic race/ethnicity and
hospital and market variables is estimated to examine whether hospital and market characteristics
moderate the relationship between race/ethnicity and receipt of IBRS. Hospitals with higher
proportion of racial and ethnic minority patients in the hospital and hospitals located in markets
with higher density of plastic surgeons and/or higher competition have wider racial and ethnic
gaps in receipt of IBRS.
In order to reduce racial/ ethnic differences in receipt of IBRS, it is important to
understand which factors contribute the most to these differences. Fairlie decomposition models
are estimated to examine the contribution of independent variables to the racial and ethnic
difference in receipt of IBRS. Racial and ethnic differences in being Medicaid insured, residing
in low income neighborhoods and receiving care at minority serving hospitals are the three
biggest contributors to racial and ethnic differences in receipt of IBRS. The results from this
study have significant implications for access to IBRS among racial and ethnic minority patients.
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Chapter 1: Introduction

The Study Problem
Breast cancer is the most common cancer in women, affecting nearly one in eight women
in the United States in their lifetimes (American Cancer Society, 2016). Around 40% of women
with early stages of breast cancer undergo mastectomy (Mahmood et al., 2013). In relation to
other breast cancer treatment modalities like breast conserving surgery, the rate of mastectomy in
women has been on the rise in recent years and is expected to rise in the future. In spite of its
growing frequency, many women believe mastectomy to be a physically and psychologically
disfiguring procedure. In a qualitative study conducted by Piot-Ziegler (2010), 13 out of the 19
women in the sample called mastectomy a mutilation of their body and its integrity (Piot‐Ziegler,
Sassi, Raffoul, & Delaloye, 2010). Around 48% of women who undergo mastectomy are selfconscious about their body image and feel less attractive after a mastectomy (Brandberg et al.,
2008). Rosenberg et al. (2013) found that women face difficulties in intimacy and sexual
relationships after mastectomy and around 10%-25% of women are diagnosed with depression
(Rosenberg et al., 2013).
Change in body image, loss of feminine identity and sexuality, and depression after
mastectomy can have far reaching impacts on various areas of a woman’s psychosocial
functioning, including their identity, confidence, mood, esteem, sexuality, self-satisfaction, and
quality of life (Heidari, Shahbazi, & Ghodusi, 2015). Meyer and Aspegren (1989) found adverse
long term psychological sequelae for women undergoing mastectomy (Meyer & Aspegren,
1
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1989). Given that 27% of these women undergoing mastectomy are less than 50 years of age,
their long term psychosocial status and quality of life are an important concern (American
Cancer Society, 2016).
Breast reconstruction surgery (BRS) is procedure to reconstruct the breast after it has
been removed during mastectomy. BRS is an important component of overall breast cancer
treatment. It improves psychosocial and quality of life outcomes for women who undergo
mastectomy (Al-Ghazal, Fallowfield, & Blamey, 2000; Nicholson, Leinster, & Sassoon, 2007;
Rubino, Figus, Lorettu, & Sechi, 2007). Clinical guidelines recommend that BRS should be
offered to all women who undergo mastectomy (National Comprehensive Cancer Network,
2007). BRS can be initiated at the time of mastectomy (immediate breast reconstruction) or it can
be done at a later date after the mastectomy and adjuvant therapy (delayed breast reconstruction).
Immediate breast reconstruction surgery (IBRS) is associated with better esthetic results and
greater psychosocial benefits for the patient as compared to delayed reconstruction (Al-Ghazal,
Sully, Fallowfield, & Blamey, 2000; Schain, Wellisch, Pasnau, & Landsverk, 1985; Wellisch,
Schain, Noone, & Little Iii, 1985).
Recognizing the benefits of BRS, the federal government enacted the Women’s Health
and Cancer Rights Act (WHCRA) in 1998 mandating that group health plans, health insurance
companies, and HMOs that cover mastectomy, must also provide coverage for BRS (American
Cancer Society, 2014). In addition, certain states have enacted laws that ensure that the state
Medicaid covers BRS (Centers for Disease Control and Prevention, 2000; Yang, Newman,
Reinke, et al., 2013). In spite of the benefits of IBRS and the federal and state mandates for its
coverage, the rate of IBRS still remains between 20-40% depending on the composition of the
cohort being analyzed (C. R. Albornoz et al., 2013; Jagsi et al., 2014; Yang, Newman, Lin, et al.,
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2013). Several studies have evaluated factors that inﬂuence receipt of IBRS (Brennan &
Spillane, 2013; Nelson, Nelson, Tchou, Serletti, & Wu, 2012). However, most studies evaluate
patient-level factors. Very few studies have examined the association between the receipt of
IBRS and hospital and market characteristics (Hershman et al., 2012; Onega et al., 2014). This
study examines the association between receipt of IBRS and hospital and market characteristics
selected based on a theoretical framework created using Resource Dependence Theory.
Uptake of IBRS after mastectomy remains low among certain patient populations,
especially among racial and ethnic minorities. Black and Hispanic women are less likely to
receive IBRS as compared to Non-Hispanic White women even after controlling for clinical
characteristics (Agarwal, Pappas, Neumayer, & Agarwal, 2011; Alderman, McMahon, &
Wilkins, 2003; Christian et al., 2006; Enewold et al., 2014; Hershman et al., 2012; In et al., 2013;
Iskandar et al., 2015; Kruper, Holt, et al., 2011; Lang et al., 2013; Mahmoudi, Giladi, Wu, &
Chung, 2015; Maly, Liu, Kwong, Thind, & Diamant, 2009; Miller & Chandru Kowdley, 2012;
Morrow et al., 2005; Offodile, Tsai, Wenger, & Guo, 2015; Reuben, Manwaring, & Neumayer,
2009; Rosson, Singh, Ahuja, Jacobs, & Chang, 2008; Sisco et al., 2012; J. F. Tseng et al., 2004;
Yang, Newman, Lin, et al., 2013; Yang, Newman, Reinke, et al., 2013). Racial and ethnic
differences in receipt of IBRS have been found consistently in literature across time, data sets
and regions. The paradigm of disparities research has moved from Stage 1—demonstrating
presence of disparities— to Stage 2—explaining the causes of disparities— and Stage 3—
reducing disparities with focused interventions (Kilbourne, Switzer, Hyman, Crowley-Matoka, &
Fine, 2006). However, research on racial and ethnic differences in IBRS is still in Stage 1 of the
disparities research paradigm.
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Thus, there is a critical gap in literature regarding the factors contributing to racial and
ethnic differences in IBRS. Examining the causes of racial and ethnic differences in IBRS is an
important intermediary step in targeting policy interventions aimed at reducing racial and ethnic
differences. Addressing factors at the hospital and market level in addition to those on the patient
level that contribute to racial disparities is important in order to identify policies that best target
racial and ethnic differences in receipt of IBRS. This study examines whether characteristics of
the hospital and hospital market where mastectomy is received moderate the relationship
between race/ethnicity and receipt of IBRS.
In order to generate policy recommendations to address racial and ethnic differences in
receipt of IBRS, it is important to determine the magnitude of contribution of racial/ethnic
differences in patient-level, hospital-level and market-level factors to the racial and ethnic
differences in receipt of IBRS. This information helps in prioritizing policy efforts towards
those factors that have the largest impact on reducing racial and ethnic differences in receipt of
BRS.
Research Questions
This dissertation aims to answer the following research questions:
1) Which characteristics of the hospital and hospital market where mastectomy is received are
associated with higher likelihood of receipt of immediate breast reconstruction surgery
(IBRS)?
2) Is the relationship between race/ethnicity and likelihood of receipt of IBRS moderated by
hospital and market characteristics?
3) Which patient, hospital and market-level characteristics contribute the most to the racial and
ethnic differences in receipt of IBRS?

4
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Conceptual Framework
This study combines the Aday Andersen framework of health service utilization with
Resource Dependence Theory. This study uses the Aday Andersen framework to conceptualize
how health policy at the federal and state level influence the health care delivery system (hospital
and market characteristics and resources) and the population (patient characteristics) and,
ultimately, receipt of immediate breast reconstruction surgery (Aday & Andersen, 1974). Receipt
of IBRS incorporates two separate components—1) IBRS is offered by the health care system
where the patient receives care and 2) IBRS is accepted by the patient. The patient-level and
policy-level factors included in the statistical model are selected based on the Aday Anderson
framework.
Resource Dependence Theory (RDT) (Pfeffer & Salancik, 1978) is used to determine the
hospital and market characteristics that are associated with a hospital offering IBRS services.
These RDT derived hospital and market characteristics are then embedded within the larger
Aday Andersen framework of health service utilization. Hypotheses for research question 1 are
derived based on the conceptual framework created using Resource Dependence Theory. Since
research questions 2 and 3 are predominantly exploratory in nature, no hypotheses are specified a
priori for these questions.
Scope and Approach
The study sample is comprised of women between 30 to 80 years of age who received a
mastectomy for breast cancer in hospitals located in Arizona, California, Florida, Kentucky,
Maryland, New Jersey, New York, North Carolina and Washington from 2010-2012. Women
with secondary metastases or previous history of breast cancer are excluded from the sample
along with women who received care at government hospitals that are not open to the general
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public. The sample is identified from the Healthcare Cost and Utilization Project (HCUP) State
Inpatient Databases (SID) and the California Office of Statewide Health Planning and
Development (OSHPD) inpatient database.
The dependent variable is receipt of immediate breast reconstruction surgery identified as
the presence of ICD-9 procedure codes for mastectomy along with ICD-9 procedure codes for
reconstruction surgery or placement of tissue expanders within the same discharge record.
Hospital-level independent variables are obtained from the American Hospital Association
(AHA) database and the Center for Medicare and Medicaid Services Hospital Cost Report
(CMS-HCR) whereas market characteristics are obtained from the Area Health Resource File
(AHRF).
A retrospective pooled cross-sectional design is used to examine the relationship between
hospital and market characteristics and receipt of IBRS. Owing to the nested nature of the model,
a mixed effects logistic regression is used to examine the hypotheses derived from research
question 1. For research question 2, the same mixed effects logistic regression from research
question 1 is used with the addition of interaction terms between race and hospital/market
characteristics. Lastly, Fairlie decomposition model is used to address research question 3.
Study Contribution
This study extends prior work examining the association between hospital characteristics
and receipt of IBRS by examining a wider set of hospital and market characteristics than
previous research (Hershman et al., 2012; Onega et al., 2014). These characteristics are chosen
based on a theoretical framework derived using Resource Dependence Theory, an organizational
theory that has been used in previous research to explain the relationship between a hospital’s
resources and constraints, and provision of a service (Banaszak-Holl, Zinn, & Mor, 1996). This
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study also extends prior work by examining whether such theory-based hospital and market
characteristics moderate the relationship between race and IBRS.
To the author’s knowledge, this is the first study to use decomposition methods to
examine the contribution of racial and ethnic differences in patient-level, hospital-level and
market-level factors towards racial and ethnic differences in receipt of IBRS. Findings from this
paper can help guide policy makers towards addressing higher-level hospital and market level
factors which have the potential of improving access to breast reconstruction for a larger number
of racial and ethnic minority patients as compared to addressing patient-level factors alone.
Policy efforts focused on changing factors at higher levels are likely to bring about larger and
more sustained effects in reducing racial and ethnic differences in receipt of IBRS.
Organization of Remaining Chapters
In Chapter 2, a review of literature relevant to the research questions in this study is
presented. In Chapter 3, the conceptual frameworks that guide this study and the testable
hypotheses generated from these frameworks are described. This is followed by an overview of
the research methodology for this study in Chapter 4. Chapter 4 includes the data sources, study
population, and analytical approaches used in this study. In Chapter 5, the results of descriptive
and statistical analyses are presented. In Chapter 6, the results of this study are summarized
followed by a discussion of their implications for policy and practice. Lastly, the limitations of
this study and avenues for future research are also presented in Chapter 6.
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Chapter 2: Literature Review

Overview of Chapter Structure
The purpose of this chapter is twofold. The first purpose is to provide background
information regarding surgical treatment options for breast cancer, especially breast
reconstruction. The second purpose of this chapter is to provide an overview of empirical
literature and establish gaps in the literature addressed by this study.
This chapter begins with a description of surgical treatment options for breast cancer: a)
breast conserving surgery; b) mastectomy alone; c) mastectomy with reconstruction. Next, the
timing and types of breast reconstruction is described. This is followed by a discussion of federal
and state policies related to breast reconstruction surgery. Empirical research literature that
examines links between hospital and market-level factors and the receipt of IBRS is then
described. This is followed by a summary of the gaps in literature addressed by research question
1. Next, an overview of the relationship between race/ethnicity and receipt of IBRS is presented.
Subsequently, the role of hospital and market characteristics in mitigating or exacerbating racial
and ethnic differences in receipt of IBRS is presented followed by a discussion of the gaps in
literature addressed by research question 2. Lastly, a summary of patient-level control variables
associated with receipt of IBRS is presented followed by a summary of the gaps in literature
addressed by research question 3.
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Surgical Treatment of Breast Cancer
Surgical treatment options for breast cancer include breast conserving surgery (BCS) also
known as lumpectomy, mastectomy alone or mastectomy with breast reconstruction surgery
(BRS).
Breast conserving surgery.
Breast conserving surgery (BCS) involves the removal of the tumor and a surrounding
margin of tissue whereas mastectomy involves removal of the entire diseased breast. Since BCS
is a conservative procedure, it is usually followed by radiation therapy to ensure that no cancer
cells are left behind after the surgery. For early stages of breast cancer, survival rates are similar
for mastectomy or BCS followed by radiation therapy (Jacobson et al., 1995). Recognizing that
BCS is safe and a more conservative option than mastectomy, the National Institutes of Health
(NIH) Consensus Development Conference on Treatment of Early-Stage Breast Cancer
recommended BCS for the majority of women with stage I or II breast cancer (National Institutes
of Health Consensus Development Panel, 1992). BCS is the predominant type of surgery for
early breast cancer (Lazovich, Solomon, Thomas, Moe, & White, 1999). However, the rates of
BCS have been falling in the recent years due to an increase in rates of mastectomy with and
without reconstruction.
Mastectomy.
Mastectomy was the most common surgical treatment option for breast cancer from its
origin in 1800s to 1980s. It involves removal of the entire diseased breast along with surrounding
lymph nodes and tissues depending on the type of mastectomy performed. Since the 1980s, BCS
has replaced mastectomy as the predominant surgical option for early stage breast cancer. This
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led to a decline in mastectomy rates. However, in the past decade, mastectomy rates began to rise
(Dragun, Huang, Tucker, & Spanos, 2012).
Kummerow et al. (2015) found that between 2003 and 2011, the number of women with
early stage cancers who chose mastectomy increased by 34%. The observed increase in
mastectomy rates is largely attributable to a rise in bilateral mastectomy from 5.4% of
mastectomies in 1998 to 29.7% in 2011, with a concurrent increase in reconstructive procedures
in their sample from 36.9% to 57.2% during the same time period. Bilateral mastectomy is
performed in cases of unilateral breast cancer as a prophylactic measure. It is also known as
contralateral prophylactic mastectomy (CPM) in literature. Similar results have been seen in
other studies (Dragun et al., 2013; Kurian et al., 2014; Tuttle, Habermann, Grund, Morris, &
Virnig, 2007). This trend is not well understood by practitioners and researchers since BCS is the
recommended procedure for early stage breast cancer cases.
Increased rates of bilateral mastectomy could be due to patient’s fear of cancer recurrence
in the contralateral breast (Dragun et al., 2013; Kurian et al., 2014; Tuttle et al., 2007). The rise
of bilateral mastectomies could also be explained by higher rates of genetic testing and celebrity
endorsements (for example, Angelina Jolie) of bilateral mastectomy (Tuttle et al., 2007; Wong et
al., 2016). Some practitioners also cite patient desire for better breast symmetry after bilateral
mastectomy followed by breast reconstruction as an explanation for the trend towards higher
bilateral mastectomies (Hawley et al., 2014; Rizki, Nkonde, Ching, Kumiponjera, & Malata,
2013).
Esthetic outcomes after reconstruction are better among women who receive a bilateral
mastectomy as compared to unilateral mastectomy (Kroll et al., 1994). A certain degree of breast
asymmetry is also observed after BCS where a larger portion of the breast is removed (Waljee et

10

11
al., 2008). Reconstruction although possible, is trickier in BCS cases due to the radiation therapy
(Slavin & Halperin, 2004). These may be some of the reasons why certain researchers attribute
the desire for BRS as a contributory factor for the rise in mastectomy rates.
Mastectomy with breast reconstruction surgery.
Breast reconstruction surgery (BRS) refers to the gamut of procedures wherein the breast
mound and the nipple-areolar complex can be surgically reconstructed after mastectomy to
match the appearance of the removed breast/breasts. Although BRS can be performed in cases of
BCS, the reconstructive procedures employed for BCS patients are very different than those for
mastectomy patients and are performed less commonly (González, 2013). Thus, for the purpose
of this study, the focus is only on BRS after mastectomy.
BRS after mastectomy is associated with a number of psychosocial and quality of life
benefits as compared to mastectomy alone. Al-Ghazal et al. (2000) found that anxiety,
depression, issues related to sexuality, lower self-esteem and poor body image were less likely in
women who underwent breast reconstruction as compared to women who underwent
mastectomy alone (Al-Ghazal, Fallowfield, et al., 2000). Nicholson et al. (2007) using patient
reported satisfaction measures found that patients who had undergone BRS after mastectomy
gave themselves significantly higher scores for cosmetic outcome, overall body satisfaction and
breast satisfaction scores in comparison with patients who had undergone mastectomy alone
(Nicholson et al., 2007). Rubino et al. (2007) demonstrated that women who underwent BRS
after mastectomy had higher levels of social adaptation, quality of social relationships, quality of
life and lower likelihood of depression when compared to women who underwent mastectomy
alone (Rubino et al., 2007).
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BRS is considered to be a safe and well tolerated procedure after mastectomy in early
stage cancer patients (Saha et al., 2013). Clinical guidelines recommend that BRS should be
offered to all patients undergoing mastectomy if there are no clinical contraindications, and the
type and timing of breast reconstruction should be decided by the patient and physician based on
patient characteristics and preferences (National Comprehensive Cancer Network, 2007).
The rate of BRS has increased over time. Using data from the National Inpatient Sample
(NIS) from 1998 to 2008, Albornoz et al. (2013) found a 78% increase in rates of U.S.
immediate breast reconstruction from 20.8% in 1998 to 37.8% in 2008, with an average increase
of 5 percent per year (C. R. Albornoz et al., 2013). Similarly, Jagsi et al. (2014) in their study of
the employment-based MarketScan Commercial Claims and Encounters database found that rate
of BRS increased from 46% in 1998 to 63% in 2007 (Jagsi et al., 2014). Variations in rates of
breast reconstruction across datasets are due to the characteristics (age, region, facility,
insurance, etc.) of the cohort.
Timing of reconstruction.
BRS can be done at the time of mastectomy under the same anesthetic; it is also known
as immediate reconstruction. Alternatively, breast reconstruction can be done months or even
years after the mastectomy; it is called delayed breast reconstruction. Reconstruction may be
delayed either to allow for completion of adjuvant therapy (chemotherapy and/or radiation
therapy) or because the patient may not be prepared or even knowledgeable about immediate
breast reconstruction. Radiation therapy can have negative esthetic effects on breast
reconstruction and is an important factor to be considered regarding timing of BRS. A new
method involves placing a tissue expander under the skin of the breast at the time of mastectomy
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which can be replaced at a later date by an implant or patient’s own tissue (autologous flap). This
is known as the immediate delayed method or 2-stage method. In cases where patients need to
undergo post mastectomy radiation, the immediate delayed or 2- stage method is preferred to
immediate reconstruction in order to avoid complications (BreastCancer.org, 2015c).
A number of research studies suggest that all else being equal, immediate and immediatedelayed breast reconstruction surgery lead to better esthetic results compared to delayed
reconstruction (Al-Ghazal, Sully, et al., 2000; Schain et al., 1985; Wellisch et al., 1985) due to
the availability of more native breast skin is to envelope the reconstructed breast. The advantages
of immediate breast reconstruction are more than just esthetic. Immediate breast reconstruction
may have greater psychosocial benefits for patients compared with delayed reconstruction since
the patient wakes up after the mastectomy with a reconstructed breast mound and does not have
to live with the deformity arising from a full mastectomy for any period (Stevens et al., 1984).
Al-Ghazal et al. (2000) compared 38 immediate breast reconstruction patients with 83 delayed
reconstruction patients and showed that immediate reconstruction patients had significantly
better body image and self-esteem whereas delayed reconstruction patients felt significantly
greater anxiety, depression, and impairment of their sexual attractiveness (Al-Ghazal, Sully, et
al., 2000). Immediate breast reconstruction is also more cost-effective as compared to delayed
breast reconstruction. In a retrospective study of 276 patients conducted at the MD Anderson
institute, 57 patients who had a mastectomy followed by a separate surgery for delayed breast
reconstruction had 62% higher mean cost to the hospital as compared to the 219 patients who
had immediate breast reconstruction (Khoo et al., 1998).
Immediate reconstruction is associated with higher incidence of complications as
compared to delayed reconstruction. Major et al. (2016) in their study of 1408 diabetic women
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found that the odds of developing 30-day overall complications were significantly higher for the
immediate reconstruction as compared with the delayed reconstruction cohort (Major et al.,
2016). The best timing for breast reconstruction is arrived at by consideration of the advantages
and disadvantages of immediate and delayed breast reconstruction, as well as the circumstances
of the individual patient (Chevray, 2008).
For this study, the definition of breast reconstruction surgery is restricted to immediate
and immediate delayed or 2-stage reconstruction surgery, collectively called immediate breast
reconstruction surgery (IBRS) henceforth. Women who may or may not have received a delayed
reconstruction at some point are included in the no reconstruction group. Immediate
reconstruction is performed more often than delayed breast reconstruction. Nearly 75-80% of all
reconstructions performed are immediate or immediate-delayed and this number is gradually
increasing with increasing awareness regarding immediate breast reconstruction (Jagsi et al.,
2014; Khoo et al., 1998; Robb, 2007).
Types of breast reconstruction.
IBRS can be done using implants or patient’s own tissue (also known as autologous
surgery) or both.
Implant reconstruction.
Reconstruction with implants is a shorter and less complex surgery as compared to
autologous surgery. It also avoids donor site (site from which patient’s own tissue is obtained
such as abdomen, back, glutes or thighs) complications that may include scarring, wound
complications, muscle weakness and hernia, etc. Implants are better for thinner women with
inadequate tissue deposits on their abdomen, back, glutes or thighs.
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Implants can be either silicon or saline. While silicone implants feel more like real breast
tissue, there is a risk of silicone implants bursting underneath the breast skin. Silicone cannot be
spontaneously absorbed within the body, unlike saline implants. Thus, placement of silicone
implants requires patients to receive regular MRIs in order to assess whether the silicone implant
has ruptured. In addition to rupture, side effects common to saline and silicone implants include
implant extrusion or capsular contracture. Implants do not last for the lifetime of a patient and
repeat surgery is needed to replace the implant after around 10 years.
Autologous reconstruction.
Reconstruction using patient’s own tissue can be done via two methods: a) fat grafting
and b) flap reconstruction. In fat grafting, fat tissue is removed from other parts of the (mainly
abdomen, glutes or thighs) by liposuction. The tissue is then processed into liquid and injected
into the breast area to recreate the breast. Fat grafting is still a relatively new procedure and no
large clinical studies have been done on the procedure. Although fat grafting is a relatively safer
procedure, its effectiveness may be low because the fat injected into the breast area may be
reabsorbed by the body over time and the breast may lose some volume (BreastCancer.org,
2015b).
Flap reconstruction can be done using a pedicled flap or a free flap. When the tissue flap
from the abdomen or back can remain attached to its original blood vessels and moved under the
skin to the chest area, it is referred to as a pedicled flap. On the other hand, when the tissue (from
the abdomen or back or thighs or buttocks) is completely separated from its original blood
vessels and picked up and moved to its new place in the chest, it is known as a free flap. In both
types, the tissue is formed into the shape of a breast and stitched into place. Commonly used
flaps are pedicled or free Transverse Rectus Abdominis Myocutaneous (TRAM) flap from the
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abdomen region, Deep Inferior Epigastric Perforator (DIEP) flap which is an abdominal free flap
most commonly used for reconstruction and a latissimus dorsi flap which may be free or
pedicled tissue taken from the back area. Autologous flap reconstruction surgery is longer, more
complex and may lead to donor site morbidity. However, flaps tolerate radiation better than
implants and do not need to be replaced after a few years (BreastCancer.org, 2015a).
Rates of implant and autologous reconstruction.
In a study of 439 patients who underwent implant or autologous flap reconstruction at a
single academic institution between 1999 to 2006, Yueh et al. (2010) found that autologous flap
reconstruction had significantly higher general and aesthetic satisfaction than implant-based
reconstruction (Yueh et al., 2010). In another study of 64 patients who underwent reconstruction
at a single institution in 2004, Tønseth et al. (2008) found that more patients in the autologous
reconstruction (with DIEP free flap) group were satisfied with the appearance of their breast and
reported an improved social relationship, and fewer patients were sad about their body image
after reconstruction than in the implant group (Tønseth, Hokland, Tindholdt, Åbyholm, &
Stavem, 2008).
According to Albornoz et al. (2013), autologous reconstructions were more frequent
compared with implant reconstructions in 1998; however, after 2002, the relationship switched
after concerns related to safety of implants were addressed. By 2008, immediate implant
reconstructions outnumbered autologous reconstructions by a ratio of 2:1 (C. R. Albornoz et al.,
2013). Similarly, Jagsi et al. (2014) in their study of the employment-based MarketScan
Commercial Claims and Encounters database observed that the proportion of autologous
reconstructions reduced from 56% in 1998 to 25% in 2007 (Jagsi et al., 2014).
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In spite of superior results, autologous flap reconstruction surgeries are being less
frequently performed now than implant surgery. This is mainly driven by patients’ desire for less
complex procedures and the increased acceptance of implants. But there are a number of
systemic factors that explain the decreasing popularity of autologous surgery. Autologous flap
reconstruction requires special surgical techniques, including microsurgery to reattach the flap’s
blood vessels after it is placed in the chest, and not all surgeons have experience with
microvascular flap reconstruction. Thus, certain hospitals in underserved regions may be unable
to provide flap reconstruction. In addition, the cost of autologous surgery to the hospital is higher
than that for implants (Alderman, Storey, Nair, & Chung, 2009). In a study of three academic
medical centers in the United States (US) and Canada, Matros et al. (2015) found that the cost
for unilateral DIEP flap was 75,184 US$ whereas the cost for a unilateral implant surgery was
53,571 US$ (Matros et al., 2015). Other studies have reported similar findings for other flaps
(Grover, Padula, Van Vliet, & Ridgway, 2013; Spear, Mardini, & Ganz, 2003). In spite of the
significantly higher costs of autologous surgery, the reimbursement for autologous surgery is
only slightly higher than that for implants with a 534 US dollar difference in Medicare
reimbursement for the two procedures in 2010 (Hernandez‐Boussard, Zeidler, Barzin, Lee, &
Curtin, 2013). Hernandez-Boussard et al. (2013) found that Medicare reimbursements for
autologous reconstruction have significantly decreased by 17% from 2000 to 2010 whereas
reimbursements for implants remained nearly unchanged (Hernandez‐Boussard et al., 2013).
This corresponds with the decrease in frequency of autologous reconstructions during the same
time period. In a study by Kulkarni et al. (2013), 63% of the plastic surgeons surveyed cited low
reimbursement as a barrier for performing autologous reconstruction (Kulkarni, Sears, Atisha, &
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Alderman, 2013). Thus, in spite of higher patient satisfaction with the procedure as compared to
implants, autologous reconstruction is less likely to be performed.
For the purpose of this study, separate supplemental analyses are conducted for type of
IBRS (autologous reconstruction vs implant reconstruction) for all three research questions in
this study.
Health Policy Related to Breast Reconstruction Surgery
Federal health policies have been enacted to increase access to BRS after mastectomy.
Recognizing that BRS is an integral part of breast cancer treatment, the federal government
enacted The Women’s Health and Cancer Rights Act (WHCRA) in 1998 (American Cancer
Society, 2014). It is also known as Janet’s law, named after Janet Franquet who was denied
reconstructive surgery after a mastectomy in 1997. The law requires that all sponsored group
health plans, insurance companies, individual policies and health maintenance organizations
offering medical and surgical benefits for a mastectomy must also offer coverage for
reconstructive surgery (including implants) in a manner determined in consultation with the
attending physician and the patient. WHCRA ensures that insurance coverage by the above
entities includes reconstruction of the breast on which the mastectomy was performed along with
surgery and reconstruction of the other breast to produce a symmetrical appearance. The act
requires that benefits paid for reconstruction are at the same level as benefits paid for other
health services covered under the plan. The WHCRA also requires insurers to inform the
enrollees about the WHCRA provision at the time of enrollment and annually thereafter. The
WHCRA does not apply to plans that do not provide coverage for mastectomy. It also does not
apply to patients covered by Medicare or Medicaid (American Cancer Society, 2014).
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Other federal laws applicable to BRS include the recently passed Breast Cancer Patient
Education Act of 2015. The Breast Cancer Patient Education Act requires the Secretary of
Health and Human Services to plan and implement an education campaign to inform breast
cancer patients about the availability and coverage of breast reconstruction and other available
alternatives post-mastectomy. Educational materials created by the Secretary of Health and
Human Services will inform women of their right to breast reconstruction under federal law (the
WHCRA) and provide women with information about when breast reconstruction or prostheses
may be appropriate within their recovery plan. This act is aimed at raising awareness regarding
BRS options especially among the underserved (The Breast Reconstruction Awareness
Campaign, 2016).
Federal policy has had mixed success in increasing access to breast reconstruction
surgery. According to a study by Alderman and Wilkins using the Surveillance, Epidemiology,
and End Results (SEER) database, reconstruction rates did not increase significantly immediately
after the WHCRA-- i.e. from 2000-2002. They also found that racial disparities in receipt of BRS
did not decline significantly after the WHCRA (Alderman, Wei, & Birkmeyer, 2006). Since
2002, a number of studies have shown that rates of breast reconstruction have increased
significantly. The WHCRA has been credited for this increase in breast reconstruction rates.
Despite the increase in reconstruction rates, only 30-40% of the women receive breast
reconstruction surgery after mastectomy (Alderman et al., 2006). Thus, there is a need for better
understanding of factors associated with receipt of BRS in order to direct policy effort since
current policies have been unable to increase utilization of BRS beyond 40% (Alderman et al.,
2006). Additionally, racial disparities have not significantly declined even a decade after the
WHCRA (Shippee, Kozhimannil, Rowan, & Virnig, 2014; Yang, Newman, Reinke, et al., 2013).
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Thus, there is a need to understand factors that contribute to racial and ethnic differences in
receipt of BRS. In the next section, empirical literature that examines factors associated with
BRS is summarized followed by a review of literature on racial and ethnic differences in receipt
of BRS and its likely causes. It is important to note that although the focus of this study is only
on IBRS, existing literature summarized in the next section often combines IBRS and delayed
reconstruction or in some cases, the authors do not specify the timing of reconstruction included
in their study. Thus, while summarizing previous literature, the term breast reconstruction or
BRS is used instead of IBRS.
Empirical Research Concerning Factors Associated with Receipt of BRS
There is a large body of empirical literature on factors associated with receipt of BRS,
most of which focuses on patient-level clinical and sociodemographic factors. While addressing
individual-level factors is important, change at the health system level has the potential to impact
a much larger number of patients. Thus, it is important to understand and address hospital and
market characteristics associated with receipt of BRS. Few studies have examined the
association between the receipt of breast reconstruction and hospital and market characteristics
(Hershman et al., 2012; Onega et al., 2014). The studies that do examine hospital and market
characteristics in relation to receipt of BRS are neither representative of the patient population
nor of the hospitals in the United States (Hershman et al., 2012; Onega et al., 2014). Thus, there
is a need to understand the gaps in literature on the relationship between hospital and market
characteristics and receipt of BRS and address them. This section begins with a summary of the
literature that examines hospital- and market-level characteristics related to receipt of BRS.
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Hospital-level and market-level factors.
Hospital characteristics associated with patient’s receipt of breast reconstruction that have
been examined in earlier empirical studies include: volume of breast reconstruction performed in
the hospital, academic/teaching status of the hospital, National Cancer Institute (NCI) cancer
center designation of the hospital, safety net status of the hospital, cooperative oncology group
participation, bed size and density of plastic surgeons in the hospital. Hospital and market
characteristics that have been examined in relation to patient’s receipt of BRS are rurality and
region. The literature examining these factors is summarized below.
A high volume of breast reconstructions performed in the hospital where a patient
receives mastectomy is associated with higher likelihood of the patient receiving BRS
(Hershman et al., 2012; Onega et al., 2014). Of all hospital characteristics examined, the
academic/teaching status of the hospital is most frequently studied in association with patient
receipt of BRS. According to the American Hospital Association (AHA), a hospital is recognized
as a teaching/academic center if it is recognized for one or more Accreditation Council for
Graduate Medical Education accredited programs or it reported a medical school affiliation to
American Medical Association or lastly, if it is a member of Council of Teaching Hospital of the
Association of American Medical Colleges (COTH) (American Hospital Association, 2014).
Patients receiving mastectomy at teaching hospitals are 1.5 to 3 times more likely to receive
BRS, especially immediate breast reconstruction (Agarwal et al., 2015; Hershman et al., 2012; In
et al., 2013; Kruper, Holt, et al., 2011; Kruper, Xu, Henderson, & Bernstein, 2011; Kruper, Xu,
Henderson, Bernstein, & Chen, 2013; Onega et al., 2014; Reuben et al., 2009; Shippee et al.,
2014; Sisco et al., 2012).
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A patient receiving mastectomy at a hospital designated as a National Cancer Institute
comprehensive cancer center has nearly 2 times higher odds of receiving BRS as compared to
patients receiving mastectomy at non-NCI designated cancer centers (In et al., 2013; Kruper,
Holt, et al., 2011; Kruper, Xu, et al., 2011; Kruper et al., 2013). NCI designated cancer centers
are recognized for their scientific leadership, resources, and the depth and breadth of their
research. There are currently 47 NCI designated cancer centers in the United States that form the
backbone of NCI’s programs for studying and controlling cancer (National Cancer Institute,
2016). A patient receiving mastectomy at a hospital that is a participant in a cooperative
oncology group has higher likelihood of receiving BRS as compared to patients receiving
mastectomy at hospitals that are not part of cooperative oncology groups (In et al., 2013; Onega
et al., 2014).
Onega et al. (2014) found that likelihood of receiving BRS is not significantly different
among patients who receive care at safety net hospitals compared to patients who receive
mastectomy at non-safety net hospitals (Onega et al., 2014). Bed size of the hospital where
patient receives mastectomy is associated with receipt of BRS by the patient. Compared to
patients who receive mastectomy at hospitals with less than 400 beds, patients who receive
mastectomy at hospitals with 400-600 beds have higher likelihood of receiving BRS (In et al.,
2013; Shippee et al., 2014). Density of plastic surgeons in the hospital where a patient receives
mastectomy is associated with receipt of BRS. An additional reconstruction surgeon per 100
annual breast procedures in a hospital where a patient receives surgical treatment for breast
cancer is associated with higher odds (OR: 1.38, 95% confidence interval: 1.29-1.59) of receipt
of reconstruction as compared to breast surgery procedures without reconstruction (C. C.
Greenberg et al., 2011).
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Lastly, urbanicity of the county where patients receive mastectomy is associated with
higher odds of receipt of BRS by the patient. Patients receiving mastectomy at urban hospitals
are 2 to 4 times more likely to receive immediate breast reconstruction as compared to patients
receiving mastectomy at rural hospitals (Hershman et al., 2012; Onega et al., 2014; Reuben et al.,
2009; Shippee et al., 2014). This may be explained by regional referral patterns, availability of
reconstructive surgeons, financial incentives and patient preferences (Alderman et al., 2003).
The region where patients receive mastectomy is also associated with odds of receipt of
BRS by the patient. Patient receiving mastectomy at hospitals located in the south and northeast
are more likely to receive BRS (OR: 1.28, 95% confidence interval: 1.21-1.35) as compared to
patients receiving mastectomy at hospitals located in midwest or west regions (Reuben et al.,
2009). This could be because hospitals in the south were pioneers of breast reconstruction
surgery (Reuben et al., 2009). Hospitals in the northeast are more likely to provide BRS because
major academic health care centers are located in the northeast (Hershman et al., 2012).
Aside from the characteristics of a hospital’s immediate market, state-level policy
characteristics are also associated with a patient’s receipt of IBRS. Policies, practice and referral
patterns related to breast reconstruction differ across states. For example, in New York and
Texas, it is mandatory for the breast surgeon to discuss reconstruction options with all patients
(Mahmoudi et al., 2015). Additionally, certain states like Pennsylvania ensure additional
coverage beyond the Women’s Health and Cancer Rights Act (WHCRA) for BRS for Medicaid
patients (Centers for Disease Control and Prevention, 2000; Yang, Newman, Lin, et al., 2013).
Mahmoudi et al. (2015) and Yang et al. (2013) found that discussing BRS options with patients
and expanding Medicaid coverage for BRS increased odds of receiving BRS for breast cancer
patients.
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Of all the literature reviewed for the purpose of this study, only a few papers examine the
association between hospital or market level factors with patient receipt of breast reconstruction
surgery. The majority of the papers include only few hospital-level controls such as teaching
status and NCI designation (In et al., 2013; Kruper, Holt, et al., 2011; Kruper, Xu, et al., 2011;
Kruper et al., 2013; Morrow et al., 2005; Reuben et al., 2009). Only two studies examine a
broader range of hospital and market characteristics. However, these two studies suffer from
certain limitations. Onega et al. only examine elderly patients with Medicare insurance whereas
Hershman et al. use a voluntary hospital database (with predominantly (>90%) urban hospitals
(Hershman et al., 2012; Makadia & Ryan, 2014; Onega et al., 2014). Thus, neither of these
studies are representative of the US population. This study aims to address this gap by including
patients between 30 to 80 years of age with all types of insurance and by including all hospitals
in the 8 states included in the study. Additionally, these two studies do not include important
hospital characteristics such as racial and ethnic mix, payer mix and financial performance, and
market characteristics such as competition, that are known to be associated with provision of
expensive and complex healthcare services. This study aims to address this gap by including
these additional hospital and market-level characteristics that are known to be related to service
provision. In all the literature on breast reconstruction, there is scarce discussion regarding a
theoretical framework for the choice of hospital and market-level factors that were examined.
This study aims to address this gap by using Resource Dependency Theory to derive hospital and
market characteristics that play a role in the receipt of IBRS. Thus, the first research question is:
RQ1. Which characteristics of the hospital and hospital market where mastectomy is
received are associated with higher likelihood of receipt of immediate breast reconstruction
surgery (IBRS)?
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Although the focus of Research Question 1 is on hospital and market characteristics,
receipt of a treatment modality is a patient-level outcome. Hence, it is important to include a
number of patient-level control variables while examining research question 1. In the next
section, summary of patient-level clinical and sociodemographic factors known to be associated
with receipt of immediate breast reconstruction surgery is provided. This is followed by an indepth review of the relationship between race and ethnicity, a patient-level sociodemographic
factor associated with receipt of immediate breast reconstruction surgery since research question
2 and 3 focus on racial and ethnic difference in receipt of IBRS.
Patient-level control variables.
Patient-level factors associated with IBRS in literature are clinical and sociodemographic.
These factors are included in this study as control variables for research question 1.
Patient-level clinical factors.
Patient-level clinical factors associated with receipt of breast reconstruction include age,
comorbid conditions, body mass index (BMI), receipt of radiation therapy, receipt of
chemotherapy, stage of tumor, tumor grade, tumor size, nodal status, laterality of mastectomy
(unilateral or bilateral) and hormone receptor status. The literature examining these factors is
summarized below.
According to a study of 10104 women who underwent mastectomy by Alderman et al.
(2003), the odds of receiving breast reconstruction for women aged 35-44 years was 1.52 (1.281.80), 55-64 years was 0.42 (0.35-0.49), 65-74 years was 0.16 (0.13-0.19) and more than 75
years was 0.04 (0.03-0.06) as compared to a reference group of women aged 45-54 years
(Alderman et al., 2003). In absence of any contraindications, BRS is considered to be a safe
procedure and improves quality of life even among elderly women (Howard-McNatt et al., 2011;
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Walton, Ommen, & Audisio, 2011). In spite of this, the reconstruction rate among elderly
remains significantly lower than younger women.
Higher number and/or severity of comorbidities measured using the Elixhauser
comorbidity score (Elixhauser, Steiner, Harris, & Coffey, 1998) or the weighted Charlson
comorbidity score (Charlson, Pompei, Ales, & MacKenzie, 1987) are associated with lower
likelihood of receiving breast reconstruction, especially immediate reconstruction. Compared to
women with a Charlson Comorbidity Index —a weighted comorbidity score—of 4, the odds of
receiving immediate breast reconstruction for women with a score of 1 was 3.41 (2.84-4.10),
score of 2 was 1.71 (1.43-2.05) and for a score of 3 was 1.53 (Reuben et al., 2009). In terms of
specific comorbid conditions, disease conditions such as Diabetes Mellitus and Hypertension are
associated with lower likelihood of BRS (Miller & Chandru Kowdley, 2012; Preminger et al.,
2012).
Obesity is another condition that is associated with a lower likelihood of breast
reconstruction. The odds of receiving BRS for obese women (BMI: 25-<30) are 0.67 (0.54-0.83)
and for severely obese women (BMI: 25-<30) are 0.44 (0.35-0.55) as compared to non-obese
(BMI:20-<25) women (Christian et al., 2006). Although obesity is not a contraindication for
BRS, it is associated with higher complications after breast reconstruction in a few studies
(Beahm, Walton, & Chang, 2006; Fischer et al., 2013). Thus, some surgeons may avoid offering
or recommending breast reconstruction to obese patients.
Tumor characteristics such as size, stage and grade are associated with receipt of BRS.
Tumor stage refers to the size and extent of the tumor and whether or not tumor cells have spread
in the body whereas tumor grade refers to the degree of abnormality of tumor cells under the
microscope which serves as an indicator for the aggressiveness of tumor cells. Compared to
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carcinoma in situ stage, higher tumor stage is associated with lower odds of BRS (In et al., 2013;
Iskandar et al., 2015). Similarly, compared to Grade 1 tumor, higher grade tumor is associated
with a lower likelihood of receipt of BRS (Lang et al., 2013). Larger tumor size is associated
with lower likelihood of breast reconstruction surgery (Christian et al., 2006; Lang et al., 2013).
The involvement of lymph nodes is associated with lower likelihood of BRS (Hershman et al.,
2012; Jagsi et al., 2014). Higher the number of involved nodes, lower is the likelihood of
immediate or delayed BRS (Christian et al., 2006; Lang et al., 2013).
Receipt of adjuvant therapy, especially radiation therapy is associated with lower odds of
receiving breast reconstruction surgery, especially immediate breast reconstruction surgery
(Alderman et al., 2003; Enewold et al., 2014; W. H. Tseng et al., 2010). Although radiation
therapy is not a contraindication for immediate reconstruction, it leads to poor esthetic results for
immediate reconstruction surgery. Delayed autologous surgery is preferred in cases where it is
known that the patient will need post-mastectomy radiation therapy (Kronowitz & Robb, 2009).
The odds of autologous reconstruction are much higher than implants for irradiated breasts since
implants are associated with higher complications and poor esthetic results after radiation
therapy (Gurunluoglu, Gurunluoglu, Williams, & Tebockhorst, 2013; Jagsi et al., 2014). Twostage immediate delayed reconstruction is another option in case of radiation therapy. Tissue
expanders can be deflated during radiation treatment and expanded after completion of radiation
therapy (S. A. Chen et al., 2013). The tissue expanders can then be replaced with implants or
more commonly, autologous tissue.
Receipt of chemotherapy before or after mastectomy is also independently associated
with lower odds of immediate breast reconstruction (Alderman, Hawley, et al., 2009; Christian et
al., 2006). Hormone receptor status is also associated with receipt of breast reconstruction in one

27

28
study (Lang et al., 2013). The relationship between laterality of mastectomy and receipt of breast
reconstruction has been receiving considerable attention by researchers and the media. The odds
of breast reconstruction are 2 to 5 times higher after bilateral mastectomy than unilateral
mastectomy (Hershman et al., 2012; Iskandar et al., 2015; Jagsi et al., 2014).
Patient-level sociodemographic factors.
Patient-level socio-demographic factors associated with receipt of breast reconstruction
include insurance, managed care, income, education, employment, geographical region, rurality,
marital status and most importantly, race and ethnicity. The literature examining these factors is
summarized below.
Type of insurance is a frequently examined factor in association with receipt of BRS.
Women with Medicaid insurance who have a mastectomy are less likely to receive BRS as
compared to women with private insurance who have a mastectomy in studies of national and
state-level databases. Similarly, compared to privately insured women, women who are Medicare
insured or women who do not have any insurance (self-pay) are less likely to receive BRS
(Alderman, Hawley, et al., 2009; Mahmoudi et al., 2015; Shippee et al., 2014; Yang, Newman,
Lin, et al., 2013). Compared to women without health insurance (self-pay) having a mastectomy,
women who are insured by Medicare or Medicaid having a mastectomy are more likely to
receive BRS and women with private insurance having a mastectomy have even higher odds of
receiving BRS (Hershman et al., 2012). Compared to women with Medicaid, women with
Medicare do not have significantly different odds of receiving BRS in one study (Kruper et al.,
2013) and have higher odds in another study (Kruper, Xu, et al., 2011). Both these studies were
based in California, a state that has Medicaid coverage for IBRS. Thus, even when Medicaid
covers BRS, Medicaid insured patients receiving a mastectomy are less likely to receive BRS.
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Even within private insurance, mastectomy patients enrolled in plans with capitation are less
likely to receive BRS (Jagsi et al., 2014). These differences in likelihood of BRS may be
explained by the reimbursement differences for BRS across various types of insurance as
mentioned in the previous section of this chapter.
Income is another sociodemographic factor examined in literature in relation to receipt of
BRS. According to Morrow et al. (2001), compared to patients with annual family income less
than 40,000$ who receive a mastectomy, patients with family income equal to or greater than
40,000$ receiving a mastectomy are twice as likely to receive BRS in a study of the National
Cancer Database (Morrow, Scott, Menck, Mustoe, & Winchester, 2001). Chen (2009) found
similar results in their study of the Los Angeles cancer registry (J. Y. Chen et al., 2009). In a
number of studies that include income, it is measured at the patient’s zip code level due to
unavailability of patient-level income in commonly available datasets. Patient residing in census
tracts or counties with higher median or mean family or household income (either continuous or
percentiles or quartiles) have a significantly higher likelihood of receipt of BRS as compared to
patients residing in low income census tracts and neighborhoods (Agarwal et al., 2011; In et al.,
2013; Jagsi et al., 2014; Mahmoudi et al., 2015; Onega et al., 2014; Rosson et al., 2008; Sisco et
al., 2012). Patients residing in census tracts with higher percentage of population below the
poverty rate have lower likelihood of receipt of BRS as compared to patients residing in census
tracts with lower percentage of population below the poverty rate (Anthony P. Polednak, 1999;
A. P. Polednak, 2001).
A patient’s educational attainment is also associated with receipt of BRS. The decision to
seek and receive BRS is a medically complex one and women with higher levels of education
may be more likely to understand and assimilate information regarding BRS and choices for
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various types of BRS. Among patients undergoing mastectomy, women with less than high
school education have lower odds ranging from 0.38-0.73 of receiving BRS as compared to
women with more than high school education (Christian et al., 2006; Morrow et al., 2005).
College graduates are 14 times more likely to score higher on breast reconstruction knowledge
survey as compared to women who have not graduated college (Lee et al., 2011). In addition,
surgeons are nearly 3 times more likely to discuss breast reconstruction with women who are
college graduates as compared to women who did not graduate from college (Caprice C.
Greenberg et al., 2008). Level of education in the patient’s neighborhood is also related to the
receipt of BRS by the patient (Mahmoudi et al., 2015; Rosson et al., 2008). This could be due to
a social network effect or association of education with higher socioeconomic status of patient’s
neighborhood (Rosson et al., 2008).
Geographical variation in receipt of BRS is observed in literature. Compared to women
living in San Francisco, women living in Connecticut, Hawaii, Iowa and Seattle are less likely to
receive breast reconstruction whereas women living in metropolitan Atlanta, metropolitan
Detroit, San Jose-Monterey, Los Angeles, New Mexico and Utah are more likely to receive BRS
(Agarwal et al., 2011; Alderman et al., 2003). Geographical differences also exist across urbanrural areas. Among patients receiving mastectomy, women residing in rural non-metropolitan
regions are less likely to receive breast reconstruction as compared to women living in urban
metropolitan regions (Agarwal et al., 2011; W. H. Tseng et al., 2010). This could be explained
by availability of plastic surgeons in certain regions. Patients residing in counties with higher
density of plastic surgeons have higher likelihood of receiving breast reconstruction surgery as
compared to patients residing in counties with lower density of plastic surgeons (Jagsi et al.,
2014; Kaplan et al., 2011).
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Compared to immigrant women receiving mastectomy, women born in the US receiving
mastectomy are 3.5 times more likely to receive BRS (Caprice C. Greenberg et al., 2008).
Employed women receiving mastectomy is have higher likelihood of receiving BRS as compared
to unemployed women receiving mastectomy even after controlling for type of insurance
(Christian et al., 2006; Kaplan et al., 2011). This could be explained by the fact that employment
is an indicator of socioeconomic status or it could be that women who are employed may be
more interested in getting a BRS for cosmetic and psychosocial reasons. Marital status is also a
predictor of receiving BRS. Women who are married or have a partner are more likely to receive
BRS as compared to women who are single (Agarwal et al., 2011; J. Y. Chen et al., 2009;
Hershman et al., 2012; In et al., 2013). This may be due to psychological, social and financial
support provided by a partner or a woman’s desire to improve cosmetic appearances for their
partner.
Race and ethnicity are the most frequently examined sociodemographic factors associated
receipt of breast reconstruction in literature. This literature is summarized in the next section.
Racial and Ethnic Differences in Receipt of BRS
This section begins with an overview of literature that examines race and ethnicity in
association with receipt of BRS followed by a description of factors that are cited as causes for
the racial and ethnic differences in literature. This is followed by a discussion of the gaps in
literature addressed by research questions 2 and 3.
Empirical research about racial and ethnic differences in receipt of BRS.
African American women undergoing mastectomy have significantly lower odds
(ranging from 0.2 to 0.9) of receiving breast reconstruction surgery as compared to non-Hispanic
women undergoing mastectomy (Agarwal et al., 2011; Alderman, Hawley, et al., 2009; J. Y.
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Chen et al., 2009; Christian et al., 2006; Hershman et al., 2012; In et al., 2013; Jagsi et al., 2014;
Kaplan et al., 2011; Kruper, Holt, et al., 2011; Lang et al., 2013; Mahmoudi et al., 2015; Miller
& Chandru Kowdley, 2012; Rosson et al., 2008; Shippee et al., 2014). Additionally, Asian
women (odds ranging from 0.2-0.6) and Native American women (odds ranging from 0.4-0.7)
also have lower likelihood of receipt of breast reconstruction compared to non-Hispanic White
women (Agarwal et al., 2011; Alderman et al., 2003; In et al., 2013; Iskandar et al., 2015;
Kruper, Holt, et al., 2011; Kruper et al., 2013; Lang et al., 2013).
Hispanic women have significantly lower odds of receiving breast reconstruction in a
number of studies as compared to non-Hispanic White women (Agarwal et al., 2011; Alderman
et al., 2003; Caprice C. Greenberg et al., 2008; Kruper, Holt, et al., 2011; Kruper et al., 2013;
Lang et al., 2013; Nelson et al., 2012; Shippee et al., 2014). The odds are especially lower for
less acculturated Latinas as compared to highly acculturated Latinas (Alderman, Hawley, et al.,
2009).
Compared to non-Hispanic African American women, women of all other races and
ethnicities are more likely to receive breast reconstruction surgery (Reuben et al., 2009). Over
time between the year 2005 to 2011, the likelihood of breast reconstruction has increased for
African American women and Hispanic women but has decreased for Asian women (Offodile et
al., 2015).
Racial and ethnic differences in receipt of BRS have persisted across time in literature
(Jagsi et al., 2014; Offodile et al., 2015; Shippee et al., 2014; Sisco et al., 2012). Racial and
ethnic differences are seen not only in national databases such as SEER and NIS but also in state
level studies (Kruper, Holt, et al., 2011; Rosson et al., 2008; Yang, Newman, Reinke, et al.,
2013), single institution studies (J. F. Tseng et al., 2004) and studies using data from the
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Department of Defense Medical Claims (Enewold et al., 2014). Alderman et al. (2006),
Mahmoudi et al. (2015) and Yang et al. (2013) have all demonstrated that racial and ethnic
differences in receipt of BRS persist in spite of state and federal policies that enhance access to
breast reconstruction (Alderman et al., 2006; Mahmoudi et al., 2015; Yang, Newman, Reinke, et
al., 2013).
Racial and ethnic differences are also observed in the type of breast reconstruction
surgery. African American women are more likely to receive an autologous reconstruction (OR:
1.45, 95% confidence interval: 1.24-1.69) but less likely to receive an implant reconstruction
(OR: 0.59, 95% confidence interval: 0.5-0.68) as compared to non-Hispanic White women
(Offodile et al., 2015). The authors explain the higher likelihood of receiving an autologous
reconstruction for African American women is because they are more likely to have higher BMI
and receive care at large, academic medical centers in inner city regions. All of these factors are
independently associated with higher odds of receiving autologous reconstruction (Offodile et
al., 2015). Women of Hispanic ethnicity have lower likelihood of receiving implant
reconstruction as compared to non-Hispanic White women. However, there are no significant
differences in likelihood of implant reconstruction between non-Hispanic White women and
Asian women.
Over time between the years 2005 to 2011, the likelihood of implant breast reconstruction
decreased for African American women, Hispanic women and Asian women. On the other hand,
the likelihood of pedicled autologous breast reconstruction increased for Hispanic women over
time between 2005 and 2011 but did not change for African American and Asian women. Lastly,
the likelihood of free flap autologous breast reconstruction increased for African American
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women over the same time period but did not change for Hispanic women and Asian women
(Offodile et al., 2015).
In the next sub-section, the hospital and market-level factors that may contribute to racial
and ethnic differences in receipt of BRS are presented followed by a summary of the gap in
literature addressed by research question 2. Next, patient-level factors that may contribute to
racial and ethnic differences in receipt of BRS are explained followed by a summary of the gap
in literature addressed by research question 3.
Factors contributing to racial and ethnic differences in receipt of BRS.
Hospital and market-level factors.
Racial and ethnic minorities are less likely to receive care at the hospitals frequented by
non-Hispanic Whites and are more likely to receive care at hospitals with poorer quality of
surgical outcomes (D. J. Gaskin et al., 2011). Onega et al. (2014) found that African Americans
are more likely to receive care at disproportionate share hospitals and less likely to receive care
at hospitals that have an NCI cancer center designation or participate in a cooperative oncology
group (Onega et al., 2014). Onega et al. (2014) also found that African Americans were more
likely to be admitted to urban, teaching hospitals with high surgery volume (Onega et al., 2014).
Urban, teaching hospitals are associated with higher rates of reconstruction (Hershman et al.,
2012; Kruper, Holt, et al., 2011; Onega et al., 2014; Reuben et al., 2009; Shippee et al., 2014).
However, Popescu et al. (2011) and Gaskin et al. (2011) found that after controlling for distance
from the hospital, African Americans are significantly less likely than Whites to receive care in
urban, teaching hospitals with high volume and high quality outcomes (D. J. Gaskin et al., 2011;
Popescu, Cram, & Vaughan-Sarrazin, 2011). In spite of the known racial and ethnic differences
in characteristics of the hospital and market where care is received, the role of hospital and
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market characteristics in explaining racial and ethnic differences in receipt of BRS has not been
explored.
Certain hospitals may be less likely to perform BRS for racial and ethnic minority
patients, thereby widening racial and ethnic differences in receipt of BRS. This could result from
a hospital’s lack of experience in treating racial/minority patients, language discordance among
providers and patients or other factors that are not fully understood. Onega et al. (2014)
examined whether hospital and market characteristics moderate the relationship between women
of color and receipt of BRS. However, they found that hospital characteristics such as teaching
status, NCI cancer center designation, participation in a cooperative oncology group and market
characteristics such as urban location do not significantly moderate the relationship between
race/ethnicity and receipt of BRS (Onega et al., 2014).
An important limitation of the Onega et al (2014) study is that their sample consisted of
women above 65 years of age wherein the rate of reconstruction is only 10% (Onega et al.,
2014). In this paper, we address the gaps in the previous literature by studying a wider age group
of women undergoing mastectomy and by examining theoretically driven hospital and market
characteristics. Thus, the second research question is:
RQ2. Is the relationship between race/ethnicity and likelihood of receipt of IBRS
moderated by hospital and market characteristics?
Patient-level factors.
Racial and ethnic differences in health status can contribute to racial and ethnic
differences in receipt of BRS. Several health status indicators such as late stage tumor, clinical
comorbidities and obesity are associated with lower likelihood of BRS (Christian et al., 2006;
Miller & Chandru Kowdley, 2012; Reuben et al., 2009). Racial and ethnic minorities are likely
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to receive late diagnoses of breast cancer at more advanced tumor stages as compared to nonHispanic Whites (Katz & Hofer, 1994; Press, Carrasquillo, Sciacca, & Giardina, 2008; Shavers
& Brown, 2002). In addition, racial and ethnic minorities may have higher comorbidities as
compared to non-Hispanic Whites (Tammemagi, Nerenz, Neslund-Dudas, Feldkamp, &
Nathanson, 2005). Higher comorbidities and late stage diagnoses may be due to poor access to
health care facilities owing to location or socioeconomic factors. It could also be a representation
of the lack of trust in the healthcare system expressed by certain racial minorities, which in turn
is a product of long-term racial discrimination. Lastly, certain racial and ethnic minorities are
more likely to be obese as compared to their White counterparts (Trust for America’s Health and
Robert Wood Johnson Foundation, 2014). This could represent racial/ethnic disparities in access
to high quality food and in access to playgrounds or parks for exercise (Sallis & Glanz, 2009).
Thus, racial/ethnic differences in stage of tumor, clinical comorbidities and obesity can
contribute to racial and ethnic differences in receipt of BRS.
Although no study explicitly examines the contribution of socioeconomic factors to the
racial/ethnic differences in receipt of BRS, a number of studies cite racial/ethnic differences in
insurance, income, education and other neighborhood factors as potential explanations for BRS
differences (Christian et al., 2006; Morrow et al., 2005; Shippee et al., 2014; J. F. Tseng et al.,
2004). Racial and ethnic minorities are more likely to be uninsured (Hoffman, 2008) or Medicaid
insured (The Henry J. Kaiser Family Foundation, 2013). Medicaid insurance and uninsured
status are associated with lower likelihood of BRS in literature (Hershman et al., 2012; Kruper,
Holt, et al., 2011; Kruper et al., 2013; Shippee et al., 2014; Yang, Newman, Lin, et al., 2013;
Yang, Newman, Reinke, et al., 2013). Thus, racial/ethnic differences in insurance status may
contribute to racial/ethnic differences in receipt of BRS.
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In addition, racial and ethnic minorities are also more likely to have lower income (Mead
& Fund, 2008) which may lead to financial barriers in receiving BRS. The WHRCA permits
states to allow private insurers to add additional premiums and out of pocket expenses to provide
BRS to the beneficiaries (American Cancer Society, 2014) which may affect access to BRS for
low-income patients. Patient’s income and the affluence of a patient’s neighborhood are
associated with higher likelihood of receipt of BRS (Agarwal et al., 2011; In et al., 2013; Jagsi et
al., 2014; Mahmoudi et al., 2015; Onega et al., 2014; Rosson et al., 2008; Sisco et al., 2012). In
addition, racial and ethnic minorities are likely to be less educated and more likely to be
unemployed as compared to non-Hispanic Whites (Ritter & Taylor, 2011; Ryan & Bauman,
2016; Williams & Jackson, 2005). Educational attainment and employment are associated with
higher likelihood of BRS (Christian et al., 2006; Caprice C. Greenberg et al., 2008; Kaplan et al.,
2011; Lee et al., 2011; Morrow et al., 2005). Thus, racial and ethnic differences in income,
educational attainment and employment may contribute to racial/ethnic differences in receipt of
BRS.
In the two sub-sections above, racial/ethnic differences in patient-level, hospital-level and
market-level characteristics that may contribute to racial/ethnic differences in receipt of BRS are
described. In order to direct policy efforts towards reducing racial and ethnic differences, these
multiple factors need to be prioritized. One way to prioritize policy efforts is to determine which
factors contribute the most to racial and ethnic differences in receipt of breast reconstruction. No
study to date has examined the multi-level factors that contribute to racial and ethnic differences
in receipt of breast reconstruction. Results from this study help fill this gap and prioritize policy
efforts. Decomposition analyses help to quantify the proportion of each factor’s contribution to
the racial and ethnic differences. Th results from these analyses aid policy makers focus their
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limited resources on addressing the factors that have the largest contribution to these differences.
Thus, the last research question is:
RQ3. Which patient, hospital and market-level characteristics contribute the most to the
racial and ethnic differences in receipt of IBRS?
Factors contributing to racial and ethnic differences in type of surgery.
Rubin et al. (2013) found that African Americans prefer autologous BRS compared to
implants since they prefer use of their own body tissue than a foreign body (implant) due to
religious and cultural reasons (Rubin, Chavez, Alderman, & Pusic, 2013). However, autologous
BRS is a more complex surgery and is not provided by all medical centers. Additionally, rates of
physician reimbursement by surgical time are lower for autologous reconstruction as compared
to implants (Alderman, Storey, et al., 2009). Even in urban areas with high availability of plastic
surgeons, racial/ethnic minorities in resource-poor hospitals may face barriers to receipt of
immediate autologous reconstruction which requires complex surgery, more time in the surgical
room and coordination of multiple surgeons but is reimbursed at a lower rate (Alderman, Storey,
et al., 2009). In order to understand the contribution of hospital and market factors in receipt of
autologous vs implant surgery, separate supplemental analyses for type of IBRS (autologous
reconstruction vs implant reconstruction) for research questions 2 and 3.
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Chapter 3: Conceptual Framework

Overview of Chapter
The purpose of this chapter is to develop a conceptual framework for the research
questions outlined in Chapter 2. The Aday Andersen Framework describes the patient-level and
health system-level factors along with the health policy context that is associated with utilization
of a health service such as Immediate Breast Reconstruction Surgery (IBRS). However, the Aday
Anderson framework does not incorporate a comprehensive set of health system (includes
hospital and market) characteristics. Thus, Resource Dependence Theory (RTD) is used to
address this gap and derive the hospital- and market-level characteristics associated with
utilization of IBRS. After describing Aday Andersen framework and RDT, the combined
conceptual framework for the current study is presented, as are the study hypotheses for
Research question 1. Research question 2 examines whether hospital and market characteristics
moderate the relationship between race/ethnicity and receipt of IBRS. No directional hypotheses
for research question 2 are presented. Research question 3 focuses on the magnitude of
contribution of the patient, hospital and market-level characteristics, derived from the Aday
Andersen framework and RDT, to the racial and ethnic differences in IBRS. Since research
question 3 examines the magnitude rather than the direction of relationships, no specific
directional hypotheses are specified for research question 3.
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Aday Andersen Framework
Andersen (1968) created the original behavioral model of health service utilization as part
of his dissertation (Andersen, 1968). In this original three-stage model with the family as the unit
of analysis, Andersen (1968) uses predisposing, enabling, and need components in an attempt to
explain families' widely differing use of medical care services. The model postulates that
utilization of a health care service takes place when a family is predisposed to receive medical
care, when conditions make health services available to the family and when the family
perceives a need for these services and responds to it. The focus is on the predisposing, enabling
and need characteristics of the family (Andersen, 1968).
Andersen and Newman (1973) modified the 1968 model to shift the unit of analysis from
the family to the individual and to include societal as well as health services system
characteristics. Later, Aday and Andersen (1974) modified the 1973 framework to include health
policy and health system characteristics. According to this revised 1974 model, utilization of
health services is dependent on 1) health policy characteristics; 2) health system characteristics;
3) predisposition of the individual to use health services (predisposing characteristics); 4) the
individual’s ability to secure these health services (enabling characteristics) and lastly 5) the
individual’s illness level that determines his/her need for health services and his/her beliefs about
their illness level (need characteristics) (Andersen & Newman, 1973). The basic Aday Andersen
framework is presented in Figure 1 followed by a brief description of all the elements in the
framework. This is followed by an adaptation of this framework to the current study.
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Figure 1. Aday Andersen Framework
1

Health policy and health services system determinants.
Aday Anderson (1974) state that access should be examined in the context of health
policy since ensuring access to care is an important goal of health policy. Health policy can bring
about change in mutable factors at the health system and the individual level in order to improve
access. Thus, these authors place health policy at the pinnacle of the framework and all other
characteristics of the health system and the individuals at risk proceed from the health policy
component. The health policy component includes policies related to financing of health care at
the system and at the individual level, education of providers and patients, availability,
distribution and type of health care manpower and lastly, organization of the health services
system.
The health services system determinants included in this model are resources and
organization. In this model, the health services system refers to the larger health care system at
the national level (Aday & Andersen, 1974). Resources refer to labor and capital devoted to
healthcare at the national level. The resource component includes total volume of resources
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relative to the population served and the distribution of these resources throughout the country.
Organization describes what the system does with its resources. The two components of the
organization described in the model are access and structure. Access refers to the means through
which a patient enters the health care system. This component refers to the barriers that need to
be overcome in order to enter the health care system. Structure is the second component of
organization. Structure deals with what happens to patients once they enter the health care
system. It encompasses the nature of medical practices of the physicians, processes of referral
and characteristics of hospital care.
Predisposing, enabling and need characteristics.
Certain individuals have a higher propensity to use health services than others. This
higher propensity is irrespective of the disease condition that necessitates care. The predisposing
characteristics at the individual level that are associated with this propensity to utilize health
services may be demographic (age and sex) or related to the social structure (education, race,
ethnicity) which in turn are related to values concerning health and illness, attitudes towards
health services and knowledge about disease and care processes.
Demographic variables such as age and sex are related to the types and amounts of past
illness and past use of health care. Past use of health care is considered to be a determinant of
future use and thus age and sex are related to an individual’s predisposition to use health
services. Social structure variables such as education, race and ethnicity among others, reflect the
status of an individual in the society. These status variables are an indicator for the patient’s
lifestyle and an accumulation of lifetime social and economic advantages and disadvantages
which shape the patient’s health status along with patient’s beliefs and behaviors regarding the
use of health services.
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Lastly, the beliefs of an individual, which to a certain extent are shaped by their
demographics and social structure, are related to their inclination toward use of health services.
For instance, patients with strong beliefs about the importance of their disease and the value of
medical care along with a positive attitude towards health services, shaped by past interactions
with the health system, are all associated with higher inclination to use health services.
Even if individuals have a propensity to seek health services and/or have a need for a
health service, they cannot do so without the means that enable them to receive health services.
Enabling characteristics in this model represent those means that enable individuals to receive
care. These include income and insurance, the resources that provide financial access to care.
Enabling characteristics also include an accessible regular source of health care.
Community characteristics such as availability of medical personnel, hospital beds and
other medical/surgical resources enable easy accessibility to health services. These community
characteristics are thus considered to be enabling factors. The distribution of these resources
within a community varies across geographical regions in the country. Thus, urbanicity and
region are also considered to be enabling characteristics.
Need characteristics are also called illness level characteristics by Andersen and Newman
(1973). The illness level can be perceived or evaluated. Perceived illness level is the individual’s
perception of their disease. On the other hand, disease conditions and their stage and severity as
diagnosed by a physician are components of the evaluated illness level. Whereas symptoms are a
component of perceived illness, physical signs as elicited on physical exam or diagnostic tests
are a component of evaluated illness level. Presence and severity of other diagnosed clinical
comorbidities is also considered a component of evaluated illness level. All these perceived and
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evaluated need characteristics serve as the immediate drivers of seeking health services in the
presence of predisposing and enabling characteristics.
Adaptation of the Aday Andersen framework for utilization of IBRS.
Utilization of IBRS is the outcome of interest for the current study. Utilization is possible
when IBRS is offered by health systems and when it is accepted by the patients. As seen from
Figure 1, the Aday Andersen framework begins with the policy context as the most distal factor
that is associated with utilization of health services. The policy context relevant for examining
the utilization of IBRS is state-level health policy related to insurance coverage and patient
education, specifically for breast reconstruction surgery. The execution of federal health policies
related to IBRS (e.g. the Women’s Health and Cancer Rights Act) varies significantly across
states (Centers for Disease Control and Prevention, 2000). States can add additional riders for
coverage of IBRS by private insurers (e.g. state of Florida). While most states provide Medicaid
coverage for IBRS, the level of reimbursement varies significantly. In addition, certain states like
Pennsylvania extend Medicaid coverage for IBRS to uninsured women. Other social, economic
and health policies that may influence any of the multilevel factors associated with receipt of
IBRS also vary across states. Thus, indicators for the state in which the patient receives care are
included in the Aday Andersen framework to address differences in policy contexts across states.
Based on the Aday Andersen framework, the health system characteristics (including
hospital and market-level factors) associated with acceptance of IBRS include volume and
distribution of resources along with entry to and structure of the organization. According to
Andersen and Newman (1973), the components of the health services system—volume and
distribution of resources along with access to and structure of the organizations—are the most
difficult to define and to relate to utilization patterns compared to other components of the
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model. In order to address these issues, Resource Dependence Theory is used to establish the
links between the characteristics of the health services system and the utilization of health
services in the paper.
As noted in Chapter 2, most of the previous literature examines patient-level factors
associated with receipt of IBRS. In this study, patient-level predisposing, enabling and need
characteristics serve as controls and are derived using the Aday Andersen framework. The
predisposing characteristics associated with receipt of IBRS are patient’s age, race and ethnicity.
Younger patient age is associated with higher likelihood of IBRS since younger age is associated
with fewer comorbidities and higher perceived benefit from IBRS (Alderman et al., 2003; In et
al., 2013). There is a physician bias towards offering IBRS to younger women as compared to
older women (Caprice C. Greenberg et al., 2008). Minority race and ethnicity are associated with
lower likelihood of receiving IBRS (Agarwal et al., 2011; Alderman, Hawley, et al., 2009; J. Y.
Chen et al., 2009; Christian et al., 2006; Hershman et al., 2012; In et al., 2013; Jagsi et al., 2014;
Kaplan et al., 2011; Kruper, Holt, et al., 2011; Lang et al., 2013; Mahmoudi et al., 2015; Miller
& Chandru Kowdley, 2012; Rosson et al., 2008; Shippee et al., 2014). Not much is known about
the reasons for these racial and ethnic differences. Research questions 2 and 3 in this study aim
to address this gap.
Enabling characteristics associated with receipt of IBRS are patient’s income and
insurance. Patients with private insurance have a higher likelihood of receipt of IBRS as
compared to patients with Medicaid or uninsured patients (Alderman, Hawley, et al., 2009;
Mahmoudi et al., 2015; Shippee et al., 2014; Yang, Newman, Lin, et al., 2013). Similarly, patient
income is also associated with higher likelihood of receipt of IBRS (Agarwal et al., 2011; In et
al., 2013; Jagsi et al., 2014; Mahmoudi et al., 2015; Onega et al., 2014; Rosson et al., 2008; Sisco
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et al., 2012). Both income and insurance are commonly studied enabling factors in most studies
that utilize the Andersen behavioral model and its derivatives.
Need characteristics examined in this study in association with receipt of IBRS are
clinical comorbidity score and an indicator for obesity. Higher number and severity of clinical
comorbidities are associated with lower likelihood of receipt of IBRS as it increases the
likelihood of complications after the surgery (Reuben et al., 2009). Similarly, obesity is
associated with poor revascularization and wound healing and is considered to be a relative
contraindication for IBRS (Beahm et al., 2006; Christian et al., 2006). In order to control for
other relative contraindications, patients with metastasis and a history of previous breast cancer
are excluded. The Aday Andersen framework modified for the purpose of this study is presented
in Figure 2.
The predisposing, enabling and need characteristics at the patient-level are expected to be
associated with the receipt of IBRS based on the Aday Andersen framework. The Aday
Andersen framework does not include hospital and market-level factors that are associated with
the receipt of health care services. Therefore, Resource Dependence Theory is used to derive the
health system i.e. hospital and market-level characteristics that will be added to the Aday
Andersen Framework to develop a conceptual framework for the current study. In the next
section, RDT and the hypotheses derived using this theory are described followed by a combined
conceptual framework used in this study.
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Figure 2. Aday Anderson Framework for Utilization of IBRS
2

Resource Dependence Theory
Overview.
Resource Dependence Theory was first described in Pfeffer and Salancik’s “The External
Control of Organizations: A Resource Dependence Perspective” (1978). Since then, RDT has
become one of the most influential theories in organizational theory and strategic management
(Hillman, Withers, & Collins, 2009). RDT characterizes the corporation as an open system,
dependent on contingencies in the external environment. An open system includes “organizations
with interdependent activities of linking and shifting coalitions of participants; the systems are
embedded in dependent or continuing exchanges with and constituted by the environments in
which they operate” (Scott & Davis, 2007). According to RDT, to understand an organization’s
behavior, one must look at its context or its environment (Pfeffer & Salancik, 1978).
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RDT suggests that organizational survival is dependent on acquiring and maintaining
access to certain resources from their environment. When organizations are dependent on
resources from their environment, they are concerned with three main issues: 1) munificence of
resources; 2) the concentration of resources among various stakeholders and lastly, 3)
interconnectedness of organizations within the environment. Munificence is the abundance of
resources available to the organization. Abundant critical resources reduce uncertainty whereas
scarcity of critical resources increases uncertainty regarding the resource. Concentration of a
resource by few stakeholders increases the stakeholders’ power over the focal organization. The
higher the concentration of the resource, the more power exerted by the stakeholder and higher
the level of uncertainty experienced by the focal organization. Lastly, interconnectedness with
organizations in the focal organization’s environment may also increase uncertainty by
increasing competition for the resource (Pfeffer & Salancik, 1978).
As uncertainty in an organization’s environment increases, it becomes important for
organizations to manage their dependence on external stakeholders. The higher an organization’s
dependence on a stakeholder, the higher the likelihood of the stakeholder making demands from
the focal organization in exchange for providing resources. The focal organization has the
discretion to either accommodate these stakeholder demands or to avoid them (Oliver, 1991).
This discretion is dependent on 1) the importance of the resource; 2) the degree of discretion that
the external stakeholder has regarding allocation and use of the resource which depends on the
competition for consuming the resource provided by the external stakeholder and 3) the
concentration of the resource, which depends on the relative magnitude of the exchange (i.e., the
proportion of a vital resource provided by the particular stakeholder) (Pfeffer & Salancik, 1978).
Thus, in cases where the stakeholder making demands of the focal organization controls an
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important resource that is not substitutable and there is high competition for the resource, the
focal organization is likely to comply with the stakeholder’s demands in order to ensure the focal
organization’s survival.
In spite of the importance of compliance for the focal organization’s survival, Davis and
Powell (1992) argue that compliance may not always be easy. Compliance may carry threats to
the focal organization. Compliance may be costly in the short term and may constrain the
organization’s future adaptation. Thus, ceteris paribus, compliance is more likely when
organizations can bear the costs of compliance (Davis & Powell, 1992). Thus, organizations with
higher capital and labor are more likely to comply with the demands of the external stakeholders
since they are able to bear the costs of such compliance. Since compliance may constrain an
organization’s future adaptation, compliance is more likely when the demands of the external
stakeholder are in line with the focal organization’s own vision and mission regarding their
future (Banaszak-Holl et al., 1996).
Hypotheses.
For the purpose of research question 1 in this study, hospital-level and market-level
factors that are likely to be associated with provision of IBRS are examined. Patients or
consumers are an important resource for a hospital. Breast cancer patients are one such source of
patients for a hospital. Assuming that breast cancer patients value access to IBRS services,
hospitals are likely to offer this service and provide IBRS to the patient if certain conditions are
met.
RDT postulates that higher the proportion of an important resource provided by a
particular stakeholder group, the higher is the likelihood of complying with that group’s
demands. In this study, breast cancer patients serve as a stakeholder group that provides the
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hospital with an important resource i.e. consumers of their services. The higher the proportion of
all patients in the hospital provided by this stakeholder group, the higher is the likelihood of the
hospital complying with their demands and providing IBRS.
Hypothesis 1A. The higher the proportion of breast cancer patients admitted by a
hospital, the higher is the likelihood of mastectomy patients receiving IBRS at the hospital.
RDT also postulates that compliance with a stakeholder’s demand is dependent on the
relative power of the focal organization as compared to the stakeholder. When there is higher
competition for a resource, it increases the stakeholder’s discretion over the organization they
want to provide their resources to. This increases the stakeholder’s power vis-à-vis that of the
focal organization. Higher discretion of the stakeholder and a large number of competitive
organizations in the focal organization’s environment increase uncertainty for the focal
organization. According to RDT, all things being equal, the higher the uncertainty regarding
procurement of an important resource from a stakeholder, the higher is the likelihood of
accommodating the stakeholder’s demands. In markets with high competition, availability of
patients as a resource becomes uncertain. In order to secure patients, a health care organization
needs to provide the service demanded by the patients (Pfeffer & Salancik, 1978; J. S. Zinn,
Weech, & Brannon, 1998) which in this case is IBRS demanded by breast cancer patients.
Hypothesis 1B. The higher the competition in a hospital’s market, the higher is the
likelihood of mastectomy patients receiving IBRS at the hospital.
Davis and Powell (1992) argue that complying with a stakeholder’s demands is costly.
Thus, compliance is more likely when organizations can bear the costs of compliance (Davis &
Powell, 1992). In a number of papers where RDT was employed, authors have argued that
organizations are more likely to meet the demands of key resource providers like patients if they
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have the necessary capital and labor to provide the service demanded by the patients (Kraatz &
Zajac, 2001; J. Zinn & Flood, 2009; J. S. Zinn et al., 1998). Capital resources include bed size
and indicators of financial performance of the hospital whereas labor resources include the
density of plastic surgeons in the hospital market (Banaszak-Holl et al., 1996; Greening & Gray,
1994). Hospital beds are the most common capital investment made by a hospital. Thus, larger
bed size represents higher capital resources (Ginsburg, 1972). Total margin of a hospital is a
commonly used broad indicator of the hospital’s financial performance (Needleman, 2003; Pink
et al., 2006). Total margin is defined as a ratio of net income to total revenue from all sources.
Better financial performance allows a hospital to bear the cost of complying with patient
demands. Thus, it can be hypothesized that all else being equal, the higher the bed size and the
higher the total margin, the higher the likelihood of provision of IBRS.
Hypothesis 1C. The higher the number of beds in a hospital, the higher is the likelihood
of mastectomy patients receiving IBRS at the hospital.
Hypothesis 1D. Higher the total margin of a hospital, higher is the likelihood of
mastectomy patients receiving IBRS at the hospital.
Labor resources associated with provision of IBRS include plastic surgeons. A hospital
will be unable to provide IBRS unless there is an availability of plastic surgeons in the hospital.
Easy availability of labor resources allows a hospital to bear the labor costs of complying with
patient demands. Thus, it can be hypothesized that all else being equal, the higher the availability
of plastic surgeons in the hospital market, the higher the likelihood of provision of IBRS.
Hypothesis 1E. The higher the density of plastic surgeons in a hospital’s market, the
higher is the likelihood of mastectomy patients receiving IBRS at the hospital. Certain other
hospital and market characteristics are associated with capital and labor resources of a hospital.
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For instance, hospitals located in an urban region are more likely than those in rural areas to have
a higher capital and labor availability (Weisgrau, 1995). According to the Hall and Owings
(2014), patients hospitalized in urban hospitals were generally more likely to have surgical
procedures performed during their hospitalization than those hospitalized in rural hospitals. This
could be due to the shortage of specialty physicians in rural areas, the lack of other staff skilled
in surgery, or the absence of costly equipment needed for specialized surgical procedures in rural
hospitals. Because of economies of scale, rural hospitals may forego offering many procedures
and instead choose to focus on patients needing basic inpatient surgical care, and on patients
needing medical, rather than surgical, treatment (Hall & Owings, 2014). Thus, it can be
hypothesized that all else being equal, hospitals located in an urban market will be associated
with a higher likelihood of provision of IBRS as compared to hospitals located in a rural market.
Hypothesis 1F. Patients receiving mastectomy at hospitals located in urban counties are
more likely to receive IBRS compared to patient receiving mastectomy at hospitals located in
rural counties.
Hospitals that predominantly serve Medicaid patients have a higher burden of providing
care to vulnerable populations. Such hospitals are usually strained for resources with high wait
times for surgical procedures (Bradley, Dahman, Shickle, & Lee, 2012). Higher wait time is
associated with lower likelihood of receipt of IBRS (Greenberg et al., 2011). Breast surgeons in
such hospitals may be too overburdened to be able to discuss reconstruction options with their
patients or refer them to a plastic surgeon. Additionally, plastic surgeons and other specialists are
less likely to accept Medicaid patients for IBRS. Thus, plastic surgeons may be less likely to
perform IBRS at hospitals with a large proportion of Medicaid patients (Paradise & Garfield,
2013). Thus, it can be hypothesized that all else being equal, hospitals with a lower proportion of
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Medicaid patients will be associated with a higher likelihood of provision of IBRS as compared
to hospitals with a higher proportion of Medicaid patients.
Hypothesis 1G. The lower the proportion of Medicaid patients admitted by a hospital, the
higher is the likelihood of mastectomy patients receiving IBRS at the hospital.
According to Hasnain-Wynia et al. (2007), minority patients receive care at underresourced low performing hospitals. A number of factors can characterize low-performing
hospitals as under-resourced including nurse staffing shortages, inadequate budgets, lack of
technical support such as health information systems, and lack of capital (Hasnain-Wynia et al.,
2007). Schatzkin (1984) argues that poor political representation of minority-serving hospitals
may lead to lesser philanthropic contributions (Schatzkin, 1984). Thus, hospitals with a high
proportion of racial and ethnic minorities may not be able to bear the cost of complying with
patient demands for IBRS. It can be hypothesized that all else being equal, hospitals with lower
proportion of racial and ethnic minority patients will be associated with a higher likelihood of
provision of IBRS as compared to hospitals with a higher proportion of minority patients.
Hypothesis 1H. The lower the proportion of racial and ethnic minority patients admitted
by a hospital, the higher is the likelihood of mastectomy patients receiving IBRS at the hospital.
Davis and Powell (1992) state that complying with a stakeholder’s demands is not always
easy for an organization since it may constrain the organization’s future adaptation. Hence,
compliance is more likely when the demands of the external stakeholder are in line with the focal
organization’s own vision and mission regarding their future (Kraatz & Zajac, 2001; J. Zinn &
Flood, 2009; J. S. Zinn et al., 1998). Teaching hospitals are known to provide a wide variety of
innovative surgical procedures (Banaszak-Holl et al., 1996). Thus, providing sophisticated but
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costly service like IBRS aligns with the mission of teaching hospitals. It can be hypothesized that
all else being equal; teaching hospitals are more likely to provide IBRS as compared to nonteaching hospitals.
Hypothesis 1I. Patients receiving mastectomy at teaching hospitals are more likely to
receive IBRS as compared to patients receiving mastectomy at non-teaching hospitals.
Not-for-profit hospitals are known to provide services needed by the community
irrespective of the financial gain from providing such services (Newhouse, 1970). Horwitz
(2005) argues that for-profit hospitals are less likely to provide services that are not known to be
profitable. Horwitz (2005) in her study of 30 health care services found that not-for-profit
hospitals are more likely than for-profit hospitals at providing services that are not highly
profitable to the hospital. Similarly, the study also found that non-federal public hospitals are
more likely than for-profit and not-for-profit hospitals to provide services that may not be
profitable (Horwitz, 2005). Eiland (2015) cites the Stewardship theory as an explanation for notfor-profit and non-federal public hospitals’ provision of services that are of broad interest to the
community in spite of the financial gain (Eiland, 2015). Thus, providing a costly service like
IBRS that may not be highly profitable but meets community needs aligns with the mission and
vision of not-for-profit hospitals and non-federal public hospitals. It can be hypothesized that all
else being equal, not-for-profit hospitals and non-federal public hospitals are more likely to
provide IBRS as compared to investor-owned for-profit hospitals.
Hypothesis 1J. Patients receiving mastectomy at private not-for-profit hospitals are more
likely to receive IBRS compared to patients receiving mastectomy at private investor-owned forprofit hospitals.
Hypothesis 1K. Patients receiving mastectomy at non-federal public hospitals are more
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likely to receive IBRS compared to patients receiving mastectomy at private investor-owned forprofit hospitals.
The hypothesis 1A to 1K are related to research question 1 wherein the hospital and
market-level factors associated with receipt of IBRS are examined. The hospital and marketlevel factors derived from RDT in this section are incorporated into the Aday Andersen
framework as health system characteristics. The patient-level characteristics included in the
framework are the predisposing, enabling and need characteristics. In addition, indicators for
states in which patients receive care serve as the health policy context. The conceptual
framework for Research Question 1 thus incorporates Resource Dependence Theory into the
Aday Andersen framework. This combined framework is presented in Figure 3.

Figure 3. Combined Conceptual Framework for Utilization of IBRS
3
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In the second research question, the hospital and market characteristics associated with
lower likelihood of receipt of IBRS for stratified samples of racial and ethnic minority women
after controlling for patient-level predisposing, enabling and need characteristics are examined.
Not much is known about how hospital and market characteristics influence provision of IBRS
services for racial and ethnic minorities. Therefore, no directional hypotheses for research
question 2 are stated. Research question 3 focuses on the magnitude of contribution of the
patient, hospital and market-level characteristics, derived from the Aday Andersen framework
and RDT, to the racial and ethnic differences in IBRS. Since research question 3 examines the
magnitude rather than the direction of relationships, no directional hypotheses are specified for
it.
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Chapter 4: Methodology

Overview of Chapter Structure
This chapter begins with a description of the data sources and the study population. This
is followed by measurement of the dependent and independent variables. Next, the analytical
approaches used to address the research questions are presented, including a detailed description
of the decomposition method used to address research question 3.
Data Sources
This study uses data extracted from nationally recognized databases at the patient-level,
hospital-level and area (market)-level. Patient-level data is obtained from State Inpatient
Databases (SIDs) that are part of the Healthcare Cost and Utilization Project (HCUP) sponsored
by the Agency for Healthcare Research and Quality (AHRQ). HCUP databases are derived from
administrative data and contain all-payer encounter-level, clinical and nonclinical information
including all listed diagnoses and procedures, discharge status, patient demographics, and
hospital charges for all patients (Healthcare Cost and Utilization Project, 2016b). The states
included in this study are Arizona, Florida, Kentucky, Maryland, New Jersey, New York, North
Carolina and Washington. In addition, data for the State of California is obtained from California
Office of Statewide Health Planning and Development (OSHPD) (Office of Statewide Health
Planning and Development, 2015). The OSHPD data is also administrative data and is similar to
the format of the HCUP SID. The data used in this study are from 2010, 2011 and 2012. Using
three years of data provides a sufficient sample size and ensures that the findings are not
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confounded by year-specific history effects. The nine states included in this study are selected
due to the diversity in racial mix of their population. For example, the states of Arizona (37% of
the population is Hispanic), Florida (26% of the population is Hispanic) and California (38% of
the population is Hispanic) have a higher proportion of Hispanic population than the national
average (18% of the population is Hispanic) whereas the states of Maryland (30% of the
population is Black) and North Carolina (21% of the population is Black) have a higher
proportion of Black population than the national average (12% of the population is Black). On
the other hand, Kentucky has a higher proportion of White population than the national average
(The Henry J. Kaiser Family Foundation, 2015). The time period 2010 to 2012 is selected to
ensure that the results are not affected by policy changes mandated by the Affordable Care Act.
Hospital-level characteristics are obtained from the American Hospital Association
(AHA) Annual Survey database and the Center for Medicare and Medicaid Services Hospital
Cost Report (HCR) Data. AHA Annual Survey database includes hospital-specific data on
approximately 6,500 hospitals and 400-plus hospital systems, including as many as 1,000 data
fields covering organizational structure, personnel, and hospital facilities and services (American
Hospital Association, 2014). The HCR data contains hospital information such as facility
characteristics and financial statement data that the hospital is required to report to the Medicare
administrative contractor in order to receive Medicare reimbursement (Centers for Medicare and
Medicaid Services, 2012). The hospital-level data are merged with the patient-level data using
the unique AHA id assigned to each hospital.
The market-level variables are derived from the Area Health Resource File (AHRF). The
AHRF database provides county-level information on a broad range of health resources and
socioeconomic indicators which might impact demand for health care (U. S. Department of
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Health and Human Services, 2016). The county in which the hospital is located is used as the
definition of the market for merging with the AHRF. This is a common practice in literature
(Garnick, Luft, Robinson, & Tetreault, 1987). The market-level data are merged with the
hospital-level data using the unique Federal Information Processing Standards (FIPS) code
assigned to each county (United States Census Bureau, 2010).
Study Population
The unit of analysis in this study is a discharge record of an individual patient. One
discharge record represents one single patient because patient discharge records are not linked
over time in this study. This is because only two (Florida and New York) of the nine states
included in the study have patient link variables to link discharge records of patients over the
study time period. Thus, the term patient-level is used to refer to discharge-level data henceforth.
Patient-level data from the 9 states included in the study are queried for observations where
patient sex is female and the primary diagnosis is breast cancer. Breast cancer diagnosis is
ascertained by selecting patients for whom the Clinical Classification System (CCS) code is 24
which represents ‘Cancer of the Breast’ and includes observations with ICD-9 diagnosis codes
for breast cancer diagnoses (174.0, 174.1, 174.2, 174.3, 174.4, 174.5, 174.6, 174.8, 174.9, 175.0,
175.9, 233.0, V103) (Healthcare Cost and Utilization Project, 2016a).
The sample is then restricted to women between 30-80 years of age. Although the median
age for breast cancer diagnosis among women is 62 years, nearly 5% of all breast cancer patients
are between 30 to 40 years of age (Zabicki et al., 2006). Additionally, Blacks are more likely to
be diagnosed at a younger age than non-Hispanic Whites (Brinton, Sherman, Carreon, &
Anderson, 2008). Hence, patients 30 years of age and older are included in this study. Patients
older than 80 years of age are excluded since reconstruction rates are significantly lower among
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this population (less than 3% rate of reconstruction) (Kruper, Holt, et al., 2011). Next, patients
who had a history of prior breast cancer as evident by their ICD-9 code for the primary diagnosis
(ICD-9 code V103) are excluded from the sample since patients with recurrent cancer may have
certain contraindications such as previous scarring or radiation therapy to the affected breast
which may be contraindications for reconstruction surgery (Hu & Alderman, 2007). Next,
patients with a secondary diagnosis of metastasis to lung, liver, brain, bone, lymph node
(common sites for metastasis from breast cancer) (Weigelt, Peterse, & Van't Veer, 2005) are also
excluded. Secondary metastases are usually a contraindication for breast reconstruction surgery
(Hu & Alderman, 2007). Secondary metastases to these sites are identified using secondary
diagnosis codes in the HCUP and OSHPD data. If any of the secondary diagnoses fields had an
ICD-9 diagnosis code for metastases to these sites, the observation is excluded from the sample.
The ICD-9 diagnosis code for metastases to these five sites are 1) Lung: 197.0, 2) Liver: 197.7,
3) Brain: 198.3, 4) Bone: 198.5, 5) Lymph node: 196.9 (Weigelt et al., 2005).
The sample is then restricted to only those observations where Mastectomy is one of the
procedures conducted. The ICD-9 procedure codes used for identifying mastectomies are 85.33,
85.34, 85.35, 85.36, 85.40, 85.41, 85.42, 85.43, 85.44, 85.45, 85.46, 85.47, 85.48 (Jagsi et al.,
2014). Lastly, the sample is restricted to non-Hispanic White, non-Hispanic Black and Hispanic
patients. Patients with any other race/ethnicity are excluded from the sample.
The final sample consists of 58,429 patient observations with 43,469 observations of nonHispanic White patients, 7,585 observations of non-Hispanic Black patients and 7,375
observations of Hispanic patients. Figure 4 presents the flow diagram for the sample with all the
exclusion criteria and number of observations excluded at each step.
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Figure 4. Flow Diagram for Sample
Variable Measurement
Dependent variable.
The dependent variable is constructed as a binary indicator for receipt of immediate or
immediate-delayed breast reconstruction (IBRS) at the time of receipt of mastectomy. Patients
are classified as undergoing immediate breast reconstruction based on the presence of ICD-9
procedure codes during the incident admission indicating autologous free or pedicled flap,
implant-based reconstruction, or placement of tissue expander (for immediate-delayed
reconstruction) (Immediate implant reconstruction: ICD-9 procedure code 85.33, 85.35, 85.53,
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85.54; Immediate autologous reconstruction: ICD-9 procedure code 85.70, 85.71, 85.72, 85.73,
85.74, 85.75, 85.76, 85.79, 85.82, 85.83, 85.84, 85.85, 85.86; Tissue expander insertion for
immediate-delayed reconstruction: ICD-9 procedure code 85.95) (Jagsi et al., 2014). In the
absence of one of these codes, patients are classified as not receiving immediate breast
reconstruction. Delayed reconstructions are not included in this study for two reasons. First,
nearly 90 to 95% of all breast reconstructions are immediate (Eltahir et al., 2015; Kaplan et al.,
2011). Second, HCUP and OSHPD data do not provide patient-level identifier variables for
linking patient visits over time. This makes it difficult to identify delayed reconstructions.
In addition to the binary variable for receipt of immediate or immediate-delayed
reconstruction, binary variables for receipt of immediate autologous reconstruction and
immediate implant reconstruction are also constructed. This is done in order to conduct
additional analyses with type of immediate reconstruction as the dependent variable.
Explanatory variables.
Hospital-level variables.
Hospital-level variables included in the model are percentage of breast cancer patients in
the hospital, percentage of Medicaid patients in the hospital, percentage of racial and ethnic
minorities in the hospital, bed size, financial performance, ownership and teaching status.
The percentage of breast cancer patients is measured using a ratio with all hospital
discharges (without any exclusions) as the denominator, and all hospital discharges with a
primary diagnosis of breast cancer determined using the ICD-9 diagnosis codes presented in the
Study Population section as the numerator. The percentage of Medicaid patients is measured
using a ratio with all hospital discharges (without any exclusions) as the denominator, and all
hospital discharges with Medicaid as the primary payer as the numerator. The percentage of
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racial and ethnic minority patients also called racial/ethnic mix is measured using a ratio with all
hospital discharges (without any exclusions) as the denominator, and all hospital discharges for
Black and Hispanic patients as the numerator. None of the sample exclusions described in the
Study Population section are applied to the numerator or denominator for these three variables.
This is because the sample exclusions are made in the context of the dependent variable i.e.
receipt of IBRS. On the other hand, these three variables are indicators of a hospital’s overall
resources and not those specific to breast cancer patients. All three of these variables are
included in statistical models as continuous variables.
The financial performance of a hospital is measured using the total margin which is a
ratio of net income to total revenue, as is commonly done in literature (Bazzoli, Chan, Shortell,
& D'Aunno, 2000; Ehreth, 1994; Levitz & Brooke Jr, 1985; Mark, Evans, Schur, & Guterman,
1998). The total margin is derived from the Center for Medicare and Medicaid Services Hospital
Cost Report data. The size of the hospital is measured as the number of beds in the hospital i.e.
the bed size. The bed size of the hospital is obtained from the American Hospital Association
(AHA) Annual Survey database. Total margin and bed size are continuous variables.
Hospital ownership is measured using three categories of not-for-profit, for-profit and
non-federal public ownership status of a hospital. The ownership category is obtained from the
American Hospital Association (AHA) Annual Survey database. Federal hospitals that serve
only special populations (e.g. military, veterans, etc.) do not report administrative data to HCUP
or OSHPD and are not included in this study.
Teaching status is measured using a binary variable. A hospital is classified as a teaching
hospital if the AHA database identifies it as having one or more resident physician training
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programs accredited by the Accreditation Council for Graduate Medical Education, or if the
hospital has a medical school affiliation (American Hospital Association, 2014).
Market-level variables.
The county where the hospital is located is used as the definition of market for this study
as is commonly done in previous literature. Market-level variables included in the model are
concentration, urbanicity, and density of plastic surgeons in the county.
Competition is measured as an inverse of the Herfindahl-Hirschman Index (HHI) of
concentration (Rhoades, 1993). HHI is calculated as the sum of the squared market share of each
hospital in the market. Market share of a particular hospital is measured as proportion with all
inpatient admissions from that particular hospital as the numerator and all inpatient admissions in
the market as the denominator. Inpatient admissions for each hospital and information on number
of hospitals in a market are derived from the AHA database. The HHI ranges between zero and
one with one representing the perfect monopoly or the most concentrated market and values
approaching zero representing the most competitive market. For example, a market with only
one hospital would have a squared market share i.e. HHI equal to one. Conversely, a market with
a large number of hospitals would have a small sum of squared market shares, and thus an HHI
near zero. HHI is included in the statistical model as a continuous variable as it can assume any
value between zero and one.
Urbanicity is measured as a four-category urban-rural designation for the county in which
the hospital is located. This categorization is a simplified adaptation of the 2013 version of the
Urban Influence Codes (UIC). Urban Influence Codes developed by the United States
Department of Agriculture Economic Research Service divide the 3,143 counties, county
equivalents, and independent cities in the United States into twelve groups. Metro counties are
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divided into two groups according to the population size of the metro area-those in large areas
have at least one million residents and those in small areas have fewer than one million residents.
Non-metro counties include all counties outside metro areas and are delineated as micropolitan
or noncore using Office of Management and Budget’s classification. Non-metro micropolitan
counties are divided into three groups distinguished by metro size and adjacency: adjacent to a
large metro area, adjacent to a small metro area, and not adjacent to a metro area. Non-metro
noncore counties are divided into seven groups distinguished by their adjacency to metro or
micro areas and whether or not they contain a town of at least 2,500 residents (Parker, 2011). For
the statistical models in this study, the twelve categories of the UIC are condensed into four
broader categories that differentiate between large metropolitan, small metropolitan,
micropolitan and rural counties. The large metropolitan category comprises of UIC 1 which
represents large metropolitan area with more than one million residents. The small metropolitan
category comprises UIC 2 which represents small metro area of less than one million residents.
The micropolitan category comprises UIC 3 which represents micropolitan area adjacent to large
metro area, UIC 5 which represents micropolitan area adjacent to small metro area or UIC 8
which represents micropolitan area not adjacent to a metro area. Lastly the rural category
comprises UIC 4, 6, 7, 9, 10, 11, 12 which represent non-core areas (Healthcare Cost and
Utilization Project, 2016b; Parker, 2011). Condensing the twelve UIC categories into four
broader categories is commonly done in literature that utilizes HCUP data to study geographical
differences in care (Barrett, Wier, & Washington, 2006; Torio & Andrews, 2006).
The density of plastic surgeons in the market is measured as number of plastic surgeons
per hundred residents in the county in the year 2010. The number of plastic surgeons in the
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county as well as total population of the county is derived from the AHRF. The variable is
included in the statistical models as a continuous variable.
Patient-level control variables.
The patient-level control variables included in the model are patient’s age, clinical
comorbidities, obesity, insurance type and income. Patient’s age at admission is obtained from
the HCUP and OSHPD databases and measured as patient-reported age in years, a continuous
variable. Clinical comorbidities are measured using the Charlson comorbidity score. In order to
compute the Charlson comorbidity score for a patient, each of the patient’s comorbid conditions
are assigned a score of one, two, three, or six, depending on the risk of dying associated with
each comorbidity. Scores are then summed to provide a total score which is considered to be a
good predictor of mortality (Charlson et al., 1987). Next, obesity is measured as binary variable.
A patient is classified as obese if the binary variable for obesity as a comorbidity in the HCUP
and OSHPD database is 1 (Elixhauser et al., 1998). Obesity is included as a separate measure
because it is not included in the calculation of the Charlson comorbidity score and it is known to
be a risk factor for complications after BRS and is an important determinant of whether a patient
gets BRS and what type of BRS procedure they receive (Saha et al., 2013). Patient’s insurance
type is operationalized as three binary variables for Medicaid, Medicare and self-pay (uninsured)
with private insurance as the reference group. This information is obtained from the primary
payer variable in the HCUP and OSHPD databases.
HCUP and OSHPD databases do not provide information on patient-level income.
However, HCUP provides quartiles of median household income in the zip code where the
patient lives. This is considered as a proxy for patient income in past literature (Hanley &
Morgan, 2008; Michalski & Nattinger, 1997). This information is obtained from the median
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income in zip code of the patient quartiles variable in the HCUP SID. This variable is not
available in the California OSHPD data. The zip-code level median household income for the
state of California is obtained from the American Community Survey and is merged to the
OSHPD database. The quartiles of this variable are then created so the format of the variable for
California is similar to that of other states. This variable is included in the statistical model as
three binary variables for income quartiles two, three and four with income quartile one, the
lowest quartile of median household income in the patient’s zip code, as the reference group.
Patient-level race and ethnicity variables.
Patient race and ethnicity is represented by two separate binary variables for nonHispanic Black and Hispanics with non-Hispanic Whites as the reference group. This
information is derived from the HCUP and OSHPD databases. The ethnicity data takes
precedence over the race data for those with a Hispanic ethnicity. Thus, anyone with a Hispanic
ethnicity is classified as a Hispanic and their race is not considered for the purpose of this study
(Nerenz, McFadden, & Ulmer, 2009). Therefore, White means non-Hispanic White and Black
means non-Hispanic Black in these databases. Henceforth in this study, the term White refers to
Non-Hispanic Whites and the term Black refers to Non-Hispanic Black. The definitions and
sources of the variables in the model are presented in Table 1.
Table 1
Variable Definitions and Sources
(Table 1: Continued)
Variable
Definition
Dependent Variable
Receipt of Immediate BRS
Binary 0/1 variable. 1 if the patient received
IBRS based on ICD-9 Procedure codes
identified from literature.
Independent variables
Patient-level

1
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Source
HCUP SID

68
(Table 1: Continued)
Variable
Black race
Hispanic ethnicity
Age
Clinical Comorbidities
Obesity
Insurance

Income

Hospital-level
Percentage of breast cancer
patients
Bed size
Total margin
Racial/ethnic mix

Medicaid mix

Ownership

Teaching status
Market-Level
Competition

Definition
Binary 0/1 variable. 1 if the patient
race/ethnicity is non-Hispanic Black.
Binary 0/1 variable. 1 if the patient ethnicity
is Hispanic regardless of race.
Continuous variable. Patient age in years.
Measured using Charlson Score. Continuous
variable.
Binary 0/1 variable. 1 if the patient is
classified as obese.
Three separate binary variables for
Medicare, Medicaid and Self-pay
(Uninsured) payer type with Private
Insurance as the omitted reference category.
Measured as median household income at
the patient’s zip code level and then
converted to quartiles with quartile 1 (the
lowest income group) being the omitted
reference category.

Source
HCUP SID

Continuous variable measured as number of
discharges from a hospital with breast cancer
as primary diagnosis*100/number of total
discharges from a hospital.
Total number of beds in the facility that are
set up and staffed.
Continuous variable measured as ratio of net
income to total revenue.
Continuous variable measured as number of
discharges from a hospital for non-Hispanic
Black and Hispanic patient*100/number of
total discharges from a hospital.
Continuous variable measured as number of
discharges from a hospital with Medicaid as
the primary payer*100/number of total
discharges from a hospital.
Two separate binary variables for not-forprofit ownership and non-federal public
ownership with for-profit as the omitted
reference category.
Binary 0/1 variable. 1 if the hospital is a
teaching hospital.

HCUP SID

Continuous variable measured as inverse of
Herfindahl-Hirschman Index. HHI ranges

AHA
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HCUP SID
HCUP SID
HCUP SID
HCUP SID
HCUP SID

HCUP SID

AHA
CMS HCR
HCUP SID

HCUP SID

AHA

AHA
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(Table 1: Continued)
Variable

Plastic surgeon density
Urbanicity

Definition
between 0 (perfect competition) to 1 (no
competition). Thus, competition ranges
between 1 to infinity.
Continuous variable measured as number of
plastic surgeons in the county per 100 total
population.
Measure using 4 categories of Urban
Influence Codes (UIC). 3 separate binary
variables for small metropolitan areas with
less than 1 million residents (UIC 2),
micropolitan areas (UIC3), rural areas that
are not metropolitan or micropolitan (UIC4)
with large metropolitan areas with at least 1
million residents as the omitted reference
category (UIC1).

Source

AHRF

HCUP SID

Note: HCUP SID is Healthcare Cost and Utilization Project State Inpatient Databases for the 8 states except
California included in the model, OSHPD is Office of Statewide Health Planning and Development Inpatient
database for the state of California, AHA is American Hospital Association Survey Database, CMS HCR is Center
for Medicare and Medicaid Services Hospital Cost Report data, AHRF is Area Health Resource File.

Analytical Approach
A pooled cross-sectional retrospective non-experimental design is used to address the
research questions. The analysis is performed in multiple steps: descriptive statistics, logistic
regression with patient-level clinical variables, mixed effects logistic regression without and with
interactions between race/ethnicity and place of care characteristics and lastly, Fairlie
decomposition.
Descriptive statistics.
The first step is to conduct descriptive analyses for the full sample and then separately for
the Blacks, Whites and Hispanics. The descriptive statistics for the dependent variable and all
independent variables are then compared across race/ethnicity (Blacks compared to Whites and
Hispanic compared to Whites) in order to determine whether the dependent variable and the
independent variables at the patient, hospital and market level variables included in the model
differ significantly across race and ethnicity.
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Paired t-tests are used for continuous variables wherein variable means for Blacks and
Hispanics are compared to variable means for Whites. For binary variables, the percentage of
observations where the variable=1 is compared across race and ethnicity and Chi-square tests are
used to test whether differences in the variables across race and ethnicity are significant.
Logistic regression.
Next, logistic regression with receipt of IBRS as the dependent variable is estimated in
order to examine if racial and ethnic differences in receipt of IBRS persist after controlling for
patients’ clinical characteristics. No hospital or market-level variables are included in the model
at this step. Black race and Hispanic ethnicity are the two explanatory variables along with
patient-level clinical variables such as age, comorbidities and obesity as control variables. Since,
all the variables are measured at the patient-level, mixed effects regression is not used for this
step. The empirical specification for this model is presented in Equation 1.
𝑙𝑜𝑔𝑖𝑡{𝑃𝑟(𝑌 = 1)} = 𝛽0 + 𝛽1 ∗ 𝐵𝑙𝑎𝑐𝑘 𝑟𝑎𝑐𝑒 + 𝛽2 ∗ 𝐻𝑖𝑠𝑝𝑎𝑛𝑖𝑐 𝑒𝑡ℎ𝑛𝑖𝑐𝑖𝑡𝑦 + 𝛽3 ∗ 𝐴𝑔𝑒 + 𝛽4 ∗
𝐶ℎ𝑎𝑟𝑙𝑠𝑜𝑛 𝑠𝑐𝑜𝑟𝑒 + 𝛽5 ∗ 𝑂𝑏𝑒𝑠𝑖𝑡𝑦 + 𝜇

(1)

where Y is a binary indicator of receipt of breast reconstruction and 𝜇 is the error term.
Odds ratios are used to present the results of the regression. Odds ratio represents the
odds that an outcome will occur given a particular exposure, compared to the odds of the
outcome occurring in the absence of that exposure. If odds ratios for Black race and Hispanic
ethnicity are less than one and are significant at P-value less than 0.05, it means that Blacks and
Hispanics respectively are less likely to receive IBRS than Whites even after controlling for
clinical characteristics.
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Mixed effects logistic regression for research question 1.
Next, the relationship between hospital and market characteristics included in the
conceptual model and receipt of IBRS is examined to address research question 1. Hypotheses
1A to 1K are tested using a mixed effect logistic regression model. Mixed effects (multi-level)
regression is used since the data is nested in nature. Patient discharges are nested within the
hospital which in turn is nested in the market (county) and finally, the state. The empirical
specification for this model is presented in Equation 2.
𝑙𝑜𝑔𝑖𝑡{𝑃𝑟(𝑌𝑖𝑗𝑘𝑙 = 1)} = 𝛽0 + 𝛽1 ∗ 𝐵𝑙𝑎𝑐𝑘 𝑟𝑎𝑐𝑒𝑖𝑗𝑘𝑙 + 𝛽2 ∗ 𝐻𝑖𝑠𝑝𝑎𝑛𝑖𝑐 𝑒𝑡ℎ𝑛𝑖𝑐𝑖𝑡𝑦𝑖𝑗𝑘𝑙 +
𝛽3 ∗ 𝑃𝑖𝑗𝑘𝑙 + 𝛽4 ∗ 𝐻𝑗𝑘𝑙 + 𝛽5 ∗ 𝑀𝑘𝑙 + 𝛽6 ∗ 𝑆𝑙 + 𝜁𝑗𝑘𝑙 + 𝜁𝑘𝑙 + 𝜇𝑖𝑗𝑘𝑙

(2)

where Y is a binary indicator of receipt of breast reconstruction and 𝑖 = (1,2, … . 𝑛𝑗𝑘𝑙 ) patients in
𝑗 = (1,2, … . 𝑛𝑘𝑙 ) hospitals in 𝑘 = (1,2, … . 𝑛𝑙 ) markets in 𝑙 = (1,2 … 9) states. P is a vector of
patient-level variables, H is a vector of hospital-level variables, M is a vector of market-level
variables and S is a vector of state fixed effects. 𝜁𝑗𝑘𝑙 is the hospital-level random effect and 𝜁𝑘𝑙 is
the market-level random effect. Error term 𝜇𝑖𝑗𝑘𝑙 is the composite error term and it incorporates
random error at the patient, hospital and market-level. In order to test hypotheses 1A to 1K,
significance of β4 and β5 in Equation 2 are examined.
Mixed effects logistic regression with interaction terms for research question 2.
Next, a mixed effects model with interaction terms between race/ethnicity and hospital
and market variables is used to examine whether hospital and market characteristics moderate
the relationship between race/ethnicity and receipt of IBRS. The empirical specification for this
model is presented in Equation 3.
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𝑙𝑜𝑔𝑖𝑡{𝑃𝑟(𝑌𝑖𝑗𝑘𝑙 = 1)} = 𝛽0 + 𝛽1 ∗ 𝐵𝑙𝑎𝑐𝑘 𝑟𝑎𝑐𝑒𝑖𝑗𝑘𝑙 + 𝛽2 ∗ 𝐻𝑖𝑠𝑝𝑎𝑛𝑖𝑐 𝑒𝑡ℎ𝑛𝑖𝑐𝑖𝑡𝑦𝑖𝑗𝑘𝑙 +
𝛽3 ∗ 𝑃𝑖𝑗𝑘𝑙 + 𝛽4 ∗ 𝐻𝑗𝑘𝑙 + 𝛽5 ∗ 𝑀𝑘𝑙 + 𝛽6 ∗ 𝑆𝑙 + 𝛽7 ∗ 𝐵𝑙𝑎𝑐𝑘 𝑟𝑎𝑐𝑒𝑖𝑗𝑘𝑙 ∗ 𝐻𝑗𝑘𝑙 + 𝛽8 ∗
𝐵𝑙𝑎𝑐𝑘 𝑟𝑎𝑐𝑒𝑖𝑗𝑘𝑙 ∗ 𝑀𝑘𝑙 + 𝛽9 ∗ 𝐻𝑖𝑠𝑝𝑎𝑛𝑖𝑐 𝑒𝑡ℎ𝑛𝑖𝑐𝑖𝑡𝑦𝑖𝑗𝑘𝑙 ∗ 𝐻𝑗𝑘𝑙 + 𝛽10 ∗ 𝐻𝑖𝑠𝑝𝑎𝑛𝑖𝑐 𝑒𝑡ℎ𝑛𝑖𝑐𝑖𝑡𝑦𝑖𝑗𝑘𝑙 ∗
𝑀𝑘𝑙 + 𝜁𝑗𝑘𝑙 + 𝜁𝑘𝑙 + 𝜇𝑖𝑗𝑘𝑙

(3)

To address research question 2, the significance of β7, β8, β9 and β10 in Equation 3 are
examined.
Fairlie decomposition for research question 3.
The decomposition approach used in this paper is Fairlie decomposition (Fairlie, 2005)
which is a non-linear modification of the more popular Blinder-Oaxaca decomposition (Blinder,
1973; R. Oaxaca, 1973). The Blinder Oaxaca method is commonly used in economics to study
the gender wage gap (R. Oaxaca, 1973; R. L. Oaxaca & Ransom, 1994). The Fairlie
decomposition method has been used in a number of health disparities studies including a study
on disparity in breast cancer screening (Jadav, Rajan, Abughosh, & Sansgiry, 2015).
The basic concept of decomposition is that inequality in receipt of breast reconstruction
reflects at the minimum, inequalities in the various factors associated with it. The decomposition
technique provides a way of assessing the relative contribution of each associated factor in
explaining the inequality. The contribution of a factor could be due to inequality in its level or
due to inequality in its effect (O’Donnell, Van Doorslaer, & Wagstaff, 2006). For example, racial
difference in the receipt of IBRS may be due to racial difference in access to a hospital that
performs such a procedure or it may be due to racial differences in the ability to take advantage
of such access. The first component represents endowments i.e. the contribution of differences in
explanatory variables across racial groups and the second component represents group

72

73
differences in the coefficients or the slope of the explanatory variables and interaction between
coefficients and endowments (Hlavac, 2014).
Blinder Oaxaca decomposition is meant to be applied to linear regressions with
continuous dependent variables. Consider Y to represent a hypothetical variable, % of women
receiving IBRS in a county, and Group A to represent Whites and Group B to represent Blacks.
The difference in mean outcome for group A and B can be represented as:
∆𝑌̅ = 𝑌̅𝐴 − ̅̅̅
𝑌𝐵

(4)

̅𝐵
∆𝑌̅ = 𝛽̂𝐴 ̅̅̅
𝑋 ′𝐴 − 𝛽̂𝐵 𝑋′

(5)

̅ is the racial difference in the % of
Y is the % of women receiving IBRS in a county. ∆Y
̅̅̅
women receiving IBRS in a county. Y
A is the % of White women receiving IBRS in a county
and ̅̅̅
YB is the % of Black women receiving IBRS in a county. X̅′ A is the value of explanatory
variable X for White women and β̂A is the coefficient of the explanatory variable for White
̅ B is the value of the explanatory variable for Black women and β̂B is the
women and X′
coefficient of the explanatory variable for Black women.
This expression can, in turn, be written as the sum of the following three terms:
̅̅̅′𝐴 − ̅̅̅
̅̅̅′ 𝐵 } + {(𝑋
̅̅̅′𝐴 − ̅̅̅
∆𝑌̅ = {(𝑋
𝑋 ′ 𝐵 )𝛽̂𝐵 } + {( 𝛽̂𝐴 − 𝛽̂𝐵 )𝑋
𝑋 ′ 𝐵 )( 𝛽̂𝐴 − 𝛽̂𝐵 )}

(6)

This is the three-fold Oaxaca Blinder decomposition of the mean outcome difference.
The first term is called endowments, the second is coefficients and the third is interaction. The
interaction term accounts for the fact that cross-group differences in explanatory variables and
coefficients can occur at the same time. This decomposition is from the point of view of Group B
i.e. the Black women as is evident from the first and second term of Equation 6. This means that
Black women are considered to be the disadvantaged group in this case. If the point of view are
to be reversed to that of Whites, the results would be different (Jann, 2008a). This is a limitation
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of the original Blinder-Oaxaca model that can be addressed using a two-fold approach as is done
in Fairlie decomposition. The twofold approach decomposes the mean outcome difference with
respect to a vector of reference coefficients 𝛽̂𝑅 . In the research literature on labor market
discrimination, the reference coefficient vector has typically been interpreted to be nondiscriminatory – in other words, as the set of regression coefficients that would emerge in a
world of no labor market discrimination (Hlavac, 2014).
̅̅̅′𝐴 − ̅̅̅
̅̅̅′𝐴 + ̅̅̅
∆𝑌̅ = {(𝑋
𝑋 ′ 𝐵 )𝛽̂𝑅 } + {( 𝛽̂𝐴 − 𝛽̂𝑅 )𝑋
𝑋 ′ 𝐵 ( 𝛽̂𝑅 − 𝛽̂𝐵 )}
Explained

(7)

Unexplained A
Unexplained B
Unexplained

As seen in Equation 7, the twofold decomposition divides the difference in mean
outcomes into a portion that is explained by cross-group differences in the explanatory variables,
and a part that remains unexplained by these differences. The unexplained portion of the mean
outcome gap has often been attributed to discrimination, but may also result from the influence
of unobserved variables. It can be further decomposed into two sub-components, labeled
“Unexplained A” and “Unexplained B” in Equation 7. If one interprets the reference coefficient
vector to be non-discriminatory, these sub-components measure the part of the mean difference
in outcomes that originates from discrimination in favor of Group A and the part that comes from
discrimination against Group B, respectively. The choice of the reference coefficients is
generally up to the researcher. A commonly used method is the one proposed by Oaxaca and
Ransom (1994) and Jann (2008) to use coefficient estimates from a regression that pools
observations from both Groups A and B, and include the group indicator variable (race) as an
additional regressor (Jann, 2008a; R. L. Oaxaca & Ransom, 1994). Fairlie decomposition
addresses the limitation of Blinder Oaxaca method by using reference coefficients from the
pooled regression. In addition to the unexplained A and unexplained B components, there is a
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third component in the unexplained portion that represents difference in intercept for group A
and group B i.e. 𝛽̂0𝐴 -𝛽̂0𝐵 . This difference in intercepts could be due to unobserved omitted
variables (Frank L Jones & Kelley, 1984).
Decomposition methods not only decompose the outcome differential into an explained
and an unexplained portion, but also estimate the detailed contributions of the single predictors
or sets of predictors included in the model. The total explained component is a simple sum of the
contributions of differences in individual predictor variables. Jones and Kelley (1984) pointed
out that the contribution of differences in individual variables to the ‘unexplained’ portion are
not easily interpretable unless they have a natural zero point and their scale does not shift (Frank
L Jones & Kelley, 1984). Thus, for the purpose of this paper, the focus is on the contribution of
variables to the explained portion, as is common in the literature that uses this method.
A known issue with using the Blinder-Oaxaca decomposition is that the decomposition
results depend on the choice of omitted category for categorical independent variables
(Gardeazabal & Ugidos, 2004; Frank Lancaster Jones, 1983; Frank L Jones & Kelley, 1984;
Yun, 2005). Categorical variables are usually modeled by including 0/1 dummy variables for the
different categories in the regression such that one of the categories (base category) is omitted to
avoid collinearity. If the base category changes, the decomposition results also change since the
differences in associated coefficients are quantified with respect to the base category. To address
this, Gardeazabal and Ugidos (2004) and Yun (2005) recommend transforming the dummy
variables before model estimation (Gardeazabal & Ugidos, 2004; Yun, 2005). The idea is to
express effects as deviations from the grand mean. This ensures that results of Blinder–Oaxaca
decomposition are independent of the choice of omitted category (Jann, 2008a; Yun, 2005).
Fairlie decomposition addresses this limitation of the Blinder Oaxaca method.
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There are two other issues with Blinder Oaxaca decomposition that are addressed in the
Fairlie method. The first issue is that the decomposition using this technique is dependent on the
relative sample size of the two groups (e.g. Whites and Blacks). It assumes that both groups have
equal sample size and 1:1 matching. Since that is rarely the case in data, a random sample of
Whites to match the number of Blacks needs to be used for the decomposition (assuming there
are more Whites in the data than Blacks). The results of decomposition are dependent on the
sample chosen. Hence, Fairlie (2005) proposed to draw at least 1000 multiple random samples
from the White population and rerun the decomposition to obtain standard errors (Fairlie, 2005).
The second issue with using the non-linear modification is that results of decomposition
are dependent on the order in which variables are entered into the model. Fairlie (2005) proposed
experimenting with different orders of variables to confirm the robustness of results. Fairlie
(2005) suggested that the best solution may be randomizing the order of variables. The ordering
of variables could be randomized at the same time as drawing the random subsample of whites
(Fairlie, 2005). In this paper, Fairlie decomposition is conducted using the user written
command ‘fairlie’ in Stata 14 using 1000 pooled random samples along with the option for
random ordering of variables in order to address the limitations of the traditional decomposition
model (Jann, 2008b).
Sensitivity Analyses
For all the analyses in the study up to this point, observations of patients who receive care
at hospitals that do not provide any IBRS services are included in the sample. However, hospitals
that do not provide any IBRS services are different from hospitals that have the ability to provide
these services but have a lower likelihood of providing IBRS; either to all patients or especially
to racial and ethnic minorities. Thus, including hospitals that do not provide any reconstruction
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services to all patients may bias the results and reduce racial and ethnic differences. Including
these hospitals may also lower the contribution of the included hospital and market-level
characteristics to racial and ethnic differences. Hence, sensitivity analyses are conducted after
excluding all hospitals that do not provide any IBRS services i.e. if the average number of IBRS
procedures in the hospital over 2010 to 2012 is zero.
Next, sensitivity analyses are conducted after combining Blacks and Hispanic into one
minority group. The idea of separating Blacks and Hispanics in the main analyses of the paper is
that Blacks and Hispanics face different cultural and linguistic barriers in access to health care
services (Conklin, 2008). Thus, separating the analyses helps generate specific practice and
policy recommendations. However, there are also a number of similarities in the socioeconomic
barriers in access to health care services faced by Blacks and Hispanics (Centers for Disease
Control and Prevention, 2005; Saloner & Lê Cook, 2013; Ward et al., 2004). Thus, sensitivity
analyses are conducted with the combined minority group compared to Whites for all the
analyses.
Additional Analyses
Immediate breast reconstruction surgery can be done either using implants, patient’s own
tissue (autologous), or tissue expanders that serve as temporary prosthesis until the time the
patient is fit to receive a reconstruction in a second stage surgery (this second stage surgery
reconstruction can be done using implants or patient’s own tissue. Not much is known about the
factors associated with the receipt of a particular type of reconstruction. Given the nature of the
data, the type of reconstruction (autologous or implant) procedure subsequently chosen by
women receiving immediate tissue expanders during their mastectomy cannot be determined.
Thus, all observations with receipt of tissue expanders are excluded so the factors associated

77

78
with receipt of immediate autologous reconstruction (AR) vs. immediate implant reconstruction
(IR) can be examined. AR and IR have relative advantages and disadvantages as explained in
Chapter 2, and no single surgery is preferred over the other. These additional analyses serve as a
first step towards understanding racial/ethnic difference in type of reconstruction and the hospital
and market factors associated with autologous reconstruction. For this analysis, the sample is
restricted to only those patients who received a breast reconstruction. Next, all patients who
received a tissue expander as part of the two-step reconstruction process are excluded. Thus, the
final sample included only those patients who received an immediate autologous reconstruction
(AR) or an immediate implant reconstruction (IR). The entire set of analyses (descriptive
statistics, patient-level logistic regression, mixed effects logistic regression, mixed effects
logistic regression with interactions and Fairlie decomposition) are repeated for this sample in
order to understand the hospital and market-level factors associated with the type of
reconstruction received (immediate autologous reconstruction vs immediate implant
reconstruction) and to understand the contribution of patient, hospital and market-level variables
to racial and ethnic differences in receipt of immediate autologous reconstruction (AR).
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Chapter 5: Results

Overview of Chapter Structure
In this chapter, the results of the analyses described in Chapter 4 are presented. In the first
section, the descriptive statistics for the dependent as well as explanatory variables for the full
sample and by race/ethnicity are reported. This is followed by the results of the patient-level
logistic regression which examines whether racial and ethnic differences in immediate breast
reconstruction surgery (IBRS) persist after controlling for patient’s clinical characteristics. Next,
the results from the multilevel mixed effects logistic regression are presented which examines
the hospital and market-level characteristics associated with receipt of IBRS in order to address
research question 1. Next, results from the mixed effects logistic regression which includes
interactions between hospital and market-level variables and race/ethnicity to address research
question 2 are presented. This is followed by presentation of results from the Fairlie
decomposition to address research question 3. In the next section, the results from the sensitivity
analyses are presented followed by results for the additional analyses. The chapter concludes
with a brief summary of the results.
Results for Descriptive Statistics
The descriptive statistics for the dependent variable and the explanatory variables at the
patient-level, hospital-level and market-level for the full sample and by race and ethicity are
presented in Table 2. Chi-square tests are used for binary and categorical variables and simple
student t-tests for continuous variables at a significance level of α = 0.05.
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Table 2
Variable Means and Percentage
(Table 2: Continued)
Variable

2

Receipt of Immediate Breast
Reconstruction Surgery (%)
Patient-level
Age
Charlson score
Obese (%)
Insurance (%)
Medicare
Medicaid
Uninsured
Private Insurance
Median household income in
the zip code (%)
Quartile 1 (lowest income)
Quartile 2
Quartile 3
Quartile 4 (highest income)
Hospital-level
Percentage of breast cancer
patients
Bed size/10
Total margin
Racial/ethnic mix
Medicaid mix
Ownership (%)
For profit
Not-for-profit
Nonfederal public
Teaching status (%)
Market-Level
Competition (1/HHI)

Full
Sample
52.77

White

Black

Hispanic

55.60

44.96**

44.12**

56.88
(11.84)
3.09
(2.06)
6.65

57.48
(11.75)
3.04
(2.04)
6.13

55.83**
(11.85)
3.27**
(2.16)
12.13**

54.45**
(11.97)
3.23**
(2.04)
4.08**

29.49
10.83
1.39
58.29

30.74
6.52
0.93
61.80

28.83**
18.59**
2.41**
50.18**

22.70**
28.61**
3.07**
45.63**

19.07
21.60
26.22
33.12

14.19
21.03
27.06
37.71

38.27**
22.83**
22.75**
16.15**

28.64**
23.72**
24.74**
22.91**

0.70
(1.98)
44.76
(34.75)
5.15
(14.37)
27.20
(19.77)
19.08
(13.86)

0.75
(2.203
43.59
(33.76)
5.77
(14.23)
22.22
(15.75)
17.41
(12.52)

0.49**
(1.07)
49.52**
(35.74)
3.93**
(11.77)
39.66**
(21.93)
23.08**
(15.15)

0.65**
(1.11)
46.73**
(38.79)
2.68**
(17.11)
43.73**
(23.70)
24.79**
(17.20)

7.42
79.73
12.84
61.52

7.28
81.44
11.28
60.51

6.62**
76.55**
16.84**
68.94**

9.13**
72.94**
17.94**
59.87

9.25
(12.95)
0.44

10.00**
(14.031)
0.42*

16.87**
(19.32)
0.44

10.31
(14.27)
Plastic surgeons/100 population 0.43
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(Table 2: Continued)
Variable
Urbanicity (%)
UIC1 (most urban)
UIC2
UIC3
UIC4 (most rural)
Sample Size

Full
Sample
(0.38)

White

Black

Hispanic

(0.38)

(0.36)

(0.38)

78.72
18.08
2.53
0.67
58,429

76.15
20.20
2.85
0.80
43,469

86.28**
11.21**
2.04**
0.47**
7,585

86.09**
12.69**
1.15**
0.07**
7,375

Note: Blacks are compared to Whites and Hispanics are also compared to Whites for significance testing. Standard
deviations are in parentheses. * represents p-value less than 0.05 whereas ** represents p-value less than 0.01.

Of the total sample (N=58,429), 74.4% are White (N=43,469), 13% are Black (N=7,585)
and 12.6% are Hispanic (N=7,375). Overall, Blacks and Hispanics less often receive immediate
breast reconstruction than Whites. Blacks and Hispanics are also younger than Whites.
However, in spite of the younger age, Blacks and Hispanics on average have more comorbidities
than Whites. Blacks are more often than Whites to be obese whereas Hispanics are less
frequently obese than Whites. Relatively more Blacks and Hispanics are uninsured or have
Medicaid as their primary payer and less frequently have private insurance or Medicare as their
primary payer than Whites. Lastly, Blacks and Hispanics more often live in zip codes with the
lowest median household income when compared to Whites.
There are a number of significant differences in hospital and market variables by race and
ethnicity of the patient. Blacks and Hispanics receive a mastectomy at hospitals that serve a
significantly lower percentage of breast cancer patients than hospitals where White patients
receive mastectomy. On the other hand, Blacks and Hispanics receive a mastectomy at hospitals
that serve a significantly higher percentage of racial and ethnic minorities (Blacks and Hispancis)
and Medicaid patients than hospitals where White patients receive mastectomy. Blacks and
Hispanics receive a mastectomy at hospitals with significantly lower financial performance than
the hospitals where White patients receive mastectomy. Relatively more Blacks and Hispanics
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receive a mastectomy at larger hospitals in urban, competitive markets than Whites. Blacks and
Hispanics more frequently receive a mastectomy at non-federal public hospitals and less often
receive a mastectomy at not-for-profit hospitals compared to Whites. Compared to Whites,
relatively fewer Blacks and relatively more Hispanics receive a mastectomy at a for-profit
hospital. Blacks more often receive a matsectomy at teaching hospitals than Whites. Lastly,
Blacks receive a mastectomy in markets that have higher density of plastic surgeons than
markets where Whites receive a mastectomy.
Patient-level Logistic Regression
Next, it is examined whether racial and ethnic differences in the dependent variable
persist after controlling for patient’s clinical characteristics. The results from this patient-level
logistic regression are presented in Table 3.
Table 3
Patient-level Logistic Regression

3

Variable
Race and ethnicity
Black race
Hispanic ethnicity
White (Reference)
Age
Charlson score
Obesity
Obese
Non-obese (Reference)
Intercept

Odds Ratio

95% CI

0.549**
0.455**

[0.520, 0.580]
[0.430, 0.481]

0.926**
0.836**

[0.924, 0.927]
[0.828, 0.843]

0.742**

[0.690, 0.798]

197.107**

[177.054, 219.431]

Note: CI=Confidence Interval. * represents p-value less than 0.05 whereas ** represents p-value less than 0.01.

As can be seen from Table 3, Blacks and Hispanics are nearly 50% less likely than
Whites to receive IBRS even after controlling for age, clinical comorbidities and obesity.
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Empirical Analyses Results: Research Question 1
Next, it is examined whether hospital and market chracteristics are associated with
receipt of IBRS while controlling for patient-level variables, in order to address Research
Question 1. To recap the theoretical hypotheses discussed in Chapter 3, it is expected that
patients receiving a mastectomy at hospitals with higher percentage of breast cancer patients,
lower percentage of Black and Hispanic patients, lower percentage of Medicaid patients, not-forprofit or public ownership, teaching status, higher bed size, and higher total margin have higher
likelihood of receiving IBRS based on Resource Dependence Theory (RDT), all else being
equal. Similarly, based on RDT, it is also expected that patients receiving a mastectomy in
markets that are urban, have higher hospital compeition, and higher plastic surgeon density have
higher likelihood of receiving IBRS, all else being equal. Lastly, for patient-level control
variables, it is expected that patients who are older, belong to a minority race or ethnicity, have a
higher comorbidity score, are obese, are insured by Medicare, Medicaid or uninsured, and reside
in low income neighborhoods have lower likelihood of receiving immediate breast
reconstruction (IBRS), all else being equal, based on the Anderson behavioral model of
utilization.
A multi-level mixed effects logistic regression is estimated for this step with patients
being nested within hospitals and hospital being nested within county (market). Hospital and
county random effects are included in the model along with state fixed effects. Apart from a
correlation of 0.68 between age and Medicare insurance, 0.53 between Medicaid mix and
racial/ethnic mix of the hospital, 0.57 between competition and large metropolitan market
(UIC1), none of the other variables are highly correlated with each other. The results are
presented in Table 4.
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Table 4
Mixed Effects Logistic Regression
(Table 4: Continued)
Variable
Patient-level
Race and ethnicity
Black race
Hispanic ethnicity
White (Reference)
Age
Charlson score
Obesity
Obese
Non-obese (Reference)
Insurance
Medicaid
Medicare
Uninsured
Private Insurance (Reference)
Quartiles of median household
income in patient’s zip code
Quartile 1 (lowest income)
Quartile 2
Quartile 3
Quartile 4 (Reference)
Hospital-level
Percentage of breast cancer patients
Bed size/10
Total margin
Racial/ethnic mix
Medicaid mix
Ownership
Not-for- profit
Non-federal public
For-profit (Reference)
Teaching status
Teaching
Non-teaching (Reference)
Market-level
Competition (1/HHI)
Plastic surgeons/100 population
Urbanicity
UIC 1 (most urban) (Reference)
UIC2
UIC3

4

Odds Ratio

95% CI

0.620**
0.718**

[0.575, 0.668]
[0.663, 0.777]

0.933**
0.821**

[0.930, 0.935]
[0.812, 0.831]

0.722**

[0.660, 0.790]

0.348**
0.486**
0.322**

[0.321, 0.378]
[0.455, 0.519]
[0.265, 0.391]

0.603**
0.690**
0.790**

[0.559, 0.650]
[0.644, 0.739]
[0.742, 0.840]

1.010
1.006**
1.000
0.994*
0.997

[0.992, 1.027]
[1.002, 1.010]
[0.997, 1.002]
[0.989, 0.999]
[0.992, 1.002]

1.321*
0.893

[1.021, 1.709]
[0.636, 1.253]

1.375**

[1.154, 1.639]

0.970*
9.820**

[0.948, 0.993]
[5.225, 18.455]

0.555**
0.151**

[0.403, 0.764]
[0.088, 0.261]
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(Table 4: Continued)
Variable
UIC4 (most rural)
State
Arizona
Florida
Kentucky
Maryland
North Carolina
New Jersey
New York
Washington
California (Reference)
Intercept

Odds Ratio
0.061**

95% CI
[0.019, 0.191]

0.775
0.712
0.327**
0.732
0.848
0.880
0.671
0.218**

[0.389, 1.546]
[0.463, 1.095]
[0.174, 0.615]
[0.389, 1.376]
[0.506, 1.422]
[0.517, 1.497]
[0.425, 1.059]
[0.115, 0.411]

98.282**

[58.807, 164.25]

Note: CI=Confidence Interval. * represents p-value less than 0.05 whereas ** represents p-value less than 0.01.

As can be seen from Table 4, Black patients have 38% lower likelihood of receiving
IBRS and Hispanic patients have 28% lower likelihood of receiving IBRS than White patients,
all else being equal. A one year increase in patient’s age is associated with 7% lower likelihood
of receiving IBRS, all else being equal. A one unit increase in Charlson comorbidity score is
associated with 18% lower likelihood of receiving IBRS, all else being equal. Compared to nonobese patients, obese patients have 28% lower likelihood of receiving IBRS. Compared to
patients insured with private insurance, patients insured with Medicaid, Medicare, or are
uninsured have 65%, 51% and 68% lower likelihood respectively of receiving IBRS, all else
being equal. Lastly, compared to patients who reside in zip codes with the highest quartile of
median household income (fourth quartile), patients residing in zip codes with the lowest quartile
(first quartile), second quartile and third quartile have 40%, 31% and 21% lower likelihood
respectively of receiving IBRS, all else being equal.
Patients receiving a mastectomy at hospitals that are not-for-profit have 32% higher
likelihood of receiving IBRS compared to the patients receiving a mastectomy at for-profit
hospitals, all else being equal. Similarly, patients receiving a mastectomy at teaching hospitals
have 38% higher likelihood of receiving IBRS compared to the patients receiving a mastectomy
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at non-teaching hospitals, all else being equal. A one percentage increase in the racial and ethnic
mix (% of all hospital patients that are Black or Hispanic) of the hospital where the patient
receives a mastectomy is associated with 0.6% lower likelihood of receipt of IBRS, all else being
equal. An increase of one bed in the hospital where patient receives a mastectomy is associated
with 6% higher likelihood of receiving IBRS, all else being equal. These results support the
hypotheses 1C, 1H, 1I and 1J presented in Chapter 3.
For market variables, one unit increase in competition in the market where patient
receives a mastectomy is associated with 3.1% lower likelihood of receiving IBRS, all else being
equal. This result does not support the hypothesis 1B that higher competition in the market is
associated with higher likelihood of receipt of IBRS. A one unit increase in number of plastic
surgeons per 100 population in the market where patient receives a mastectomy is associated
with nearly 800% higher likelihood of receiving IBRS, all else being equal. Lastly, compared to
the most urban market (UIC1), patients receiving a mastectomy in small metropolitan markets
(UIC2), micropolitan (UIC3) markets, and rural (UIC4) markets have 45%, 85% and 94% lower
likelihood respectively of reciving IBRS, all else being equal. The results for density of plastic
surgeons and urbanicity support the hypotheses 1E and 1F respectively. Compared to patients
who receive a mastectomy in the state of California, patients receiving a mastectomy in
Kentucky have 67% lower likelihood of receiving IBRS and patients receiving a mastectomy in
Washington have 78% lower likelihood of receiving IBRS.
Empirical Analyses Results: Research Question 2
Interactions between race/ethnicity and hospital characteristics and race/ethnicity and
market characteristics are added to the multi-level mixed effects logistic regression model
estimated in the previous step in order to address research question 2. Research question 2
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examines whether the relationship between race/ethnicity and likelihood of receipt of IBRS is
moderated by hospital and market characteristics. No directional hypothesis for research question
2 are specified in Chapter 3. Separate statistical models are estimated for the White-Black and
White-Hispanic samples. The results from these two models are presented in Table 5. Only the
interaction terms that are significant at p-value<0.05 are presented.
Table 5
Mixed Effects Logistic Regression with Interaction Terms

5

Variable
Patient-level
Race and ethnicity
Black race
Hispanic ethnicity
White (Reference)
Hospital-level
Racial/ethnic mix
Medicaid mix
Market-level
Competition
Plastic surgeons/100
population
Urbanicity
UIC2
UIC1 (Reference)
Interaction between
Black/Hispanic and
hospital variables
Racial/ethnic mix
Medicaid mix
Interaction between
Black/Hispanic race/and
market variables
Competition
Plastic surgeons/100
population
UIC2

White-Black sample
Coefficient 95% CI
−0.450**

[−0.822, −0.078]

−0.004
−0.005

[−0.009, 0.001]
[0.991, 1.000]

2.265**

[1.653, 2.878]

−0.006*
0.007*

−0.246*

White-Hispanic sample
Coefficient 95% CI

−0.162

[−0.541, 0.271]

−0.029*
2.391**

[−0.052, − 0.006]
[1.752-3.030]

−0.522**

[−0.846, −0.198]

−0.006*
−0.368**

[−0.012, −0.001]
[−0.596, −0.141]

−0.651**

[−0.914, −0.387]

[−0.011, −0.001]
[0.000, 0.014]

[−0.465, −0.027]

Note: CI=Confidence Interval. * represents p-value less than 0.05 whereas ** represents p-value less than 0.01.
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For the White-Black model, interactions between Black race and Medicaid mix of the
hospital, racial/ethnic mix of the hospital and density of plastic surgeons in the market are
significant. Although the probability of receipt of IBRS decreases for both Blacks and Whites
with increasing racial/ethnic mix of the hospital, the decrease in probability for Blacks is greater
than for Whites. Thus, White-Black differences in receipt of IBRS within the hospital widen as
the racial/ethnic mix of the hospital increases from the 1st percentile to the 90th percentile.
Although the probability of receipt of IBRS decreases for both Blacks and Whites with
increasing Medicaid mix of the hospital, the decrease in probability for Whites is greater than for
Blacks. Thus, White-Black differences in receipt of IBRS within the hospital decrease as the
Medicaid mix of the hospital increases from the 1st percentile to the 90th percentile. Although the
probability of receipt of IBRS increases for both Blacks and Whites with increasing density of
plastic surgeons in the market, the increase in probability for Whites is greater than for Blacks.
Thus, White-Black differences in receipt of IBRS within the hospital widen as the density of
plastic surgeons increases from the 1st percentile to the 90th percentile. Thus, Medicaid mix and
racial/ethnic mix of the hospital, and density of plastic surgeons in the market moderate the
relationship between Black race and receipt of IBRS.
For the White-Hispanic model, the interactions between Hispanic ethnicity and
competition, plastic surgeon density, and urbanicity are significant. Although the probability of
receipt of IBRS decreases for both Hispanics and Whites with increasing competition in the
market, the decrease in probability for Hispanics is greater than for Whites. Thus, WhiteHispanic differences in receipt of IBRS within the hospital widen as the competition in the
market increases from the 1st percentile to the 90th percentile. On the other hand, although the
probability of receipt of IBRS increases for both Hispanics and Whites with increasing density of
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plastic surgeons in the market, the increase in probability for Whites is greater than for
Hispanics. Thus, White-Hispanic differences in receipt of IBRS within the hospital widen as the
density of plastic surgeons in the market increases from the 1st percentile to the 90th percentile.
Lastly, although the probability of receipt of IBRS for both Hispanics and Whites is lower in
small metropolitan markets (UIC2) than large metropolitan markets (UIC1), the decrease in
probability for Hispanics is greater than for Whites. Thus, White-Hispanic differences in receipt
of IBRS in small metropolitan markets (UIC2) are significantly wider than those in large
metropolitan markets (UIC1). Thus, competition, plastic surgeon density and small metropolitan
(UIC2) status of the market moderate the relationship between Hispanic ethnicity and receipt of
IBRS.
Empirical Analyses Results: Research Question 3
Fairlie decomposition is performed separately on the White-Black sample and the WhiteHispanic sample to examine the contribution of independent variables to the racial/ethnic
differences in receipt of IBRS. These analyses will address research question 3. No directional
hypotheses are presented for research question 3 in Chapter 3. The results for the White-Black
sample are presented first followed by the results for the White-Hispanic sample.
White-Black sample.
The predicted probability of receipt of IBRS is 0.571 for Whites and 0.465 for Blacks.
Therefore, a gap or total difference of 0.106 or 10.6 percentage points exists between these two
groups. Table 6 presents the decomposition results for all independent variables included in the
decomposition model for the White-Black sample. The proportion of the total White-Black
difference in receipt of IBRS explained by White-Black differences in independent variables is
found to be 0.049 (46% of the total difference). Next, the contribution of the variable age is

89

90
Table 6
Decomposition Results for the White-Black Sample

6

Variable

Patient-level
Charlson score
Obesity
Insurance
Medicaid
Medicare
Uninsured
Private insurance (Reference)
Median household income in patient’s
zip code
Hospital-level
Percentage of breast cancer patients
Bed size/10
Total margin
Racial/ethnic mix
Medicaid mix
Ownership
Not-for- profit
Non-federal public
For profit (Reference)
Teaching status
Market-level
Competition (1/HHI)
Plastic surgeons/100 population
Urbanicity
State

Decomposition
coefficient

Standard % contribution to
Error
explained component
(after subtracting
contribution of age)

0.006**
0.004**

0.000
0.001

9.483
5.514

0.025**
−0.000*
0.003**

0.001
0.000
0.000

37.911
−0.665
4.517

0.032**

0.002

48.729

0.000
−0.003**
0.001**
0.021**
−0.002

0.000
0.001
0.000
0.000
0.000

0.243
−3.875
1.548
31.521
−2.265

0.001
0.000

0.000
0.000

0.672
0.446

−0.001

0.000

−1.170

−0.001**
−0.000
−0.007**
−0.014**

0.000
0.000
0.001
0.001

−0.569
−0.042
−10.852
−21.256

Note: * represents p-value less than 0.05 whereas ** represents p-value less than 0.01.

subtracted from the total explained component since racial differences in receipt of IBRS due to
racial differences in a factor like age does not merit any policy efforts. The coefficient for age
(not presented in Table 6) is −0.017. After subtracting the coefficient of age from the explained
component of the total difference [0.049− (−0.017)], the net explained component is 0.066 (62%
of the total difference). Table 6 presents the decomposition coefficients, standard error and %
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contribution to net explained component for all the independent variables at the patient, hospital
and market level. The contribution of a variable is computed as a proportion of decomposition
coefficient of the variable to the net explained component (after subtracting the decomposition
coefficient for age). A positive decomposition coefficient implies that the variable contributes to
increasing the racial difference whereas a negative decomposition coefficient implies that the
variable contributes to decreasing the racial difference.
All patient-level variables contribute significantly to the White-Black difference in
receipt of IBRs at p-value<0.05. At the patient-level, if Black patients had the same mean
Charlson score as White patients, the explained component of the White-Black difference in
receipt of IBRS would reduce by 9.5%. If Black patients have the same lower likelihood of
obesity as Whites, the explained component of the White-Black difference in receipt of IBRS
would reduce by 5.5%. In terms of insurance, if Black patients had the same lower likelihood of
being on Medicaid as Whites, the explained component of the White-Black difference in receipt
of IBRS would reduce by 37.8%. Similarly, if Black patients had the same lower likelihood of
being uninsured as Whites, the explained component of the White-Black difference in receipt of
IBRS would reduce by 4.5%. On the other hand, if Black patients had the same higher likelihood
of being insured with Medicare as Whites, the explained component of the White-Black
difference in receipt of IBRS would increase by 0.66% and this would consequently increase the
total White-Black gap. Thus, the lower likelihood of being insured with Medicare among Black
patients contributes to decreasing the racial gap in receipt of IBRS. In terms of income, if Black
patients had the same likelihood of residing in high income neighborhoods as Whites, the
explained component of the White-Black difference in receipt of IBRS would reduce by 48.73%.
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Racial differences in hospital-level variables such as racial/ethnic mix, total margin and
bed size contribute significantly to the racial difference in receipt of IBRS. If Black patients
received a mastectomy at hospitals with the same mean racial/ethnic mix as the hospitals where
White patients receive a mastectomy, the explained component of the White-Black difference in
receipt of IBRS would reduce by 31.5%. Similarly, if Black patients received a mastectomy at
hospitals with the same mean total margin as the hospitals where White patients receive a
mastectomy, the explained component of the White-Black difference in receipt of IBRS would
reduce by 1.6%. On the other hand, if Black patients received a mastectomy at hospitals with the
same mean bed size as the hospitals where White patients receive a mastectomy, the explained
component of the White-Black difference in receipt of IBRS would increase by 3.9% and this
would consequently increase the total White-Black gap. Thus, Black patients receiving a
mastectomy at hospitals with higher mean bed size than the hospitals where White patients
receive a mastectomy contributes to decreasing the racial gap in receipt of IBRS.
Racial differences in market-level variables such as competition and urbanicity,
contribute significantly to the racial difference in receipt of IBRS. If Black patients received a
mastectomy in markets with the same mean competition as the markets where White patients
receive a mastectomy, the explained component of the White-Black difference in receipt of IBRS
would increase by 0.6% and this would consequently increase the total White-Black gap. Thus,
Black patients receiving a mastectomy in markets with higher competition than the markets
where White patients receive a mastectomy contributes to decreasing the racial gap in receipt of
IBRS. Similarly, if Black patients had the same likelihood as Whites of receiving a mastectomy
in markets that are small metropolitan, micropolitan and rural areas, the explained component of
the White-Black difference in receipt of IBRS would increase by 10.9% and this would
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consequently increase the total White-Black gap. Thus, compared to White patients, the lower
likelihood of Black patients receiving a mastectomy in markets that are small metropolitan,
micropolitan and rural areas contributes to decreasing the racial gap in receipt of IBRS.
Lastly, if Black patients had similar distribution across states as Whites (for example if
Black patients are as likely to live in states with predominantly large White populations such as
Kentucky and Washington), the explained component of the White-Black difference in receipt of
IBRS would increase by 21.3% and this would consequently increase the total White-Black gap.
Thus, compared to White patients, the lower likelihood of Black patients of residing in certain
states with predominantly White population contributes to decreasing the racial gap in receipt of
IBRS.
Based on the results in Table 6, White-Black difference in the median household income
of the zip code in which patients reside is the largest contributor (48.7%) to the explained
component of the White-Black difference in receipt of IBRS. This is followed by the
contribution (37.8%) of racial difference in the likelihood of being Medicaid-insured. Racial
difference in the racial/ethnic mix of the hospital where mastectomy is received is the third
largest contributor (31.5%) to the explained component of the White-Black difference in receipt
of IBRS.
White-Hispanic sample.
The predicted probability of receipt of IBRS is 0.571 for Whites and 0.455 for Hispanics.
Therefore, a gap or total difference of 0.116 or 11.6 percentage points exists between these two
groups. Table 7 presents the decomposition results for all independent variables included in the
decomposition model for the White-Hispanic sample. The proportion of the total White-Hispanic
difference in receipt of IBRS explained by White-Hispanic differences in independent variables
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Table 7
Decomposition Results for the White-Hispanic Sample

7

Variable

Patient-level
Charlson score
Obesity
Insurance
Medicaid
Medicare
Uninsured
Private insurance
Median household income in
patient’s zip code
Hospital-level
Percentage of breast cancer patients
Bed size/10
Total margin
Racial/ethnic mix
Medicaid mix
Ownership
Not-for- profit
Non-federal public
For profit (Reference)
Teaching status
Market-level
Competition (1/HHI)
Plastic surgeons/100 population
Urbanicity
State

Decomposition
coefficient

Standard
Error

% contribution to
explained component
(after subtracting
contribution of age)

0.005**
−0.001**

0.000
0.000

5.055
−1.318

0.055**
−0.009**
0.005**

0.002
0.001
0.000

61.637
−9.844
5.836

0.020**

0.001

22.603

−0.000
−0.002**
0.003**
0.023**
0.003

0.000
0.000
0.001
0.003
0.002

−0.035
−1.734
3.513
25.573
3.155

0.004**
0.000

0.001
0.001

4.175
0.441

−0.000

0.000

−0.012

−0.008**
−0.001**
−0.009**
−0.000

0.001
0.000
0.001
0.001

−8.600
−0.938
−9.770
−0.100

Note: * represents p-value less than 0.05 whereas ** represents p-value less than 0.01.

is found to be 0.056 (48% of the total difference). After subtracting the coefficient of age from
the explained component of the total difference, the net explained component is 0.089 (77% of
the total difference). Table 7 presents the decomposition coefficients, standard error and %
contribution to net explained component for all the independent variables at the patient, hospital
and market level. The contribution of a variable is computed as a proportion of decomposition
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coefficient of the variable to the net explained component (after subtracting the decomposition
coefficient for age). A positive decomposition coefficient implies that the variable contributes to
increasing the ethnic difference whereas a negative decomposition coefficient implies that the
variable contributes to decreasing the ethnic difference.
All patient-level variables contribute significantly to the White-Hispanic difference in
receipt of IBRS. At the patient-level, if Hispanic patients had the same mean Charlson score as
White patients, the explained component of the White-Black difference in receipt of IBRS would
reduce by 5.1%. On the other hand, if Hispanic patients had the same higher likelihood of being
obese as Whites, the explained component of the White-Hispanic difference in receipt of IBRS
would increase by 1.3% and this would consequently increase the total White-Hispanic gap.
Thus, the lower likelihood of being obese among Hispanic patients contributes to decreasing the
ethnic gap in receipt of IBRS. In terms of insurance, if Hispanic patients had the same lower
likelihood of being Medicaid-insured as Whites, the explained component of the White-Hispanic
difference in receipt of IBRS would reduce by 61.6%. Similarly, if Hispanic patients had the
same lower likelihood of being uninsured as Whites, the explained component of the WhiteHispanic difference in receipt of IBRS would reduce by 5.8%. On the other hand, if Hispanic
patients had the same higher likelihood of being Medicare-insured as Whites, the explained
component of the White-Hispanic difference in receipt of IBRS would increase by 9.8% and this
would consequently increase the total White-Hispanic gap. Thus, the lower likelihood of being
Medicare-insured among Hispanic patients contributes to decreasing the ethnic gap in receipt of
IBRS. In terms of income, if Hispanic patients had the same likelihood of residing in high
income neighborhoods as Whites, the explained component of the White-Hispanic difference in
receipt of IBRS would reduce by 22.6%.
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Ethnic differences in hospital-level variables such as racial/ethnic mix, total margin, bed
size and not-for-profit ownership contribute significantly to the ethnic difference in receipt of
IBRS. If Hispanic patients received a mastectomy at hospitals with the same mean racial/ethnic
mix as the hospitals where White patients receive a mastectomy, the explained component of the
White-Hispanic difference in receipt of IBRS would reduce by 25.6%. Similarly, if Hispanic
patients received a mastectomy at hospitals with the same mean total margin as the hospitals
where White patients receive a mastectomy, the explained component of the White-Hispanic
difference in receipt of IBRS would reduce by 3.5%. If Hispanic patients had the same higher
likelihood of receiving a mastectomy at not-for-profit hospitals as White patients, the explained
component of the White-Hispanic difference in receipt of IBRS would reduce by 4.2%. On the
other hand, if Hispanic patients received a mastectomy at hospitals with the same mean bed size
as the hospitals where White patients receive a mastectomy, the explained component of the
White-Hispanic difference in receipt of IBRS would increase by 1.7% and this would
consequently increase the total White-Hispanic gap. Thus, Hispanic patients receiving a
mastectomy at hospitals with higher mean bed size than the hospitals where White patients
receive a mastectomy contributes to decreasing the ethnic gap in receipt of IBRS.
Ethnic differences in market-level variables such as competition, density of plastic
surgeons and urbanicity contribute significantly to the ethnic difference in receipt of IBRS. If
Hispanic patients received a mastectomy in markets with the same mean competition as the
markets where White patients receive a mastectomy, the explained component of the WhiteHispanic difference in receipt of IBRS would increase by 8.6% and this would consequently
increase the total White-Hispanic gap. Thus, Hispanic patients receiving a mastectomy in
markets with higher competition than the markets where White patients receive a mastectomy
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contributes to decreasing the ethnic gap in receipt of IBRS. Similarly, if Hispanic patients had
the same likelihood as Whites of receiving a mastectomy in markets that are small metropolitan,
micropolitan and rural areas, the explained component of the White-Hispanic difference in
receipt of IBRS would increase by 9.8% and this would consequently increase the total WhiteHispanic gap. Thus, compared to White patients, the lower likelihood of Hispanic patients
receiving a mastectomy in markets that are small metropolitan, micropolitan and rural areas
contributes to decreasing the ethnic gap in receipt of IBRS. Ethnic difference in distribution of
Hispanics and whites across states does not contribute significantly to the explained component
of the White-Hispanic difference in receipt of IBRS.
Based on the results in Table 7, White-Hispanic difference in the likelihood of being
Medicaid-insured is the largest contributor (61.6%) to the explained component of the WhiteHispanic difference in receipt of IBRS. This is followed by the contribution (25.6%) of WhiteHispanic difference in the racial/ethnic mix of the hospital where mastectomy is received.
Ethnic difference in the median household income of the zip code in which patients reside is the
third largest contributor (22.6%) to the explained component of the White-Hispanic difference in
receipt of IBRS.
Sensitivity Analyses
Excluding hospitals that do not offer reconstruction.
In the first set of sensitivity analyses, all the observations where a mastectomy is received
at a hospital that provided no breast reconstruction surgery during the study period, 2010 to 2012
are excluded. The original sample consisted of 58,429 total observations of patients who
received a mastectomy from 992 hospitals. Of these, 286 hospitals provided zero reconstruction
surgeries between 2010 and 2012. For the sensitivity analysis, 2,739 observations from these 286
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hospitals are dropped. Thus, the sample size for this sensitivity analyses has 55,690 total
observations from 706 hospitals. All the analyses are repeated on this sample. The descriptive
statistics for this sample along with descriptive statistics by race/ethnicity are presented in Table
8.
Table 8
Sensitivity Analysis 1-Variable Means and Percentage
(Table 8: Continued)
Variable
Restricted
Sample
Receipt of Immediate Breast
55.37
Reconstruction Surgery (%)
Patient-level
Age
56.62
(11.80)
Charlson score
3.08
(2.07)
Obese (%)
6.65
Insurance (%)
Medicare
28.53
Medicaid
10.53
Uninsured
1.36
Private Insurance
59.58
Median household income in the zip
code (%)
Quartile 1 (lowest income)
18.11
Quartile 2
21.00
Quartile 3
26.61
Quartile 4 (highest income)
34.27
Hospital-level
Percentage of breast cancer patients
0.73
(2.03)
Bed size/10
46.18
(34.89)
Total margin
5.23
(14.58)
Racial/ethnic mix
27.17
(19.49)
Medicaid mix
18.80
(13.81)
Ownership (%)
For profit
6.94
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White

Black

Hispanic

58.25

46.84**

47.05**

57.20
(11.71)
3.03
(2.05)
6.09

55.65**
(11.84)
3.25**
(2.17)
12.25**

54.17**
(11.88)
3.22**
(2.05)
4.15**

29.69
6.21
0.92
63.18

28.19**
18.33**
2.35**
51.13**

21.78**
28.63**
3.03**
46.56**

13.05
20.41
27.46
39.07

37.66**
22.71**
23.15**
16.48**

28.57**
22.80**
25.05**
23.58**

0.78
(2.25)
45.01
(33.85)
5.87
(14.42)
22.38
(15.62)
17.11
(12.49)

0.50**
(1.09)
50.70**
(35.82)
4.01**
(11.89)
39.54**
(21.95)
22.94**
(15.21)

0.67**
(1.14)
48.43**
(39.33)
2.65**
(17.46)
42.89**
(23.32)
24.56**
(17.00)

6.86

6.11**

8.31**
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(Table 8: Continued)
Variable
Not-for-profit
Nonfederal public
Teaching status (%)
Market-Level
Competition (1/HHI)
Plastic surgeons/100 population
Urbanicity (%)
UIC1 (most urban)
UIC2
UIC3
UIC4 (most rural)
Sample size

Restricted
Sample
80.52
12.54
63.98

White

Black

Hispanic

82.24
10.91
62.85

77.17**
16.72**
71.37**

73.79**
17.90**
63

10.27
(14.00)
0.45
(0.38)

9.33
(12. 80)
0.45
(0.38)

9.90**
(13.73)
0.44*
(0.37)

16.30**
(18.79)
0.45
(0.39)

80.96
17.69
1.24
0.11
55,690

78.64
19.78
1.44
0.14
41,494

87.93**
10.99**
1.06**
0.03*
7,280

87.49**
12.25**
0.25**
0.01**
6,916

Note: Blacks are compared to Whites and Hispanics are also compared to Whites for significance testing. Standard
deviations are in parentheses. * represents p-value less than 0.05 whereas ** represents p-value less than 0.01.

Compared to the original sample, this sample has higher reconstruction rates for all races
and ethnicities. Other patient-level characteristics are similar to the original sample. In terms of
hospital characteristics, the mean percentage of breast cancer patients in a hospital, mean bed
size and mean total margin are higher in this sample compared to the original sample whereas the
mean racial/ethnic mix and the mean Medicaid mix are lower than the original sample.
Additionally, the percentage of for-profit and public hospitals is lower whereas the percentage of
not-for-profit hospitals is higher in this sample than the original sample. These changes in
hospital characteristics between the original sample and this sample are seen across all races and
ethnicities.
Among market characteristics, mean competition for all race/ethnicities combined and for
Whites is lower than the original sample while it is higher than the original sample for Blacks
and Hispanics. Density of plastic surgeons is higher for this sample than the original sample for
all races and ethnicities. The proportion of patients living in the large and small metropolitan
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counties is higher than the original sample whereas the proportion of patients living in
micropolitan and rural counties is lower than the original sample.
The results for the patient-level logistic regression to examine whether racial and ethnic
differences persist even after controlling for race and ethnicity are similar to the primary findings
from the original sample and hence, have not been presented here. Next, results from the mixed
effects logistic regression model to examine the association between hospital and market
characteristics and the receipt of immediate breast reconstruction surgery are presented in Table
9.
Table 9
Sensitivity Analysis 1-Mixed Effects Logistic Regression
(Table 9: Continued)
Variable
Odds Ratio 95% CI
Patient-level
Race and ethnicity
Black race
0.622**
[0.577, 0.670]
Hispanic ethnicity
0.723**
[0.668, 0.782]
White (Reference)
Age
0.933**
[0.930, 0.935]
Charlson score
0.821**
[0.812, 0.831]
Obesity
Obese
0.722**
[0.660, 0.789]
Non-obese (Reference)
Insurance
Medicaid
0.347**
[0.320, 0.376]
Medicare
0.488**
[0.456, 0.521]
Uninsured
0.325**
[0.267, 0.395]
Private insurance (Reference)
Quartiles of median household
income in patient’s zip code
Quartile 1 (lowest income)
0.605**
[0.561, 0.652]
Quartile 2
0.692**
[0.646, 0.742]
Quartile 3
0.788**
[0.741, 0.839]
Quartile 4 (Reference)
Hospital-level
Percentage of breast cancer patients 1.010
[0.993, 1.028]
Bed size/10
1.002
[0.999, 1.006]
Total margin
1.000
[0.997, 1.002]
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(Table 9: Continued)
Variable
Racial/ethnic mix
Medicaid mix
Ownership
Not-for- profit
Non-federal public
For profit (Reference)
Teaching status
Teaching
Non-teaching (Reference)
Market-level
Competition (1/HHI)
Plastic surgeons/100 population
Urbanicity
UIC1 (most urban) (Reference)
UIC2
UIC3
UIC4 (most rural)
State
Arizona
Florida
Kentucky
Maryland
North Carolina
New Jersey
New York
Washington
California (Reference)
Intercept

Odds Ratio
0.995*
0.997

95% CI
[0.991, 1.000]
[0.993, 1.002]

1.091
0.866

[0.855, 1.393]
[0.631, 1.188]

1.135

[0.966, 1.334]

0.987
4.802**

[0.970, 1.003]
[2.966, 7.776]

0.660**
0.513*
0.278

[0.512, 0.851]
[0.296, 0.890]
[0.070, 1.105]

0.842
0.718
0.436**
1.010
0.953
0.957
0.865
0.294**

[0.485, 1.464]
[0.509, 1.015]
[0.248, 0.766]
[0.605, 1.685]
[0.609, 1.490]
[0.628, 1.457]
[0.600, 1.247]
[0.174, 0.499]

161.863**

[104.525, 250.654]

Note: CI=Confidence Interval. * represents p-value less than 0.05 whereas ** represents p-value less than 0.01.

The magnitude of coefficients and p values for patient-level characteristics are similar to
the primary findings. However, there are significant differences in the effect size and p-values
for hospital-level and market-level characteristics. Hospital characteristics such as bed size, notfor-profit ownership and teaching status that are significant in the primary findings are no longer
significantly associated with receipt of IBRS. Market characteristics such as competition and
receiving care in rural markets (rather than large metropolitan markets) that are significant in the
primary findings are no longer significantly associated with receipt of immediate breast
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reconstruction surgery. The percentage of total residual variance explained by county-level
random effects and hospital-level random effects is also lower than the original analysis.
The results for the analyses including interactions between race/ethnicity and hospital and
market characetristics are similar to the primary findings and are not being presented here. The
only exception is that the interaction between Blacks and Medicaid mix of the hospital is no
longer significant whereas it is significant in the primary findings.
Next, the results of Fairlie decomposition are repeated for this restricted sample. The
predicted probability of receipt of IBRS is 0.595 for Whites and 0.483 for Blacks. Therefore, a
gap or total difference of 0.112 or 11.2 percentage points exists between these two groups. Table
10 presents the decomposition results for all independent variables included in the decomposition
model for the White-Black sample. The proportion of the total White-Black difference in receipt
of IBRS explained by White-Black differences in independent variables is found to be 0.053
(47% of the total difference). Next, the contribution of the variable age is subtracted from the
total explained component similar to the original analyses. After subtracting the coefficient of
age, the net explained component is 0.069 (61% of the total difference). Table 10 presents the
decomposition coefficients, standard error and % contribution to net explained component for all
the independent variables at the patient, hospital and market level. The contribution of a variable
is computed as a proportion of decomposition coefficient of the variable to the net explained
component (after subtracting the decomposition coefficient for age). A positive decomposition
coefficient implies that the variable contributes to increasing the racial difference whereas a
negative decomposition coefficient implies that the variable contributes to decreasing the racial
difference.
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Table 10
Sensitivity Analysis 1-Decomposition Results for the White-Black Sample

10

Variable

Patient-level
Charlson score
Obesity
Insurance
Medicaid
Medicare
Self-pay
Private insurance (Reference)
Median household income in patient’s
zip code
Hospital-level
Percentage of breast cancer patients
Bed size/10
Total margin
Racial/ethnic mix
Medicaid mix
Ownership
Not-for- profit
Non-federal public
For profit (Reference)
Teaching status
Market-level
Competition (1/HHI)
Plastic surgeons/100 population
Urbanicity
State

Decomposition
coefficient

Standard % contribution to
Error
explained component
(after subtracting
contribution of age)

0.007**
0.004**

0.000
0.001

9.638
5.695

0.026**
−0.001**
0.003**

0.001
0.000
0.000

37.980
−1.158
4.446

0.033**

0.002

47.495

0.000
−0.002**
0.001*
0.020**
−0.003**

0.000
0.001
0.000
0.003
0.001

0.265
−2.738
1.214
29.681
−4.985

0.000
0.001

0.000
0.000

0.261
0.681

0.001

0.001

0.804

−0.000*
0.000
−0.005**
−0.015

0.000
0.000
0.001
0.001

−0.241
0.353
−7.482
−21.701

Note: * represents p-value less than 0.05 whereas ** represents p-value less than 0.01.

The results presented in Table 10 are similar to the primary findings. The only notable
difference is that racial difference in the Medicaid mix of the hospital where mastectomy is
received now contributes significantly to the racial difference in receipt of IBRS. This means that
if Black patients received a mastectomy at hospitals with the same mean Medicaid mix as the
hospitals where White patients receive a mastectomy, the explained component of the WhiteBlack difference in receipt of IBRS would increase by 5%. Thus, Black patients receiving a
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mastectomy at hospitals with higher mean Medicaid mix than the hospitals where White patients
receive a mastectomy contributes to decreasing the racial gap in receipt of IBRS.
The results of Fairlie decomposition for the White-Hispanic sample after excluding
observations from hospitals that did not provide any breast reconstruction surgery between 2010
and 2012 are similar to the primary findings and therefore are not presented here.
Combining Blacks and Hispanics into one group.
For the next sensitivity analysis, Blacks and Hispanics are combined into one minority
race and ethnicity group, henceforth called minority. To recap Chapter 4, the idea of separating
Blacks and Hispanics in the original analyses is to generate specific practice and policy
recommendations. However, there are a number of similarities in the socioeconomic barriers in
access to health care services faced by Blacks and Hispanics. Hence, sensitivity analyses with the
combined minority group compared to Whites are conducted for all the research questions. The
descriptive statistics for Whites and the combined minority group are presented in Table 11.
Table 11
Sensitivity Analysis 2-Variable Means and Percentage
(Table 11: Continued)
Variable
White
Receipt of Immediate Breast Reconstruction
55.60
Surgery (%)
Patient-level
Age
57.48
(11.75)
Charlson score
3.04
(2.04)
Obese (%)
6.13
Insurance (%)
Medicare
30.74
Medicaid
6.52
Uninsured
0.93
Private Insurance
61.80
Median household income in the zip code (%)
Quartile 1 (lowest income)
14.19
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Combined minority group
44.55**

55.15**
(11.93)
3.25**
(2.10)
8.16**
25.81**
23.52**
2.73**
47.94**
33.49**
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(Table 11: Continued)
Variable
Quartile 2
Quartile 3
Quartile 4 (highest income)
Hospital-level
Percentage of breast cancer patients
Bed size/10
Total margin
Racial/ethnic mix
Medicaid mix
Ownership (%)
For profit
Not-for-profit
Nonfederal public
Teaching status (%)
Market-Level
Competition (1/HHI)
Plastic surgeons/100 population
Urbanicity (%)
UIC1 (most urban)
UIC2
UIC3
UIC4 (most rural)
Sample size

White
21.03
27.06
37.71

Combined minority group
23.27**
23.74**
19.51**

0.75
(2.20)
43.59
(33.76)
5.77
(14.23)
22.22
(15.75)
17.41
(12.52)

0.57**
(1.10)
48.14**
(37.30)
3.31**
(14.64)
41.66**
(22.91)
23.93**
(16.21)

7.28
81.44
11.28
60.51

7.85**
74.77**
17.38**
64.47**

9.25
(12.95)
0.44
(0.38)

13.39**
(17.20)
0.43
(0.37)

76.15
20.20
2.85
0.80
43,469

86.18**
11.94**
1.60**
0.27**
14,960

Note: The combined minority group is compared to Whites for significance testing. Standard deviations are in
parentheses. * represents p-value less than 0.05 whereas ** represents p-value less than 0.01.

As can be seen from Table 11, the descriptive statistics for the combined minority group
are similar to those for Blacks and Hispanics in the original sample. The results for the patientlevel logistic regression and the mixed effects regression to examine the association between
hospital and market characteristics and receipt of IBRS are similar to the primary findings and
are therefore not presented here. Next, results from the mixed effects regression model that
includes interactions between the combined minority group and hospital and market-level
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characteristics are presented in Table 12. Only the interactions that are significant at pvalue<0.05 are presented.
Table 12
Sensitivity Analysis 2-Mixed Effects Logistic Regression with Interaction Terms

12

Variable
Patient-level
Minority
Hospital-level
Racial/ethnic mix
Market-level
Plastic surgeons/100 population
Urbanicity
UIC1 (most urban) (Reference)
UIC2
Interaction between combined minority group
and hospital variables
Racial/ethnic mix
Interaction between combined minority group
and market variables:
Plastic surgeons/100 population
Urbanicity
UIC1 (most urban) (Reference)
UIC2

Coefficient 95% CI
−0.316*

[−0.599, −0.033]

−0.004

[−0.009, 0.001]

2.371**

[1.739, 3.002]

−0.526**

[−0.847, −0.205]

−0.005*

[−0.009, −0.001]

−0.303**

[−0.473, −0.133]

−0.378**

[−0.559, −0.197]

Note: CI=Confidence Interval. * represents p-value less than 0.05 whereas ** represents p-value less than 0.01.

As can be seen from Table 12 the interactions between minority group and racial/ethnic
mix, plastic surgeon density and urbanicity are significant. Although the probability of receipt of
IBRS decreases for both minorities and Whites with increasing racial/ethnic mix in the market,
the decrease in probability for minorities is greater than for Whites. Thus, White-minority
differences in receipt of IBRS widen as the racial/ethnic mix increases from the 1st percentile to
the 90th percentile. On the other hand, although the probability of receipt of IBRS increases for
both minorities and Whites with increasing density of plastic surgeons in the market, the increase
in probability for Whites is greater than for minorities. Thus, White-minority differences in
receipt of IBRS within the hospital widen as the density of plastic surgeons in the market
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increases from the 1st percentile to the 90th percentile. Lastly, although the probability of receipt
of IBRS for both minorities and Whites is lower in small metropolitan markets (UIC2) than
large metropolitan markets (UIC1), the decrease in probability for minorities is greater than for
Whites. Thus, White-minority differences in receipt of IBRS in small metropolitan markets
(UIC2) are significantly wider than those in large metropolitan markets (UIC1). Thus,
competition, plastic surgeon density and small metropolitan (UIC2) status of the market
moderate the relationship between minority race and ethnicity and receipt of IBRS.
Next, the results of the Fairlie decomposition for the White-minority sample are
presented in Table 13. The predicted probability of receipt of IBRS is 0.571 for Whites and 0.46
for minorities. Therefore, a gap or total difference of 0.111 or 11.1 percentage points exists
between these two groups. Table 13 presents the decomposition results for all independent
variables included in the decomposition model for the White-minority sample. The proportion of
the total White-minority difference in receipt of IBRS explained by White-minority differences
in independent variables is found to be 0.054 (49% of the total difference). After subtracting the
coefficient of age from the explained component of the total difference, the net explained
component is 0.08 (72% of the total difference). Table 13 presents the decomposition
coefficients, standard error and % contribution to net explained component for all the
independent variables at the patient, hospital and market level. The contribution of a variable is
computed as a proportion of decomposition coefficient of the variable to the net explained
component (after subtracting the decomposition coefficient for age). A positive decomposition
coefficient implies that the variable contributes to increasing the racial and ethnic difference
whereas a negative decomposition coefficient implies that the variable contributes to decreasing
the racial and ethnic difference.
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Table 13
Sensitivity Analysis 2-Decomposition Results for the White-minority Sample

13

Variable

Patient-level
Charlson score
Obesity
Insurance
Medicaid
Medicare
Uninsured
Private insurance (Reference)
Median household income in patient’s
zip code
Hospital-level
Percentage of breast cancer patients
Bed size/10
Total margin
Racial/ethnic mix
Medicaid mix
Ownership
Not-for- profit
Non-federal public
For profit (Reference)
Teaching status
Market-level
Competition (1/HHI)
Plastic surgeons/100 population
Urbanicity
State

Decomposition
coefficient

Standard % contribution to
Error
explained component
(after subtracting
contribution of age)

0.006**
0.001**

0.001
0.001

7.016
1.675

0.040**
−0.005**
0.004**

0.002
0.001
0.001

50.156
−6.272
5.216

0.026**

0.001

32.774

0.000
−0.002**
0.002**
0.024**
0.002

0.001
0.001
0.001
0.003
0.001

−0.014
−2.711
2.823
29.843
2.713

0.003**
0.000**

0.001
0.001

3.277
−0.042

−0.000**

0.000

−0.299

−0.004**
−0.000
−0.008**
−0.009**

0.001
0.000
0.001
0.001

−4.967
−0.088
−10.183
−10.675

Note: * represents p-value less than 0.05 whereas ** represents p-value less than 0.01.

At the patient-level, if minority patients had the same mean Charlson score as White
patients, the explained component of the White-minority difference in receipt of IBRS would
reduce by 7%. If minority patients have the same lower likelihood of obesity as Whites, the
explained component of the White-minority difference in receipt of IBRS would reduce by 1.7%.
In terms of insurance, if minority patients had the same lower likelihood of being on Medicaid as
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Whites, the explained component of the White-minority difference in receipt of IBRS would
reduce by 50.16%. Similarly, if minority patients had the same lower likelihood of being
uninsured as Whites, the explained component of the White-minority difference in receipt of
IBRS would reduce by 5.2%. On the other hand, if minority patients had the same higher
likelihood of being Medicare-insured as Whites, the explained component of the White-minority
difference in receipt of IBRS would increase by 6.2% and this would consequently increase the
total White-minority gap. Thus, the lower likelihood of being Medicare-insured among minority
patients contributes to decreasing the racial and ethnic gap in receipt of IBRS. In terms of
income, if minority patients had the same likelihood of residing in high income neighborhoods as
Whites, the explained component of the White-minority difference in receipt of IBRS would
reduce by 32.8%. All the patient-level variables contribute significantly to the White-minority
difference in receipt of IBRS.
Racial differences in characteristics of the hospital where patient receives a mastectomy,
such as racial/ethnic mix, total margin, bed size, and not-for-profit ownership contribute
significantly to the racial and ethnic difference in receipt of IBRS at p-value less than 0.05. If
minority patients received a mastectomy at hospitals with the same mean racial/ethnic mix as the
hospitals where White patients receive a mastectomy, the explained component of the Whiteminority difference in receipt of IBRS would reduce by 29.84%. Similarly, if minority patients
received a mastectomy at hospitals with the same mean total margin as the hospitals where
White patients receive a mastectomy, the explained component of the White-minority difference
in receipt of IBRS would reduce by 2.8%. On the other hand, if minority patients received a
mastectomy at hospitals with the same mean bed size as the hospitals where White patients
receive a mastectomy, the explained component of the White-minority difference in receipt of
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IBRS would increase by 2.7% and this would consequently increase the total White-minority
gap. Thus, minority patients receiving a mastectomy at hospitals with higher mean bed size than
the hospitals where White patients receive a mastectomy contributes to decreasing the racial gap
in receipt of IBRS. If minority patients had the same higher likelihood of receiving a mastectomy
at not-for-profit hospitals as White patients, the explained component of the White-minority
difference in receipt of IBRS would reduce by 3.3%.
Racial and ethnic differences in characteristics of the market where patient receives a
mastectomy, such as competition and urbanicity, contribute significantly to the racial and ethnic
difference in receipt of IBRS. If minority patients received a mastectomy in markets with the
same mean competition as the markets where White patients receive a mastectomy, the explained
component of the White-minority difference in receipt of IBRS would increase by 4.9% and this
would consequently increase the total White-minority gap. Thus, minority patients receiving a
mastectomy in markets with higher competition than the markets where White patients receive a
mastectomy contributes to decreasing the racial and ethnic gap in receipt of IBRS. Similarly, if
minority patients had the same likelihood as Whites of receiving a mastectomy in markets that
are small metropolitan, micropolitan and rural areas, the explained component of the Whiteminority difference in receipt of IBRS would increase by 10.2% and this would consequently
increase the total White-minority gap. Thus, compared to White patients, the lower likelihood of
minority patients receiving a mastectomy in markets that are small metropolitan, micropolitan
and rural areas contributes to decreasing the racial and ethnic gap in receipt of IBRS. Lastly, if
minority patients had similar distribution across states as Whites (for example if minority
patients are as likely to live in states with predominantly large White populations such as
Kentucky and Washington), the explained component of the White-minority difference in receipt
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of IBRS would increase by 10.7% and this would consequently increase the total White-minority
gap. Thus, compared to White patients, the lower likelihood of minority patients of residing in
certain states with predominantly White population contributes to decreasing the racial and
ethnic gap in receipt of IBRS.
Based on the results in Table 13, White-minority difference in the likelihood of being
Medicaid-insured is the largest contributor (50.2%) to the explained component of the Whiteminority difference in receipt of IBRS. This is followed by the contribution (32.8%) of racial and
ethnic difference in the median household income of the zip code in which patients reside.
Racial and ethnic difference in the racial/ethnic mix of the hospital where mastectomy is
received is the third largest contributor (29.8%) to the explained component of the Whiteminority difference in receipt of IBRS.
Additional Analyses
Additional analyses are performed to understand the hospital and market-level factors
associated with the type of reconstruction received (immediate autologous reconstruction vs
immediate implant reconstruction) and to understand the contribution of patient, hospital and
market-level variables to racial and ethnic differences in receipt of immediate autologous
reconstruction. The additional analyses are conducted for immediate autologous reconstruction
(AR) as the dependent variable for a sample restricted to those patients who received either an
immediate autologous reconstruction (AR) or immediate implant reconstruction (IR). All
patients who receive mastectomy but do not receive reconstruction are dropped from this sample.
Descriptive statistics for this restricted sample by race and ethnicity are presented in Table 14.
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Table 14
Additional Analysis-Variable Means and Percentage
(Table 14: Continued)
Variable
Restricted
Sample
Receipt of Immediate Autologous
72.17
Reconstruction (%)
Patient-level
Age
52.97
(9.89)
Charlson score
2.56
(1.86)
Obese (%)
6.58
Insurance (%)
Medicare
14.69
Medicaid
6.98
Uninsured
1.18
Private Insurance
77.14
Median household income in the zip
code
Quartile 1 (lowest income) (%)
13.46
Quartile 2 (%)
17.91
Quartile 3 (%)
26.05
Quartile 4 (highest income) (%)
42.58
Hospital-level
Percentage of breast cancer patients
0.69
(2.52)
Bed size/10
50.17
(36.61)
Total margin
5.62
(11.20)
Racial/ethnic mix
27.07
(19.07)
Medicaid mix
17.74
(12.54)
Ownership (%)
For profit
4.07
Not-for-profit
84.20
Nonfederal public
11.72
Teaching status (%)
66.21
Market-Level
Competition (1/HHI)
10.52
(13.72)
Plastic surgeons/100 population
0.50
(0.37)
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White

Black

Hispanic

71.43

80.29**

67.63**

53.54
(9.79)
2.53
(1.84)
5.77

51.33**
(9.81)
2.63
(1.97)
12.88**

50.82**
(10.23)
2.71**
(1.88)
4.75**

15.17
4.12
0.81
79.90

13.54
13.33**
2.23**
70.89**

12.6**
20.16**
2.61**
64.64**

9.27
17.16
25.85
47.72

29.99**
21.55**
26.70
21.76**

23.84**
18.95
26.72
30.48**

0.72
(2.77)
49.24
(36.27)
6.21
(10.37)
23.21
(16.10)
16.62
(11.84)

0.53
(0.05)
53.98**
(34.52)
3.60**
(13.16)
37.09**
(20.76)
20.87**
(13.34)

0.65
(0.98)
52.27**
(40.92)
3.75**
(13.74)
42.78**
(23.65)
22.05**
(14.75)

4.28
85.21
10.51
65.32

2.99**
80.15**
16.85**
74.65**

3.9**
81.86**
14.24**
62.37

10.18
(13.49)
0.49
(0.36)

9.18**
(12.01)
0.54*
(0.42)

14.60**
(16.37)
0.53
(0.41)
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(Table 14: Continued)
Variable
Urbanicity
UIC1 (most urban) (%)
UIC2 (%)
UIC3 (%)
UIC4 (most rural) (%)
Sample size

Restricted
Sample

White

Black

Hispanic

86.29
13.15
0.54
0.03
11,142

84.14
15.19
0.65
0.02
8,526

91.78**
7.8**
0.35
0.07
1,436

95.08**
4.92**
0**
0
1,180

Note: Blacks are compared to Whites and Hispanics are also compared to Whites for significance testing. Standard
deviations are in parentheses. * represents p-value less than 0.05 whereas ** represents p-value less than 0.01.

Table 14 presents the descriptive results for the dependent variable i.e. receipt of
immediate autologous surgery and independent variables at the patient-level, hospital-level and
market-level for the entire restricted sample and by race and ethnicity. Of the total sample for
this analysis (N=11,142), 76.5% are White (N=8,526), 12.9% are Black (N=1,436) and 10.6%
are Hispanic (N=1,180). Overall, Blacks more often receive immediate autologous
reconstruction (AR) than Whites whereas Hispanics less often receive AR than Whites. The
distribution of all other patient-level, hospital-level and market-level variables by race/ethnicity
is similar to the descriptives for the main analyses. The only exception is that there are no
significant racial and ethnic differences in the percentage of breast cancer patients at the hospital
where reconstruction is received.
Next, it is examined whether racial and ethnic differences in receipt of AR persist even
after controlling for clinical characteristics using a logistic regression. This is similar to the
patient-level logistic regression step for the main analyses. The results for the logistic regression
with AR as the dependent variable (IR as reference group) are presented in Table 15.
As can be seen from Table 15, Black patients are more likely to receive an AR whereas
Hispanic patients are less likely to receive an AR than Whites even after controlling for clinical
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Table 15
Additional Analysis-Patient-level Logistic Regression

15

Variable
Race and ethnicity
Black race
Hispanic ethnicity
White (Reference)
Age
Charlson score
Obesity
Obese
Non-obese (Reference)
Intercept

Odds Ratio

95% CI

1.58**
0.841*

[1.375, 1.816]
[0.738, 0.96]

1.002
1.011

[0.998, 1.006]
[0.989, 1.034]

1.781**

[1.463, 2.167]

2.149**

[1.695, 2.724]

Note: CI=Confidence Interval. * represents p-value less than 0.05 whereas ** represents p-value less than 0.01.

characteristics. Age and clinical comorbidities are not significantly associated with receipt of
AR. Obesity is associated with higher likelihood of AR vs IR.
Next, hospital and market characteristics associated with receipt of AR vs IR are
examined while controlling for patient-level variables. The results for this step of the analyses
are presented in Table 16.
Table 16
Additional Analysis-Mixed Effects Logistic Regression
(Table 16: Continued)
Variable
Odds Ratio
Patient-level
Race and ethnicity
Black race
1.379**
Hispanic ethnicity
1.119
White (Reference)
Age
1.018**
Charlson score
1.032*
Obesity
Obese
1.578**
Non-obese
Insurance
Medicaid
1.011
Medicare
0.653**
Uninsured
0.795
Private insurance (Reference)

16
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95% CI

[1.141, 1.666]
[0.922, 1.358]
[1.011, 1.025]
[1.003, 1.062]
[1.246, 2.015]

[0.802, 1.275]
[0.544, 0.785]
[0.431, 1.467]
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(Table 16: Continued)
Variable
Quartiles of median household
income in patient’s zip code
Quartile 1 (lowest income)
Quartile 2
Quartile 3
Quartile 4 (Reference)
Hospital-level
Percentage of breast cancer patients
Bed size/10
Total margin
Racial/ethnic mix
Medicaid mix
Ownership
Not-for- profit
Non-federal public
For profit (Reference)
Teaching status
Teaching
Non-teaching (Reference)
Market-level
Competition (1/HHI)
Plastic surgeons/100 population
Urbanicity
UIC1 (most urban) (Reference)
UIC2
UIC3
UIC4 (most rural)
State
Arizona
Florida
Kentucky
Maryland
North Carolina
New Jersey
New York
Washington
California (Reference)
Intercept

Odds Ratio

95% CI

1.219*
1.255**
1.005

[1.008, 1,473]
[1.064, 1.480]
[0.877, 1.152]

1.019
1.001
1.000
0.992
1.006

[0.992, 1.046]
[0.995, 1.008]
[0.993, 1.007]
[0.983, 1.000]
[0.995, 1.016]

2.144**
3.576**

[1.277, 3.599]
[1.859, 6.882]

1.150

[0.850, 1.557]

1.009
2.643**

[0.989, 1.030]
[1.284, 5.440]

0.778
1.847
0.171

[0.510, 1.187]
[0.525, 6.491]
[0.007, 4.388]

0.671
1.017
2.148
2.178
1.969
3.190**
1.478
1.598

[0.290, 1.550]
[0.580, 1.783]
[0.741, 6.232]
[0.975, 4.866]
[0.882, 4.393]
[1.630, 6.245]
[0.841, 2.598]
[0.633, 4.032]

0.167*

[0.074, 0.375]

Note: CI=Confidence Interval. * represents p-value less than 0.05 whereas ** represents p-value less than 0.01.

As can be seen from Table 16, Black patients have 38% higher likelihood of receiving
AR than Whites, all else being equal. The likelihood of AR for Hispanic patients are not
significantly different than those for Whites. A one year increase in a patient’s age is associated
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with 1.7% higher likelihood of receiving AR, all else being equal. A one unit increase in
Charlson comorbidity score is associated with 3% higher likelihood of receiving AR, all else
being equal. Compared to non-obese patients, obese patients have 58% higher likelihood of
receiving AR. Compared to patients with private insurance, Medicare patients have 35% lower
likelihood of receiving AR, all else being equal. Lastly, compared to patients who reside in zip
codes with the highest quartile of median household income (fourth quartile), patients residing in
zip codes with the lowest quartile (first quartile) and second quartile have 22% and 25% higher
likelihood respectively of receiving AR, all else being equal.
Ownership of the hospital and density of plastic surgeons in the market are the only
hospital and market-level variables significantly associated with receipt of AR. Patients
receiving a reconstruction at hospitals that are not-for-profit have more than 100% higher
likelihood of receiving AR compared to the patients receiving a reconstruction at for-profit
hospitals, all else being equal. Similarly, patients receiving a reconstruction at public hospitals
have more than 200% higher likelihood of receiving AR compared to the patients receiving a
reconstruction at for-profit hospitals, all else being equal. For market variables, a one unit
increase in number of plastic surgeons per 100 total population in the market where patient
receives reconstruction is associated with nearly 100% higher likelihood of receiving AR, all else
being equal. Next, significant interactions between race/ethnicity and hospital and market
variables are presented in Table 17.
For the White-Black model, the interaction between Black race and urbanicity of the
market is significant. Although the probability of receipt of AR for both Blacks and Whites is
lower in small metropolitan markets (UIC2) than large metropolitan markets (UIC1), the

116

117
Table 17
Additional Analysis-Mixed Effects Logistic Regression with Interaction Terms

17

Variable
Patient-level
Race and ethnicity
Black race
Hispanic ethnicity
White (Reference)
Market-level
Competition
Urbanicity
UIC2
UIC1 (Reference)
Interaction between
Black/Hispanic and
market variables
Competition
UIC2

White-Black sample
Coefficient 95% CI

0.391

White-Hispanic sample
Coefficient
95% CI

[−0.155, 0.937]
−0.446

[−1.126, 0.234]

0.003

[−0.019, 0.025]

−0.265

[−0.623, 0.092]

−0.250

[−0.604, 0.105]

−0.387*

[−0.717, −0.057]

−0.007*
−0.490**

[−0.014, 0.001]
[−0.959, −0.021]

Note: CI=Confidence Interval. * represents p-value less than 0.05 whereas ** represents p-value less than 0.01.

decrease in probability for Blacks is greater than for Whites. Thus, White-Black differences in
receipt of AR in small metropolitan markets (UIC2) are narrower than those in large
metropolitan markets (UIC1).
For the White-Hispanic model, the interactions between Hispanic ethnicity, and
competition and urbanicity are significant. Although the probability of receipt of AR decreases
for both Hispanics and Whites with increasing competition in the market, the decrease in
probability for Hispanics is greater than for Whites. Thus, White-Hispanic differences in receipt
of AR within the hospital widen as the competition in the market increases from the 1st percentile
to the 90th percentile. Similarly, although the probability of receipt of AR for both Hispanics and
Whites is lower in small metropolitan markets (UIC2) than large metropolitan markets (UIC1),
the decrease in probability for Hispanics is greater than for Whites. Thus, White-Hispanic
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differences in receipt of AR in small metropolitan markets (UIC2) are significantly wider than
those in large metropolitan markets (UIC1). Thus, competition and small metropolitan (UIC2)
status of the market moderate the relationship between Hispanic ethnicity and receipt of AR.
The decomposition results for this additional analyses are conducted separately for the
White-Black sample and the White-Hispanic sample. The results for the White-Black sample are
presented first. The White-Black difference in receipt of AR is −0.081 which means that Black
patients have 8.1 percentage points higher predicted probability of receiving AR than White
patients. The proportion of the total White-Black difference/gap in receipt of AR explained by
White-Black differences in independent variables is found to be −0.035 (43% of the total
difference). The total difference and explained component have a negative sign since Black
patients have higher likelihood than White patients of receiving AR. Since this is the first study
analyzing factors associated with racial and ethnic differences, the contribution of age for this
analyses is not excluded in order to understand the contribution of all factors including age.
Table 18 presents the decomposition coefficients, standard error and % contribution to explained
component for variables that significantly contributed to racial differences in receipt of AR. A
negative sign on the decomposition coefficients indicates that these variables contribute to
increasing the White-Black gap either by contributing to increasing the likelihood of AR for
Black patients or decreasing the likelihood of AR for White patients.
Black patients are more likely to be obese and obesity is associated with higher likelihood
of receipt of AR. This contributes to increasing the explained component of White-Black
differences in receipt of AR by 13.69%. White patients are more likely to be Medicare-insured
and being Medicare-insured is associated with lower likelihood of receipt of AR. This
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Table 18
Additional Analysis-Decomposition Results for the White-Black Sample

18

Variable
Patient-level
Obesity
Insurance
Medicare
Private insurance (Reference)
Hospital-level
Bed size/10
Ownership
Non-federal public
For profit (Reference)
Teaching status
Market-level
Plastic surgeons/100 population
State

Decomposition Standard
coefficient
Error

% contribution to
explained component

−0.005**

0.001

13.619

−0.001**

0.000

4.134

−0.002*

0.001

6.056

−0.006**

0.002

16.153

−0.005**

0.001

14.718

−0.003**
−0.018**

0.001
0.003

9.245
51.876

Note: * represents p-value less than 0.05 whereas ** represents p-value less than 0.01.

contributes to increasing the explained component of White-Black differences in receipt of AR
by 4.1%.
In terms of hospital characteristics, Black patients are more likely than White patients to
receive a reconstruction at hospitals with higher bed size. This contributes to increasing the
explained component of White-Black differences in receipt of AR by 6%. Similarly, Black
patients are more likely than White patients to receive a reconstruction at public hospitals and
teaching hospitals which contributes to increasing the explained component of BlackWhite
differences in receipt of AR by 16% and 15% respectively. Black patients are more likely than
White patients to receive a reconstruction in markets with a higher density of plastic surgeons
which contributes to increasing the explained component of White-Black differences in receipt
of AR by 9%. Lastly, the distribution of Black and White patients across states contributes to
increasing the explained component of BlackWhite differences in receipt of AR by 52%.
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Next, the decomposition results for the White-Hispanic sample are presented. The WhiteHispanic difference in receipt of AR is 0.051 which means that Hispanic patients have 5.1
percentage points lower predicted probability of receiving AR than White patients. The
proportion of the total White-Hispanic difference/gap in receipt of AR explained by WhiteHispanic differences in independent variables is found to be 0.038 (75% of the total difference).
The total difference and explained component have a positive sign since Hispanic patients have
lower likelihood than White patients of receiving AR. Table 19 presents the decomposition
coefficients, standard error and % contribution to explained component for variables that
significantly contributed to ethnic differences in receipt of AR. A positive sign on the
decomposition coeffiecients indicates that these variables contribute to increasing the WhiteHispanic gap either by contributing to increasing the likelihood of AR for White patients or
decreasing the likelihood of AR for Hispanic patients.
Table 19
Additional Analysis-Decomposition Results for the White-Hispanic Sample
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Variable
Patient-level
Age
Insurance
Medicare
Private insurance (Reference)
Hospital-level
Bed size/10
Ownership
Non-federal public
For profit (Reference)
Teaching status
Market-level
Plastic surgeons/100 population
State

Decomposition
coefficient

Standard % contribution to
Error
explained component

0.007**

0.002

18.492

−0.002**

0.001

−4.088

−0.001*

0.001

−2.899

−0.004**

0.001

−10.153

0.003**

0.001

6.524

−0.002**
0.032**

0.001
0.003

−5.708
82.763

Note: * represents p-value less than 0.05 whereas ** represents p-value less than 0.01.
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Hispanic patients are more likely to be younger. However, higher age is associated with
higher likelihood of receipt of AR. This contributes to increasing the explained component of
White-Hispanic difference in receipt of AR by 18.5%. White patients are more likely to be
Medicare-insured and being Medicare-insured is associated with lower likelihood of receipt of
AR. This contributes to decreasing the explained component of White-Hispanic difference in
receipt of AR by 4.1%.
In terms of hospital characteristics, Hispanic patients are more likely than White patients
to receive a reconstruction at hospitals with higher bed size. This contributes to decreasing the
explained component of White-Hispanic difference in receipt of AR by 3%. Similarly, Hispanic
patients are more likely than White patients to receive a reconstruction at public hospitals.
Patients receiving reconstruction at public hospitals have higher likelihood of receivng AR. This
contributes to decreasing the explained component of White-Hispanic difference in receipt of AR
by 10%. On the other hand, Hispanic patients are less likely than White patients to receive a
reconstruction at teaching hospitals. This contributes to increasing the explained component of
White-Hispanic difference in receipt of AR by 6.5%. Hispanic patients are more likely than
White patients to receive a reconstruction in markets with a higher density of plastic surgeons.
This contributes to decreasing the explained component of White-Hispanic differences in receipt
of AR by 6%. Lastly, the distribution of Hispanic and White patients across states contributes to
increasing the explained component of White-Hispanic differences in receipt of AR by 83%.
Overall Summary of Results
This chapter began with descriptive statistics followed by empirical analyses for the three
research questions. This is followed by results for sensitivity analyses and additional analyses.
The descriptive statistics indicate that Black and Hispanic women in the sample are less likely to
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receive IBRS than White women. Additionally, Black and Hispanic women have significantly
different patient-level characteristics than White women. Black and Hispanic women are more
likely to be younger, have higher comorbidities, be obese (Blacks only), be Medicaid-insured or
be uninsured, and reside in low-income neighborhoods than White women. Racial and ethnic
differences in receipt of IBRS persisted even after controlling for clinical characteristics such as
age, comorbidities and obesity in the patient-level logistic regression. These results are similar
for both the sensitivity analyses.
Black and Hispanic women receive care at hospitals with significantly different
characteristics than the hospitals where White women receive care. The descriptive statistics
show that Black and Hispanic women are more likely to receive a mastectomy at hospitals with
for-profit or public ownership, higher bed size but fewer breast cancer patients, higher racial and
ethnic mix and higher Medicaid mix with a smaller total margin than White women. Black and
Hispanic women are also more likely to receive a mastectomy at hospitals located in urban
markets with higher competition than White women. The descriptive statistics results are similar
for both the sensitivity analyses.
In order to address research question 1, a mixed effects logistic regression model is used
to examine the hospital and market-level variables associated with receipt of IBRS after
controlling for patient characteristics. The results of this empirical analyses show that higher bed
size, lower racial and ethnic mix, not-for-profit ownership, teaching status, higher market
concentration, higher density of plastic surgeons in the market, and large metropolitan status of
the market are all significantly associated with higher likelihood of receipt of IBRS.
In the sensitivity analyses, after excluding hospitals that did not provide any breast
reconstruction between 2010 and 2012, racial/ethnic mix of the hospital where mastectomy is

122

123
received is the only hospital-level variable significantly associated with receipt of IBRS whereas
density of plastic surgeons and urbanicity are the market-level variables associated with receipt
of IBRS. In the second sensitivity analyses where Black and Hispanic women are combined into
one minority group, the results of the mixed effects logistic regression model are similar to the
original analysis.
In order to address research question 2, mixed effects logistic regression models with
interactions between race/ethnicity and hospital and market variables are used to examine
whether hospital and market variables moderated the relationship between race/ethnicity and
receipt of IBRS. The results from the White-Black model show that hospitals with higher racial
mix have a larger White-Black gap in receipt of IBRS whereas hospitals with higher Medicaid
mix have a smaller White-Black gap in receipt of IBRS. Similarly, markets with higher density
of plastic surgeons have a larger White-Black gap in receipt of IBRS. Results from the WhiteHispanic model show that markets with a higher density of plastic surgeons have a larger WhiteHispanic gap in receipt of IBRS. Additionally, small metropolitan markets and markets with
higher competition have a larger White-Hispanic gap in receipt of IBRS. After excluding
hospitals that did not provide any breast reconstruction between 2010 and 2012 in the sensitivity
analyses, the results of the mixed effects multilevel logistic regression models with interactions
between race/ethnicity and hospital and market variables are similar to the original analysis with
one exception: the interaction between Black race and Medicaid mix is no longer significant.
In the second sensitivity analyses after combining Black and Hispanic women into one
minority group, the interaction terms between the combined minority group and racial/ethnic mix
of the hospital, density of plastic surgeons in the market and urbanicity of the market are
significant. The results from the White-minority model show that hospitals with higher
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racial/ethnic mix have a larger White-minority gap in receipt of IBRS. Similarly, small
metropolitan markets with higher density of plastic surgeons have a larger White-minority gap in
receipt of IBRS.
In order to address research question 3, decomposition analyses are used to examine the
patient-level, hospital-level and market-level variables that contribute to racial and ethnic
differences in receipt of IBRS. The results show that racial and ethnic differences in type of
insurance and median household income of residential zip codes are the largest contributors to
racial and ethnic differences in receipt of IBRS at the patient-level. At the hospital-level, a racial
and ethnic difference in the racial/ethnic mix of the hospital where mastectomy is received is the
largest contributor to racial and ethnic differences in receipt of IBRS. Additionally, racial and
ethnic differences in total margin and ownership of the hospital where mastectomy is received
also contribute to racial and ethnic differences in receipt of IBRS. On the other hand, racial and
ethnic differences in the bed size of the hospital where mastectomy is received, market
competition, density of plastic surgeons in the market and urbanicity of the market contribute
towards reducing the racial and ethnic differences in receipt of IBRS for Blacks and Hispanics.
Lastly, distribution of Black patients across states contributes towards decreasing the WhiteBlack difference in receipt of IBRS. These results are similar for the sensitivity analyses where
hospitals that did not provide any reconstruction between 2010 and 2012 are excluded. The only
notable difference is that racial difference in the Medicaid mix of the hospital where mastectomy
is received contributes significantly to the racial difference in receipt of IBRS in the sensitivity
analyses. The results are similar to the original analyses for the sensitivity analyses where Black
and Hispanic women are combined into one minority category.

124

125
In the additional analyses for type of breast reconstruction, Black women are more likely
to receive immediate autologous reconstruction (AR) and less likely to receive immediate
implant reconstruction (IR) than Whites whereas it is the opposite for Hispanic women. These
racial and ethnic differences persisted after controlling for clinical characteristics. Factors
associated with higher likelihood of AR and lower likelihood of IR are higher age, obesity,
higher clinical comorbidities, private insurance, residence in lower income neighborhoods, notfor-profit or public ownership of hospital where reconstruction is received and higher density of
plastic surgeons in the market where mastectomy is received.
For the additional analysis for type of reconstruction, the interaction between Black race
and urbanicity of the market is significant. Although the probability of receipt of AR for both
Blacks and Whites is lower in small metropolitan markets (UIC2) than large metropolitan
markets (UIC1), the decrease in probability for Blacks is greater than for Whites. Thus, WhiteBlack differences in receipt of AR in small metropolitan markets (UIC2) are narrower than those
in large metropolitan markets (UIC1). For the White-Hispanic model, the interactions between
Hispanic ethnicity, and competition and urbanicity are significant.
In the decomposition analysis for AR, White-Black differences in likelihood of obesity
and Medicaid insurance and White-Black differences in hospital and market characteristics
where reconstruction is received such as bed size, ownership, teaching status and density of
plastic surgeons in the market and the state in which the market is located contribute to
increasing the White-Black gap in receipt of AR either by increasing the likelihood of receipt of
AR for Blacks or decereasing it for Whites. On the other hand, White-Hispanic differences in
age, teaching status of the hospital where reconstruction is received and the state in which the
market is located contribute to increasing the White-Hispanic gap either by increasing the
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likelihood of receipt of AR for Whites or decereasing it for Hispanics. Whereas, White-Hispanic
differences in Medicare insurance, bed size and ownership of the hospital where reconstruction is
received and density of plastic surgeons in the market where reconstruction is received
contribute to decreasing the White-Hispanic gap in receipt of AR either by increasing the
likelihood of receipt of AR for Hispanics or decereasing it for Whites.
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Chapter 6: Discussion

Overview of Chapter Structure
This chapter begins with a summary of results of the empirical analyses presented in
Chapter 5 followed by the unique contribution of the study and implications of these results for
practice and policy. This is followed by a summary of results of the additional analyses and its
implications. The chapter concludes with a discussion regarding the limitations of this study and
avenues for further research.
Summary and Interpretation of Empirical Results
Research question 1.
Research question 1 is ‘Which characteristics of the hospital and hospital market where
mastectomy is received are associated with higher likelihood of receipt of immediate breast
reconstruction surgery (IBRS)?’ Hospital and market-level variables examined in this analysis
are derived using a conceptual framework based on Resource Dependence Theory and the
patient-level control variables are derived using a conceptual framework based on the Aday
Anderson healthcare utilization model. The analyses are conducted using a mixed effects logistic
regression model. Sensitivity analyses are performed after excluding hospitals that did not
provide any reconstruction services between 2010 and 2012. Another sensitivity analysis is
performed after combining Blacks and Hispanics into one minority category.
Table 20 presents the list of hypotheses for research question 1 and whether they are
supported in the empirical analysis and the sensitivity analysis after excluding hospitals that did
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Table 20
Summary of Results for Research Question 1

20

Hypothesis

Full
sample

1A: The higher the proportion of breast cancer patients
admitted by a hospital, the higher is the likelihood of
mastectomy patients receiving IBRS at the hospital.
1B: The higher the competition in a hospital’s market,
the higher is the likelihood of mastectomy patients
receiving IBRS at the hospital.
1C: The higher the number of beds in a hospital, the
higher is the likelihood of mastectomy patients
receiving IBRS at the hospital.
1D: The higher the total margin of a hospital, the
higher is the likelihood of mastectomy patients
receiving IBRS at the hospital.
1E: The higher the density of plastic surgeons in a
hospital’s market, the higher is the likelihood of
mastectomy patients receiving IBRS at the hospital.
1F: Patients receiving mastectomy at hospitals located
in urban counties are more likely to receive IBRS
compared to patient receiving mastectomy at hospitals
located in rural counties.
1G: The lower the proportion of Medicaid patients
admitted by a hospital, the higher is the likelihood of
mastectomy patients receiving IBRS at the hospital.
1H: The lower the proportion of racial and ethnic
minority patients (racial and ethnic mix) admitted by a
hospital, the higher is the likelihood of mastectomy
patients receiving IBRS at the hospital.
1I: Patients receiving mastectomy at teaching hospitals
are more likely to receive IBRS as compared to
patients receiving mastectomy at non-teaching
hospitals.
1J: Patients receiving mastectomy at not-for-profit
hospitals are more likely to receive IBRS compared to
patients receiving mastectomy at private investorowned for-profit hospitals.
1K: Patients receiving mastectomy at non-federal
public hospitals are more likely to receive IBRS
compared to patients receiving mastectomy at private
investor-owned for-profit hospitals.

Not
supported

Sample after excluding
hospitals that did not
provide any reconstruction
Not
Supported

Reverse
supported

Not
Supported
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Supported Not
Supported
Not
supported

Not
Supported

Supported Supported

Supported Supported

Not
supported

Not
Supported

Supported Supported

Supported Not
Supported

Supported Not
Supported

Not
supported

Not
Supported
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not provide any reconstruction services between 2010 and 2012. The results for the sensitivity
analyses after combining Blacks and Hispanics into one minority group are similar to those for
the full sample and hence, are not presented in Table 20.
Hospital-level variables associated with higher likelihood of receipt of IBRS are higher
bed size, lower proportion of racial and ethnic minority patients admitted by the hospital,
teaching status and not-for-profit ownership. Thus, hypotheses 1C, 1H, 1I and 1J are supported
whereas hypotheses 1A, 1D, 1G and 1K are not supported. Higher bed size and teaching status
are indicators of capital and labor resources (Banaszak-Holl et al., 1996). Since providing IBRS
services require capital and specialized labor, patients receiving a mastectomy at hospitals with a
higher bed size or teaching status have a higher likelihood of receiving IBRS. This finding is
similar to previous literature (In et al., 2013; Shippee et al., 2014). Patients receiving a
mastectomy at hospitals with a lower proportion of racial and ethnic minority patients have a
higher likelihood of receiving IBRS. A lower proportion of racial and ethnic minority patients
admitted by the hospital is associated with higher resources even after controlling for financial
performance and payer mix of the hospital (Hasnain-Wynia et al., 2007). Lastly, not-for-profit
ownership is also associated with access to capital and labor resources (Devereaux et al., 2002).
In addition, not-for-profit hospitals have a mission to provide services required by the
community (Eiland, 2015; Horwitz, 2005; Newhouse, 1970).
Market-level variables associated with higher likelihood of receipt of IBRS are lower
market competition, urbanicity and higher density of plastic surgeons in the market. Thus,
hypotheses 1E and 1F are supported whereas the results contradict hypothesis 1B. The results of
the empirical analyses show that lower, not higher, market competition is associated with higher
likelihood of receipt of IBRS. An explanation could be that hospitals in competitive markets are
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more likely to provide services that are more profitable (Cunningham, Bazzoli, & Katz, 2008).
Reconstruction surgeries are not considered to be profitable for the hospital and require
considerable capital and labor resources (Claudia R Albornoz et al., 2014). Hospitals prefer to
offer cosmetic surgeries which have higher margins than reconstruction surgeries with lower
profit margins (Krieger & Lee, 2004). Hospitals in concentrated markets may have more slack to
provide services such as IBRS which are more resource intensive and have lower financial
returns (A. M. Jones, 2012). The results also show that compared to patients who receive a
mastectomy in large metropolitan markets, patients receiving a mastectomy in small
metropolitan, micropolitan and rural markets have a lower likelihood of receiving IBRS. This
finding is similar to previous literature (Agarwal et al., 2011; Hershman et al., 2012; W. H.
Tseng et al., 2010). Hospitals located in large metropolitan regions have better access to capital
and labor resources (Hall & Owings, 2014; Weisgrau, 1995). Lastly, the results show that higher
density of plastic surgeons in the markets is associated with higher likelihood of receipt of IBRS.
This finding is similar to previous literature (Jagsi et al., 2014; Kaplan et al., 2011). Plastic
surgeons are the labor resource required by hospitals to provide IBRS services. A higher density
of plastic surgeons may ensure better access and shorter waiting times (Jagsi et al., 2014; Kaplan
et al., 2011). A higher density of plastic surgeons in the county also increases the likelihood of
breast surgeons referring their patients to plastic surgeons. Referrals to plastic surgeons are an
important determinant of receipt of IBRS in the literature (Preminger et al., 2012).
In the first sensitivity analysis, hospitals that do not offer any reconstruction services
between 2010 and 2012 are excluded. The purpose of this sensitivity analysis is to ascertain
whether the hospital and market-level variables included in the study only determine provision of
IBRS services or they also determine the likelihood of receiving IBRS in a hospital that provides
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these services. The second column of Table 20 presents only those variables that are significantly
associated with a hospital providing IBRS services whereas the variables that are significant in
both columns two and three are also associated with likelihood of receiving IBRS in a hospital
that offers it. The only hospital-level variable significant in both the columns is proportion of
racial and ethnic minority patients admitted by the hospital. This means that proportion of racial
and ethnic minority patients admitted by the hospital is associated not only with a hospital
providing IBRS services at all but also with the likelihood of a patient receiving IBRS in a
hospital that provides these services. This could be because hospitals serving a higher proportion
of racial and ethnic minorities have lower volume of breast reconstructions and poor surgical
outcomes (Breslin et al., 2009) which may discourage breast surgeons from recommending, and
patients from receiving IBRS. Additionally, hospitals that predominantly serve racial and ethnic
minority patients tend to have longer surgical wait times and this may dissuade patients from
receiving IBRS (Hsia et al., 2012). Thus, patients who wish to receive IBRS need to choose
hospitals not just based on whether they offer IBRS services but also based on other factors such
as volume of reconstructions performed, surgical outcomes and wait times. All the market-level
variables are significant in both the columns.
The two columns in Table 20 show the hospital and market characteristics associated
with provision of IBRS by a hospital and receipt of IBRS by patients in hospitals that provide
IBRS respectively. It is important to understand both of these factors so that policymakers can
not only focus on providing resources to certain hospitals to provide IBRS but also address the
issues that restrict patients from availing IBRS services where available.
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Research question 2.
Research question 2 is ‘Is the relationship between race/ethnicity and likelihood of
receipt of IBRS moderated by hospital and market characteristics?’ To address this research
question, interactions between race/ethnicity and hospital and market variables are added to the
model used to address research question 1. The results of research question 2 add to those of
research question 1 by examining the hospital and market variables that moderate the
relationship between race/ethnicity and receipt of IBRS. Table 21 presents the list of hospital and
market variables that significantly moderate the relationship between race/ethnicity and receipt
of IBRS along with the direction of the moderation effect in the original analyses and both the
sensitivity analyses. Negative moderation indicates that increasing the value of the hospital or
market variable (for continuous variables) or change in level as compared to the reference group
(for categorical and binary variables) increases the racial/ethnic gap in receipt of IBRS while the
reverse is true for positive moderation.
No a priori hypotheses are specified for research question 2. Only one previous study
examines interactions between Black race and hospital and market variables and found no
significant interactions between Black race and variables such as breast cancer surgery volume,
teaching status, National Cancer Institute designated cancer center status, disproportionate share
hospital status and urbanicity of the market in relation to receipt of IBRS (Onega et al., 2014).
The current study has a number of additional variables that were not included in Onega et al.
(2014) study.
White-Black sample.
In the White-Black sample, although, like Onega et al. (2014), most of the interaction terms are
not significant, three variables do have a significant moderating effect. Higher proportion of
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Table 21
Summary of Results for Research Question 2

21

Variable

Hospital-level
Percentage of breast
cancer patients
Bed size/10
Total margin
Racial/ethnic mix
Medicaid mix
Ownership
Not-for- profit
Non-federal public
For profit (Reference)
Teaching status
Market-level
Competition (1/HHI)
Plastic surgeons/100
population
Urbanicity
UIC1 (most urban)
(Reference)
UIC2
UIC3
UIC4 (most rural)

Full sample

WhiteBlack

WhiteHispanic

Sample after excluding
hospitals that do not
provide reconstruction
WhiteWhiteBlack
Hispanic

NS

NS

NS

NS

NS

NS
NS
Negatively
moderates
Positively
moderates

NS
NS
NS

NS
NS
NS

NS

NS
NS
Negatively
moderates
NS

NS

NS
NS
Negatively
moderates
NS

NS
NS

NS
NS

NS
NS

NS
NS

NS
NS

NS

NS

NS

NS

NS

NS

Negatively
moderates
Negatively
moderates

NS

Negatively
moderates
Negatively
moderates

NS

Negatively
moderates
NS
NS

NS

Negatively
moderates
NS
NS

Negatively
moderates
NS
NS

Negatively
moderates

NS
NS
NS

Negatively
moderates

NS
NS

Combined
minority
sample

Negatively
moderates

Note: NS represents coefficients of interaction terms that are not significant at p-value<0.05

racial and ethnic minority patients admitted by the hospital and higher density of plastic surgeons
in the market negatively moderate the relationship between Black race and receipt of IBRS
whereas higher proportion of Medicaid patients admitted by the hospital positively moderates the
relationship between Black race and receipt of IBRS.
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A higher proportion of racial and ethnic minority patients admitted by the hospital and
density of plastic surgeons in the market negatively moderate the relationship between Black
race and receipt of IBRS—that is, the gap between White and Black reconstruction rates
increases. Hospitals with a high proportion of racial and ethnic minority patients are underresourced. They have nurse staffing shortages, inadequate budgets, lack of technical support
such as health information systems, and lack of capital (Hasnain-Wynia et al., 2007). Given the
under-resourced nature of these hospitals, they may find it difficult to provide culturally
competent care to racial and ethnic minority patients since such services require resources
(Weech-Maldonado et al., 2012). Cultural competency is the ability of health care institutions to
effectively deliver health care services that meet the social, cultural, and linguistic needs of
patients (Weech-Maldonado et al., 2012).On the other hand, hospitals with higher Medicaid mix
have a narrower White-Black gap in receipt of IBRS. Hospitals with a high Medicaid mix are
more likely to be disproportionate share hospitals (DSH) (Mitchell, 2013). DSH have better
political representation and higher access to resources which may enable them to provide
culturally competent care to Black patients (Moy, Valente Jr, Levin, & Griner, 1996). It could
also be that hospitals with a high Medicaid mix are located in more racially segregated areas
where there may be greater social support and information networks for Black patients (Darrell J
Gaskin & Hadley, 1999). These support mechanisms may encourage Black patients to be more
involved in their care and demand reconstruction services.
At the market-level, markets with higher density of plastic surgeons have a wider WhiteBlack gap in receipt of IBRS. While density of plastic surgeons is associated with increased
likelihood of receipt of IBRS, racial and ethnic minority patients may be unable to enjoy the
benefits of higher density of plastic surgeons. According to Greenberg et al. (2008), this could be
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due to racial/ethnic differences in referral to a plastic surgeon, quality of communication between
patient and breast surgeon or patient and plastic surgeon (Caprice C. Greenberg et al., 2008).
92% of patients who are referred to a plastic surgeon receive IBRS (Preminger et al., 2012).
However, breast surgeons are less likely to refer Black patients to plastic surgeons than White
patients (J. F. Tseng et al., 2004). Even if minority patients are referred to plastic surgeons, the
quality of that communication may not be the same as with a White patient due to cultural or
language barriers or due to provider biases (Bird & Bogart, 2000; Gordon, Street Jr, Sharf, Kelly,
& Souchek, 2006; Johnson, Roter, Powe, & Cooper, 2004; Keating, Weeks, Borbas, &
Guadagnoli, 2003). Another explanation could be that racial and ethnic minorities are
underrepresented among the plastic surgery workforce in United States (Silvestre, Serletti, &
Chang, 2016). Studies show that minority physicians provide culturally competent care
(Komaromy et al., 1996) and lack of minority plastic surgeons may be affecting the provision of
culturally competent plastic surgery services to racial and ethnic minority patients. All of these
factors may explain the moderation effect of density of plastic surgeons in the market on the
relationship between race/ethnicity and receipt of IBRS.
The results after excluding hospitals that did not provide any reconstruction between
2010 and 2012 are largely similar with the exception that the interaction between proportion of
Medicaid patients admitted by the hospital and Black race is not significant in the sensitivity
analysis.
White-Hispanic sample.
For the White-Hispanic sample, higher proportion of racial and ethnic minority patients
admitted by the hospital, higher density of plastic surgeons and higher competition in the market
along with small metropolitan status of the market negatively moderate the relationship between

135

136
Hispanic ethnicity and receipt of IBRS. These results are similar to the sensitivity analyses after
excluding hospitals that did not provide any reconstruction between 2010 and 2012. Providing
culturally competent services requires resources (Weech-Maldonado et al., 2012) and hospitals
in highly competitive markets may be unable to divert their limited resources from providing
services which offer a competitive advantage to providing culturally competent care (Hadley,
Zuckerman, & Iezzoni, 1996). Markets located in small metropolitan areas have a larger WhiteHispanic gap as compared to markets in large metropolitan areas. Hospitals in large metropolitan
areas have better access to capital and labor resources as compared to small metropolitan areas
(Hall & Owings, 2014; Weisgrau, 1995). Hence, the lack of resources may hinder hospitals in
small metropolitan areas to provide culturally competent services. Additionally, Hispanic
patients are largely concentrated in the most urban markets and hospitals located in small
metropolitan regions may not have the experience to provide culturally competent care to
Hispanic patients. Lastly, in the combined White-minority sample, higher proportion of racial
and ethnic minority patients admitted by the hospital, higher density of plastic surgeons in the
market along with small metropolitan status of the market negatively moderate the relationship
between combined racial and ethnic minority status and receipt of IBRS.
The findings from Table 21 suggest that minority serving hospitals and hospitals located
in markets with high density of plastic surgeons provide disparate care for Black and Hispanic
patients. Thus, providing resources to such hospitals so they can offer IBRS services may not be
enough in order to ensure equitable access to IBRS for Black and Hispanic patients. In spite of
offering IBRS, these hospitals may have fewer providers who accept Medicaid and uninsured
patients, which may in turn lead to longer wait times for these patients. Longer wait times
combined with race/ethnicity based selection of patients for IBRS due to provider biases may
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explain the disparate likelihood of receiving IBRS for minorities at these hospitals. The disparate
care for minority patients could also be due to lack of resources and training for providing
culturally appropriate care in these hospitals.
Hospitals located in small metropolitan markets and markets with high competition
provide disparate care for Hispanic patients (and for combined minority sample only in small
metropolitan markets) but not for Black patients. The experience of Hispanic patients in the
health care system differs from Black patients since they face not only the cultural barriers faced
by Black patients but also language barriers. Although most hospitals provide interpreter services
to a certain extent, hospitals may be less likely to make investments towards strengthening
interpreter services if they are located in markets with fewer Hispanic patients as in small
metropolitan markets. In competitive markets, hospitals may be forced to divert their limited
resources towards providing services that generate higher revenue streams rather than
strengthening their interpreter services which may not yield any competitive advantage in the
short term. Thus, findings from table 21 suggest that Hispanic patients are at a greater risk for
receiving disparate care than Black patients in certain markets due to additional language
barriers.
Research question 3.
Research question 3 is ‘Which patient, hospital and market-level characteristics
contribute the most to the racial and ethnic differences in receipt of IBRS?’
At the patient-level, the results of the decomposition analysis show that racial and ethnic
differences in type of insurance (Racial and ethnic minorities are more often Medicaid insured)
and median household income in the zip code (Racial and ethnic minorities more often reside in
low income neighborhoods) are the largest contributors to the racial and ethnic difference in
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receipt of IBRS. Although IBRS is covered by Medicaid, Medicaid patients have a lower
awareness regarding availability and coverage of IBRS services. It could also be because of low
availability of plastic surgeons who accept Medicaid patients or it could be because breast
surgeons and/or plastic surgeons may not discuss IBRS with Medicaid patients given the low
Medicaid reimbursement for IBRS (Alderman, Atisha, et al., 2011; Alderman, Storey, et al.,
2009). Racial and ethnic minorities are disproportionally more likely to reside in lower income
neighborhoods. These neighborhoods concentrate poverty and lack of education. Patients
residing in these neighborhoods may not have the health literacy to seek IBRS, or may not have
access to plastic surgeons who accept Medicaid, or may be unable to afford the out of pocket
expenses of IBRS, or may be employed in jobs where it may not be possible for them to take
time away from work to recuperate from a complex and intensive IBRS surgery (D. J. Gaskin,
Dinwiddie, Chan, & McCleary, 2012; D. J. Gaskin et al., 2011). The results for the patient-level
variables are robust to the sensitivity analyses wherein hospitals that did not provide any
reconstruction services between 2010 and 2012 are excluded.
Among hospital characteristics, proportion of racial and ethnic minority patients admitted
by the hospital is the largest hospital-level contributor to increasing the racial and ethnic
difference in IBRS. Racial and ethnic minorities are disproportionately more likely to receive
care at hospitals with a high racial/ethnic mix. Such hospitals may be unable to access the
necessary capital and labor resources required for provision of IBRS services (Hasnain-Wynia et
al., 2007). This result is robust to the sensitivity analyses wherein hospitals that did not provide
any reconstruction services between 2010 and 2012 are excluded.
Racial and ethnic differences in other hospital-level characteristics such as total margin,
Medicaid mix and not-for-profit ownership also contribute to increasing racial and ethnic
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differences in receipt of IBRS to a lesser extent. Racial and ethnic minority patients often receive
care at under-resourced hospitals with low total margin and high Medicaid mix whereas they
don’t often receive a mastectomy at over-resourced not-for-profit hospitals. At the market-level,
racial and ethnic minority patients often receive a mastectomy in large metropolitan markets with
high competition and this contributes to decreasing the racial and ethnic differences in receipt of
IBRS.
Unique Contribution of the Study
This study makes several important contributions to the literature on factors associated
with receipt of immediate breast reconstruction surgery, especially for racial and ethnic
minorities. Previous research has focused largely on the association between patient
characteristics and receipt of IBRS. This study shows that hospital and market characteristics are
also related to receipt of IBRS. Not only does this study support the evidence regarding
existence of racial and ethnic differences in receipt of IBRS, but also adds to this literature by
showing the hospital and market factors that moderate the relationship between race/ethnicity
and receipt of IBRS. Additionally, the results of this study also show that characteristics of the
hospital and market where racial and ethnic minority patient receive care contribute to the racial
and ethnic gap in receipt of IBRS. Understanding how hospital and market characteristics
influence the receipt of IBRS among racial and ethnic minority patients offer implications for
policy and practice.
Implications for Policy and Practice
The results of this study offer multiple implications for policy and practice. The results
add to the evidence regarding racial and ethnic differences in receipt of IBRS. It is important for
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patients, surgeons, practitioners and policy makers to be aware that this is an important issue and
that steps need to be taken at multiple levels to mitigate these differences.
Research Question 1.
First, because certain hospital and market characteristics are associated with higher
likelihood of receipt of IBRS, directing patients who wish to receive reconstruction to the
hospitals where they have a higher likelihood of receipt of IBRS is important. However,
directing patients to the hospitals where they have a higher likelihood of receipt of IBRS may be
difficult due to certain access limitations faced by vulnerable racial and ethnic minority patients.
In such cases, it is important to ensure that the hospitals where racial and ethnic minority patients
are most likely to receive care can offer these services to them. Racial and ethnic minority
patients are more likely to receive a mastectomy at hospitals that predominantly serve racial and
ethnic minority patients and Medicaid insured patients. However, such hospitals typically have
poor access to capital and labor resources and, thus, may not have the resources to provide IBRS,
which is not considered to be a profitable service.
Policy makers need to focus their efforts on improving availability of resources for
hospitals that predominantly serve vulnerable patients in order to improve delivery and quality of
IBRS services. In order to do so, it is important to understand the structural constraints faced by
hospitals in providing complex care services such as IBRS. Understanding the structural
constraints will help policy makers design innovative value-based payment models that
incentivize hospitals in a way that helps them address these structural constraints (Lewis, Fraze,
Fisher, Shortell, & Colla, 2017). While many minority-serving hospitals are also
disproportionate share hospitals and receive DSH payments, it is important to note that reduction
in DSH payments under health reform may further affect the ability of these hospitals to provide
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complex IBRS services (Lasser et al., 2016). Another option to lower the cost of providing IBRS
services is to establish breast reconstruction centers of excellence where a higher volume of
IBRS services can be concentrated and economies of scale can be achieved to reduce costs
(Alderman, Storey, et al., 2009). Lastly, in order to ensure availability of plastic surgeons who
accept Medicaid patients, hospitals need to incentivize plastic surgeons by increasing their share
of the reimbursement. Aldermen et al. (2009) found that hospitals receive a higher financial
margin for providing IBRS services to Medicaid patients due to facility charges alone as
compared to plastic surgeons who receive a comparatively lower financial margin for providing
IBRS (Alderman, Storey, et al., 2009). Thus, in order to ensure provision of IBRS services to
Medicaid patients within their hospitals, hospital administrators may need to revisit the payment
arrangements with the plastic surgeons.
Research Question 2.
Certain hospital and market characteristics negatively moderate the relationship between
race/ethnicity and receipt of IBRS. Blacks and Hispanics are disproportionately less likely than
Whites to receive IBRS at minority serving hospitals and hospitals located in markets with
higher density of plastic surgeons. Providing culturally competent care has been proposed as a
way to mitigate racial and ethnic difference in care. Griffith et al. (2007) identify cultural
competency as an important tool to reduce institutional racism (Griffith et al., 2007). Cultural
competency allows health care institutions to provide services that are socially and culturally
appropriate for racial and ethnic minority patients. Cultural competency includes training
providers to recognize, acknowledge and address their implicit biases towards patients of racial
and ethnic minorities. Weech-Maldonado et al. (2012) argue that providing culturally competent
care requires resources and hospitals with better access to resources will be able to provide
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culturally competent care. Thus, it is important to ensure that hospitals where racial and ethnic
minorities are disproportionately less likely to receive IBRS have the knowledge and resources
to provide culturally competent care in order to mitigate racial and ethnic differences in receipt
of IBRS. Diversifying the plastic surgery workforce in order to increase the numbers of minority
plastic surgeons is another long-term strategy to address cultural discordance between patients
and providers (Silvestre, Serletti, & Chang, 2017).
In addition, Hispanic patients are disproportionately less likely than Whites to receive
IBRS at hospitals located in competitive markets and hospitals located in small metropolitan
markets. In addition to cultural barriers faced by all minority patients, Hispanic patients also face
significant language barriers. Hospitals located in competitive and small metropolitan markets
may not have access to resources to provide interpreter services. While states are not obligated to
reimburse hospitals for the cost of language services, states do have the option of claiming
Medicaid and/or the State Children's Health Insurance Program (SCHIP) reimbursement for the
cost of interpreting services, either as an administrative expense or optional covered service.
However, currently only 15 states directly reimburse providers for language services under
Medicaid. States like Arizona, California and Florida included in this study that have a high
proportion of Hispanic patients do not offer direct reimbursement for language services to their
providers (Youdelman, 2007). Policymakers in these states should focus on seeking federal
matching to provide reimbursement for language services under public programs. It is also
important to make hospital administrators aware of the costs arising due to inadequate care in
absence of interpreter services in order to make a case for providing interpreter services even in
the absence of third party reimbursement (Timmins, 2002).
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Research Question 3.
Patient-level factors.
The results of the decomposition suggest that although certain hospital and marketcharacteristics are important contributors, patient-level factors such as type of insurance and
income are the largest contributors to racial and ethnic differences in receipt of IBRS. Black and
Hispanic patients are more often Medicaid insured than Whites. This explains nearly 30 to 40%
of the racial and ethnic gap in receipt of IBRS. Although Medicaid offers coverage for IBRS, the
reimbursements provided by Medicaid are very low compared to Medicare or private insurance
(Alderman, Storey, et al., 2009). Thus, plastic surgeons are less likely to accept Medicaid
patients for IBRS (Alderman, Atisha, et al., 2011). Additionally, Medicaid patients are often
unaware that Medicaid provides coverage for IBRS (Shippee et al., 2014). Thus, Medicaid
patients may not initiate the discussion regarding IBRS with their surgeon. Thus, it is important
to raise awareness regarding IBRS coverage among Medicaid patients. Several states such as
New York and Texas mandate breast surgeons to discuss breast reconstruction with patients and
offer a referral to a plastic surgeon. Expanding such policies to other states under the recently
passed Breast Cancer Patient Education Act of 2015 is another way to increase awareness of
IBRS among Medicaid patients. It is necessary to ensure that these mandates are enacted across
hospitals and providers. Given that Medicaid reimbursement for IBRS is very low and dissuades
plastic surgeons from accepting Medicaid payments, increasing the Medicaid reimbursement for
IBRS may be a potential area of focus for policy makers.
Another patient-level factor that contributes nearly 30-40% to racial and ethnic
differences in receipt of IBRS is income. Although the Women’s Health Care Right Act of 1998
mandates insurance providers to offer coverage for IBRS, certain states such as Florida have
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enacted riders that allow insurance companies to impose additional out-of-pocket costs for
patients (Centers for Disease Control and Prevention, 2000). Thus, reducing out-of-pocket
expenditures for IBRS can be another focus area for policymakers. Some ways to implement this
may be restricting states like Florida from imposing riders that permit insurance companies to
impose additional out-of-pocket costs for IBRS. Another option may be to offer subsidies to
cover out-of-pocket expenses for IBRS services to low income women via public programs or
grants. Lastly, private insurers should ensure that they have plastic surgeons that provide breast
reconstruction within their network. Women residing in certain regions in the country may not
have access to IBRS services by in-network providers and may be forced to pay higher out-ofpocket costs to receive IBRS by an out-of-network provider (Nance-Nash, 2011).
Hospital and market-level factors.
Of all the place of care factors included in the model, receiving care at hospitals that
predominantly serve racial and ethnic minorities i.e. minority serving hospitals contribute the
most to the racial and ethnic gap in receipt of IBRS (32% to the White-Black gap and 26% to the
White-Hispanic gap). Thus, hospital managers and policy makers need to focus on these
hospitals. There may be several avenues for intervention. The first would be training breast
surgeons in these hospitals to discuss reconstruction with their patients. The second avenue for
intervention is to provide cultural competency training to surgeons and other staff so that there
are no language or cultural barriers to receiving IBRS. Another issue with minority serving
hospitals is that they are usually associated with poor access to resources so providing these
hospitals with the required capital and labor resources through innovative payment models is
another potential are of focus for policy makers. Lastly, if these hospitals are unable to provide
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these services, there is a need for strengthening referral networks to plastic surgeons in the
community or other hospitals.
Additional Analyses for Type of Reconstruction
Not much is known about the factors associated with receipt of immediate autologous
reconstruction (AR) vs immediate implant reconstruction (IR). This study addresses this gap by
examining the factors associated with receipt of AR. This study specifically focuses on the
relationship between race/ethnicity and receipt of AR including factors that modify this
relationship and factors that contribute to the racial and ethnic differences in receipt of AR.
Although this is not the main finding of this study, these additional analyses provide a baseline
exploration which can help guide future research in this area.
The results of the additional analysis examining factors associated with receipt of AR
show that Black race, older age, higher clinical comorbidity score, obesity and residing in low
income neighborhoods are patient-level variables associated with higher likelihood of receipt of
AR. The result for the relationship between Black race and receipt of AR is similar to the results
found by Alderman et al. (2003) and Offodile et al. (2015). The result for the relationship
between income and receipt of AR is similar to the results found by Jagsi et al. (2014). None of
the other patient-level variables included in the study were previously examined in relation to
receipt of AR. Hospital and market-level variables associated with receipt of AR are not-forprofit and public ownership, and density of plastic surgeons in the market. The result for the
relationship between density of plastic surgeons in the market and receipt of AR is similar to that
found by Jagsi et al. (2014).
The results from the interaction model show that Black and Hispanics are
disproportionately less likely than Whites to receive AR in small metropolitan markets than large
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metropolitan markets. These results are similar to those seen for IBRS. Lastly, decomposition
results show that higher incidence of obesity and receiving care at public, teaching hospitals in
markets with high density of plastic surgeons contributes to higher likelihood of AR for Black
patients. For Hispanic patients, receiving care at public, teaching hospitals in markets with high
density of plastic surgeons increases the likelihood of receiving AR whereas being younger and
receiving a reconstruction at non-teaching hospitals contributes to lower likelihood of receiving
AR. Thus, the results of this additional analyses show that Black patients are more likely
whereas Hispanic patients are less likely to receive AR. It is difficult to conclude whether these
racial and ethnic differences are driven by patient preferences or patient characteristics such as
obesity (obese women are usually recommended to have AR) or by place of care characteristics
such as public ownership, teaching status and higher plastic surgeon density. It is interesting to
note that type of insurance does not play a role in the type of reconstruction received despite
significant differences in reimbursement for AR vs IR by type of insurance (Alderman et al.,
2009). Thus, although low reimbursement by Medicaid may affect overall receipt of IBRS, it
does not affect receipt of AR specifically. There is no clear clinical consensus about preference
of AR over IR or vice versa since AR provides better aesthetic results but IR is a safer procedure
(Benditte-Klepetko, Lutgendorff, Kastenbauer, Deutinger, & van der Horst, 2014; Yueh et al.,
2010). Hence, this study does not provide any practice or policy implications of these results but
merely explores these relationships.
Limitations
This study has several limitations. The first limitation is the inability to control for
unobserved characteristics such as patient preferences and provider bias. IBRS is an elective
procedure and patient preference is one of the most important determinants of receiving this
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procedure. However, several studies suggest that patients who did not receive IBRS were not
given appropriate information regarding IBRS options and that these patients also suffer from
higher decisional regret after foregoing reconstructiom (Alderman, Hawley, et al., 2011). Thus,
even though IBRS is an elective procedure, it is important to understand factors that can increase
likelihood of receiving IBRS, especially for the vulnerable racial and ethnic minority patients.
Provider bias is another important unobserved factor since provider recommendation is an
important detreminant of receipt of IBRS (J. Y. Chen et al., 2009). It is expected that adding a
measure of provider bias would help explain a larger proportion of the White-minority difference
in receipt of IBRS.
The second limitation is the inability to control for observed characteristics such as grade
and stage of the tumor, patient income and referral to plastic surgeons due to the nature of the
data. Black patients are known to be diagnosed at a higher stage and grade of breast cancer.
Hence, the inability to control for these tumor characteristics may bias the results. Although
quartiles of median household at the zipcode level is included in this study as a proxy for patient
income, this measure is imprecise. Given that the zip code level income is a very significant
determinant of receipt of IBRS and a significantly large contributor to the racial and ethnic
differences in receipt of IBRS, it is important to include a more precise measure of patient
income. Lastly, since this study uses administrative data, there is no way to determine if the
breast surgeon referred the patient to a plastic surgeon since referral to a plastic surgeon is an
important step in receipt of IBRS.
The third limitation is using county to measure market-level effects since the county is a
larger geographical area and county-level average of hospital competition and plastic surgeon
availability may not apply to the immediate hospital environment. The fourth limitation is that
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the results may be biased due to high correlation between hospital-level variables such as racial
and ethnic mix and Medicaid mix and between market-level variables such as competition and
large metropolitan status of the market. The fifth limitation is the inability to observe delayed
breast reconstruction due to the nature of the data. Patients who receive delayed reconstruction
for any reason are combined with patients who do not receive any reconstruction. This may bias
the results of the analyses especially since racial and ethnic minority patients are more likely to
receive delayed reconstruction as compared to Whites (Alderman, Hawley, et al., 2011).
The sixth limitation is that the study is restricted to inpatient mastectomies while 20% of
all mastectomies are performed in the outpatient setting and this number is on the rise (Kruper et
al., 2013). White patients are disproportionately more likely to receive a mastectomy and IBRS
in an outpatient setting (Kruper et al., 2013). Excluding outpatient observations may therefore
underestimate the racial and ethnic difference in receipt of IBRS in this study. The seventh
limitation is the inability to account for the nested structure of the data in the decomposition
model since Fairlie command in Stata does not allow for a mixed effects model. Lastly, the
generalizability of the results of this study is limited since this study is restricted to a
convenience sample of 9 states and may not be generalizable to the entire country.
Implications for Future Research
This study opens up multiple avenues for future research. This study is retricted to
quantitive methods and a secondary, administrative dataset. Given that breast reconstruction is an
elective procedure that is primarily driven by shared decision making between the patient and the
provider, qualitative studies using primary data collection would yield insights to better
understand patients’ decision making process regarding breast reconstruction. Understanding the
decision making process of the patient will help practitioners and policy makers understand
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where efforts need to be targetted in order to incease receipt of IBRS. Additionally, individual
patient charts could be reviewed to find out if breast surgeons referred patients to plastic
surgeons and whether plastic surgeons recommended IBRS to patients. Qualitative studies are
also needed to understand patient decision making regarding the type of reconstruction received
i.e. autologous or implant reconstruction.
Future studies using claims datasets such as the SEER-Medicare may address certain
limitations of this study. Such datasets may allow for examination of delayed reconstructions and
outpatient reconstructions. It may also allow for inclusion of tumor characteristics in the
analysis. Using a finer measure of hospital markets such as zip codes or census tracts may also
help address the issue of using county to define markets. Using a nationally representative
dataset may help improve the generalizability of the findings of this study. Lastly, statistical
analyses that allow for estimating decomposition models that take into account the nested
structure of the data may help to reduce the bias in the results of this study.
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